Sunday, 29 March 2020

Asthma in Pregancy



Many a senior obstetricians have expressed concern by quoting that asthma is the   commonest chronic   medical illness to complicate   pregnancy, affecting up to  5-12%   of women of childbearing age. It is    often undiagnosed( due to lack of routine checkup)  and therefore often  may be undertreated  .The responsibility bestows on us  as pregnancy  provides an   opportunity   to  pick up new cases of asthma  (diagnosis of    asthma)  and to optimize   the treatment   of women   already known   to have asthma.
Clinical features: The commonest symp is dry cough.  This is followed by breathlessness (SOB= shortness of breath particularly in walking staircase –going to roof for domestic purposes) . 3)  Wheezy   breathing on auscultation. Symptoms are commonly worse   at night and in the early morning . There    may be some definite  clear provoking  trigger factors such as Pollen , pet dogs, cat,(Animal  dander  ) etc. Signs of B asthma   are often absent unless seen during an acute attack . Therefore some cases may be missed in first ANC vests and many women dont disclose more so if in-law is present  and accompany   her. As such many early preg cases with mild to moderate cases are missed. Another drawback of  ours is  though most physicians keep a pulse oximetry at their clinics obstetricians don’t .In acute stage however, we the obstetricians can diagnose  by  watching her a tendency to frequent  cough ,inability to complete sentence and observing  increased respiratory rate .Wheeze be heard at ANC visits , and as we can auscultate chest we can listen to rhonchus  . Bronchoconstriction is often intermittent and caused    by the following  smooth  muscle spam   in the airway       walls backed up by b) Inflammation with swelling  and excessive production of mucus . A hallmark of asthma    is variability and reversibility of the bronchoconstriction
How to confirm the diagnosis of B asthma?? At a specialized clinic (Resp Medicine specialists)  by spirometry the degree of bronchoconstriction can be  measured with  a PEFR or more preferably spirometry(TFT)  which  measures       FEV  and forced vital capacity  .Where     the history    suggests a high probability of asthma or the FEV   / FVC  ratio is  <0.7   a trial of  treatment is indicated.

When does SOB (shortness of breath ) exacerbate??  Ans;-A typical    feature is morning dipping in the peak   flow.  In fact a > 20 %   diurnal variation   in PEFR  for 3 or more days a week during    a 2 week PEFR diary   is diagnostic. During the first day spirometry (TFT) most of pulmologist often ask on report of FEV(forced exp volume) after administering  a B  sympathomimmetic bronchodilator to confirm nature & degree of reversibility. If there is greater    than 15%   improvement    in FEV   following    inhalation of a B  sympathomimmetic bronchodilator(salbutamol)  then the inference is B asthma. Another test which is not so commonly done is degree of fall in % of  FEV  following    6 minutes of exercise . This  degree of fall indicates  a asthma.
 
Not to stop Asthma medication in pregancy :What may be effects of  pregnancy on asthma: Asthma may improve, deteriorate or remain unchanged during pregnancy .A) Women   with only mild disease   are unlikely to experience problems.  B) But those    with severe asthma are at greater risk of deterioration particularly    late in pregnancy. But we as caregivers should remember that women whose symptoms    improve during the last    trimester of pregnancy may experience postnatal   deterioration. It is like thyroid storm or say  Postpartum thyroiditis
 Deterioration in disease control is commonly caused by reduction or even    complete cessation of medication   due to fears about its safety. Home      peak    flow monitoring and written   personalized self management plans   should be encouraged.


.


-        Drugs for   asthma in Pregancy :- The treatment    of asthma   in preganncy is essentially no different    from the treatment of   asthma including systemic steroids are safe    in pregancy and during   lactation.
-       The challenge in the management   of pregnant women   with asthma  is to ensure adequate  pre conception     or early  pregnancy   counseling    so  that women do nt stop  important  anti inflammatory inhaled  therapy .At the first vist after the diag is made about asthma by a pulmologist after Spirometry the pregnant women   should be advised that  their asthma is unlikely to adversely affect  their  pregnancy    and almost all drugs are safe , The benefit of drugs (mainly inhalers)  outweigh any risk to foetus . Moreover, maintaining good control of asthma throughout pregnancy      may   minimize    any added small risks. Another duty bestow on us .It is we,  who should always advice that      in the management   of asthma  it  is  the prevention    rather than the treatment is of paramount importance .All kinds of acute    attacks must be prevented by regular inhalers as prescribed by the pulmologist . The     aim of treatment is to achieve   virtual total freedom   from symptoms   such that the lifestyle of the individual is not affected.  Regrettably many women both I pregnancy period and at breast feeding time , they  accept   asthma as a common incurable diseases.   However, chronic  symptoms   such as wheezing or chest tightness on waking as an inevitable consequence of their disease  . This is    inappropriate and pregnancy provides    an ideal   opportunity to counsel such women    with asthma .:
1) Women    should be advised to stop smoking 2) No pets & regular  cleaning of bed sheets/ linens/avoid carpets/ cleansing  of house dusts/Care of mites /avoid pollens. Foods if she  has allergy. Explanation   and reassurance   regarding  the importance   and safety  of regular medication in pregnancy    is essential   to ensure  compliance.  Women with asthma should be encouraged to avoid known trigger factors
-        

How do we know that there is   complete control   of asthma?? Ans:- complete control   is defined as the absence    of 1) daytime symptoms 2)    night time awakening due to asthma 3) no  need for rescue medication   for  exacerbations  4) no limitation  on   activity   including exercise and  at clinic visits 5) normal FEV  or PEFR> 80 %  predicted.
It is   important     to check the woman’s   inhaler technique since failure to do this   may result in unnecessary escalation of therapy some women require    a breath actuated inhaler.
Mild     intermittent asthma is managed with inhaled short acting reliever   medication as required.
If usage   of a reliever inhaler exceeds three times per week regular inhaled anti inflammatory medication    with a steroid preventer inhaler   should be commenced
·    A) Short acting B agonist (salbutamol) : Brand name: LEVOLIN Inhaler (levo salbutamol). Such is B2   agonists if administered orally  then  via  the systemic circulation  salbutamol ingested  cross the placenta rapidly but very little of a given   inhaled dose      reaches the lungs and only a minute fraction of this   reaches   the systemic circulation  from inhaled Levo salbutamol
-       B) long acting    reliever    B  agonist    e.g.  salmenterol :These LABA=long acting Beta agonists . SALMETROL IS VAILABLE AS SEROBID. Brand TIOVA( Tiotropium Bromide) .Such are   salmenterol are  safe   in  pregnancy.  They   should not be discontinued    or withheld in those who require   them  for good asthma control

C) Steroid inhaler :- Use of both  inhaled and oral steroids is safe   in pregnancy . Only minimal amounts of inhaled corticosteroid preparations are systemically   absorbed.  Use of     a large   volume  spacer may improve   drug delivery and   is recommended   with  high doses of inhaled    steroid dosage   and if appropriate   given an emergency     supply of oral steroids .
-       There is no    evidence for an increased   incidence of   congenital   malformations or adverse fetal   effects   attributable to the use of inhaled beclomethasone or budesonide. Fluticasone propionate    is a longer acting   inhaled  corticosteroid  that may be  used for    used     for those requiring high   doses of   inhaled steroids

D)  Leukotriene receptor antagonist:-
E) Combination inhalers  of corticosteroids  plus  LABA for example  budesonide / for  moterol  and fluticasone / salmeterol  are widely   available     and may aid    compliance. One such example is Foracort which contains FORMOTTEROL & Budesonide .And another is Seroflow ( Salmeterol & Fluticasone) –Copal.  They also ensure   that the LABA is not taken    without inhaled  steroid   although   to increase   the dose   of inhaled   steroid   without   exceeding  the maximum    dose  of  LABA may   necessitate changing  the strength   of the inhaler    rather than asking    the patient   to take more puffs.
Steroids with short acting b agonists: These are Aerocort( Beclomethasone & salbutamol). AEROCRT SPRAY.


E)  Slow release   oral Theophylline
F) Oral B   agonist if fails   to achieve adequate    control by inhaler then salbutamol Tab(Asthalin, Salbetol, , Ventrolin   etc)  
G) Continuous   or frequent use   of oral    steroids becomes necessary. The lowest dose providing adequate    control should be used if necessary   with  steroid  sparing   agents . Prednisolone is   metabolized  by the placenta and very   little   active drug   reaches   the fetus. Although some   workers    have found   an increased incidence of   cleft palate with   first trimester    exposure    to steroids  this finding    is refuted in larger prospective case-   control   and database    linkage    studies. There is no evidence   of an    increased risk    of miscarriage. Stillbirth   other congenital   malformations or neonatal death  attributable to maternal    steroid therapy. There   is a non significant   increase in the relative risk of pre eclampsia    in women with    asthma treated with   oral but  not inhaled steroids . However  it is unclear  whether    this is an effect on  steroids or asthma control and severity. 
Although suppression   of the fetal    hypothalamic pituitary   adrenal    axis   is a theoretical    possibility     with  maternal systemic   steroid therapy there is little   evidence    from clinical   practice to support  this .
Long  term high dose   steroids may   increase the risk of preterm    rupture   of the membranes.
There are   concerns regarding    the potential   adverse    effects of steroid   exposure  in utero    and neurodevelopmental problems  in the child. It is   unlikely     that lower   doses of Prednisolone that does    not cross   the  placenta   as well as betamethasone or  dexamethasone will   have similar    adverse   effects.
Oral  steroids  will increase  the risk of infection gestational diabetes and   cause  deterioration in blood   glucose control in women with   established   diabetes   in pregnancy Blood   glucose   should be    checked  regularly the hyperglycaemia is amenable to treatment with diet       metformin  and if required     insulin and is  reversible    or  cessation or reduction   of steroid dose. The development   of hyperglycaemia   is not    an indication  to discontinue or decrease the dose of oral   steroids the    requirements for which     must be    determined by the asthma. Oral  steroids   for medical   disorders in the mother should  not be withheld   because    of pregnancy.
Other  therapies
It is important    to treat any   gastroesophageal reflux as this   can exacerbate    asthma .Studies show no different in perinatal   mortality    congenital malformations birthweight    . Apgar scores or delivery   complications when pregnant women with   asthma   treated   with inhaled B2  agonists are compared   with women  with     asthma   not using   B2   agonists and non asthmatic controls.
.
The addition       of systemic corticosteroids to control  exacerbations of asthma  is safe and these must not be withheld if current   medications are inadequate.
No   adverse fetal    effects have been    reported with the use of the   following   drugs
-       Inhaled  chromoglycates  nedocromil
-       Inhaled   anti cholinergic drugs
-       These  are no longer    recommended   as first line treatment    of asthma    but have  been  used extensively  in the past
-       No significant    association   has been demonstrated between major    congenital malformations or  adverse  perinatal  outcome and  exposure   to methylaxanthines.
-       In those   few women      who are    dependent   on Theophylline    , alterations in dose  should be guided by drug    levels. Both  Theophylline and    aminophylline readily cross the placenta   and fetal   Theophylline levels   are similar   to those of the  mother.
Leukotriene   receptor  antagonists
These agents      block   the effects  of cysteinyl leukotrienes   in the airways
Studies  do not    suggest any increased  risk of congenital malformation   or other adverse   outcomes with their use in pregnancy
If  leukotriene    antagonists   are required    to achieve adequate  control of asthma  then they should   not be withheld in pregnancy
Los dose    aspirin
It is  important   to consider   the possibility  of aspirin  sensitivity and  severe   bronchospasm  in a   minority of women   with   asthma .
Low dose    aspirin    is indicated in pregnancy as prophylaxis    for women at high risk of pre eclampsia   antiphospholipid syndrome or migraine prophylaxis
  Pregnant    women with   asthma should be asked about a history of aspirin    sensitivity   before   being  advised to take low dose aspirin and before   using non steroidal anti inflammatory drugs  for pain relief postpartum .
Intrapartum   management
Asthma   attacks in labour are   exceedingly rare because   of endogenous   steroid production. Women should    not discontinue their   inhalers   during labour    and there is   no evidence    to suggest   that B2   agonists   given via  the inhaled   route  impair   uterine  contraction   or delay  the onset of labour.  Women    receiving    oral steroids  should receive    parenteral hydrocortisone to cover the   stress of labour    and until oral   medication   is restarted. Prostaglandin E2 used  to induced labour    to ripen the cervix   and prostaglandin El    for termination     of preganncy or for treatment   or prevention   of     postpartum    hemorrhage   are bronchodilators and    are safe to use.
The use of    prostaglandin    F2a to treat    life threatening   postpartum   hemorrhage  may be   unavoidable   but it can    cause bronchospaem and should  be used    with  caution in  women    with asthma.


All  forms of pain relief in labour   including epidural   analgesia and Entomic can  be used  safely  by women with     asthma    although   in the unlikely  event of an acute   severe    asthmatic attack, opiates for pain    relief   should only  be used with extreme caution . Regional   rather  than  general   anesthesia is preferable   because   of the decreased  risk of chest   infection   and atelectasis.
Ergometrine has  been reported  to cause   bronchospasm in particular   in association   with general   anesthesia  but this    does not    seem to be  a practical problem    when Syntometrine    is used for the prophylaxis of  postpartum hemorrhages.
Restrictions during Breastfeeding is asthmatics??
The risk of   atopic   disease   developing   in the child of a woman with  asthma is about 1 in 10 or 1 in 3 if  both parents are   atopic. There  is some evidence   that breastfeeding may reduce  this risk . This  may be a result   of the delay  in the introduction  of cow’s  milk protein . All the drugs    discussed above  including   oral steroids , are  safe to use in  breastfeeding mothers. Prednisolone is   secreted in breast milk but   there have  been no reported   adverse clinical effects in infants   breastfed by mothers receiving  Prednisolone. Concerns regarding  neonatal  adrenal   function    are unwarranted with  doses  below 30 mg/day  
Effect  of asthma on pregnancy :For   most    women there   are no adverse effects of their asthma on pregnancy outcome. Severe    poorly controlled asthma   associated    with chronic or intermittent maternal hypoxemia may adversely affect   the fetus.
Acuter severe   asthma
Acuter  severe    attacks  of asthma  are dangerous    and should   be vigorously  managed  in hospital .
The treatment    is no different    from the emergency    management   of acute severe asthma    in th non pregnant patient
Women with severe asthma   and one or   more of the   following   adverse   psychosocial factors    are at risk   of death :
-       Psychiatric   illness
-       Drug    or alcohol   abuse
-       Unemployment
-       Denial
-       The features   of acute   severe   asthma are
-       PEFR  33% -50 %   best/  predicted
-       Respiratory     rat > 25 / min
-       Heart    rate > 110  / min
-       Inability to complete  sentences   in one breath
The   management    of acute severe   asthma should    include
-       High   flow oxygen
-       B2  agonists     administered    via a nebulizer driven  by oxygen.
-       B2  agonists    can be administered by repeated   activations of a metered dose    inhaler via  an appropriate large   volume  spacer. Repeated  doses  or continuous  nebulization   may be  indicated for those   with a poor   response. 
-       Nebulized  ipratropium   bromide   should be   added for   severe   or poorly responding   asthma.
-       Corticosteroids   
-       i.v.  rehydration   is often    appropriate
-       Chest X ray should  be   performed   if there is any clinical   suspicion   of pneumonia    or pneumothorax  or if th woman    fails  to improve.
-       IF  the PEFR does     not improve   to > 75 %  predicted   the woman    should be  admitted  to hospital   . If she is discharged this must be  with a course of oral   steroids  and arrangements  for review.
-       Steroids are more likely  to be withheld   from  pregnant than non  pregnant    women   with asthma    presenting    via emergency  departments  . This is inappropriate    and  leads  to an increase  in ongoing   exacerbation of asthma .
-       Life  threatening  clinical   features  are
-       PEFR  < 33%   predicted
-       Oxygen   saturation < 92% 
-       pO2 <8 kPa
-       Normal    or raised pCO2> 4.6kPa
-       Silent    chest   cyanosis   feeble  respiratory  effort  
-       Bradycardia arrhythmia hypotension
-       Exhaustion confusion   coma 
-       Management    of life   threatening   or acute severe asthma   that fails  to respond  should  involve   consultation with the critical care team and consideration  should   be give to
-       i.v. B2  agonists
-       i.v.  magnesium sulphate 1.2-2 g   infusion   over 20  minutes
-       i.v. aminophylline




Saturday, 28 March 2020

Intra uterinw contraceptives Copper T coil Contraceptives


Extract from my Bok:  for Group  members: CHAPTER – IV(Final)
Intrauterine Devices: Intrauterine contraceptives:
(Contraceptive Coil)
INDEX
   
Basics of IUDs – P, Type of IUD – P, Information on string of IUD – P, Brand names & Life span – P, Mode of Action – P, How soon become effective – P, Contraceptive efficacy – P, Users satisfaction & Continuation Rate – P, Advantages as contraceptive – P, Side effect and their management – P, Disadvantages as contraceptive – P, Candidacy for IUDs – P, Who criteria & Checklist – P, IUD & Timing of insertion – P, Insertion Procedure – P, Follow up – P, When to remove (Indications for removal) – P, Procedure of removal – P, Switching to some other method – P, Return of fertility – P, Complications, Health Risks & warring – P, Skill of HCP – P, Pill or IUD which one to choose – P, LNG IUS or copper beaing IUD – P, Conclusion – P, Further Reading – P, Webs – P.

The basics of IUDs:
An IUD (also called IUC) is a small ‘T-shaped’ flexible plastic device that is inserted inside the womb (uterus) through birth canal to avert pregnancy (Fig-1). It is the world’s most widely used reversible birth control method for women. The letters ‘IUD’ stands for “Intrauterine Device” and IUC is for intrauterine contraceptives. Both abbreviations are for the same device. The ‘contraceptive coil’ or ‘loops’ are just other names for the same contraceptive. Earlier it was used to be called as IUCD i.e. intrauterine contraceptive device. Globally the present abbreviation is IUD and only in some countries it is called IUC.
IUD is an easy, convenient, highly effective form of contraception that does not interfere with sexual spontaneity. Once introduced the IUD is immediately effective. It can also be used as emergency contraceptive i.e.  as after sex conceptive if the IUD is fitted within seven days of unprotected sex. The sooner the device is fitted after unprotected sex more will be the contraceptive efficacy.
Not all IUDs are alike. There are several types, and they come in different sizes and varying shapes. Like other drugs and devices there is long history of its evolution and hundreds of IUD have been tried in last two centuries. Readers will be surprised to know that the idea of putting some device inside the womb to prevent conception initiated with contraception camels. Camels frequently undergo long journey in the desert. To avoid pregnancy during this long voyage some pebbles (stone like material) used to be inserted in the womb of camel. Thus the camels did not fall sick in the voyage.
Basically there are two types of IUDs. One is copper impregnated IUDs which when fitted inside the womb release copper ions and other one is progesterone hormone containing IUDs which releases in sick the womb. It is the released copper or progesterone which effect contraception though plastic frame itself has some contraceptive effect. Copper bearing IUDs have proven the test of time and most popular form of IUD. In fact, there is a museum which exhibits over 300 IUD designed over two centuries collected from different countries.
Copper containing IUDs are the most inexpensive long-term reversible method of contraception. It can be removed at any time and fertility resumes within couple of months. The IUD requires no daily attention and this is the distinct advantage over contraceptive pills, or condom. The only responsibility of the acceptor is to confirm the placement of IUD after each menstrual period by feeling the thread of IUD which hangs in the upper part of birth canal. The thread is tied to the lowermost part of the device.
Like other contraceptives it has its own limitations and disadvantages. For instance, IUDs must be inserted and removed by a health care professional. It should never be removed by the client even if the thread is easily palpable. Occasionally the device causes menstrual irregularities and cramps in the lower part of belly (uterine cramps). Rarely there can be spontaneous expulsion of the device through birth canal particularly during excessive straining at defecation.

Principal Types of IUDs:
    Classification of Medicated IUDs: All modern IUD contain some active sustances either in the form of metal (e.g. copper) contain synthetic progesterone hormones. So modern IUDs are called medicated IUDs. Unmedicated i.e. only plastic devices are less effective. Though these were once popular in the decade sixties and seventies are no longer used nowadays.



Classification of Medicated IUDs:
Medicated IUDs are of two types a) Copper bearing IUDs and b) Hormone releasing IUDs. First group and most widely used is copper bearing IUDs has a band of copper (either in the form of wire or sleeve) worn around the plastic device. This type of copper bearing device can be kept inside the womb for 3-14 years depending upon the copper content. The most popular copper containing IUD is T-cu-380A which when fitted is effective for fourteen years. In U.K. & U.S.A. it is sold under the brand name of ‘PARAGARD’. The second group is hormone containing IUDs which contains a special hormonal reservoirs from which small amount of female hormone called ‘progesterone’ is released daily inside the womb and effect contraception.
This second group of IUDs again is of two types depending upon the type of progesterone used. If ‘pure progesterone’ is used then it has to be replaced annually. Such device is available in the market under the trade name Progestasert but for varying reasons it is no longer used and it was never been available in Indian market.
The other type of hormone containing IUD is impregnated with ‘levonorgestrel’ type of progesterone. This relatively newer type of hormonal IUD is gaining popularity at a very fast rate because it has the ability to ameliorate variety of gynecological diseases in addition to contraceptive effect. Fortunately it has become available in India since 2002 (under the brand name Mirena IUS Fig.-2). Scientists often call it ‘LNG-IUS’ or LNG-20. The word LNG-     stands for ‘levonongestrel intrauterine system’. In this book the word ‘LNG-IUS’ will be used to mean this type of hormone releasing IUD. The contraceptive efficacy of this IUS lasts for five years.
Many other IUDs which were used in the twentieth century are no longer used. These are safe coils, Lippes loop, Dalcon Shield, Cu-7. The modern copper IUDs however are safe, effective and inexpensive method of achieving reversible contraception in properly selected women.
Most copper medicated IUDs have an abbreviation depending on the design of the frame and exposed surface area of copper wire. For instance the most commonly used copper containing device is abbreviated as T-Cu-380A which means the shape of the device is ‘T’, and the exposed copper wire winded around the device is 380 sq.mm. In fact this copper wire is winded both in vertical limb as well as on the collar i.e. transverse bar of the plastic device.



Remarks on the string of IUD:
As mentioned earlier the only commitment of the client after the IUD is fitted is to cheek the presence in the upper part of vagina at monthly intervals. Thus it is worthy to know few relevant points pertaining to the string attached to IUD.
Both copper medicated and hormone containing IUDs have one or two ‘filaments’ or ‘strings’ – that is threaded through a hole in the bottom of the vertical arm of the device which is shaped as T (sig. Fig.-3). The strings are tied in the device with a knot and strings hang through the lower opening of the cervix into the upper birth canal. The string is monofilament i.e. a single strand of strong plastic. Contrary to popular belief, this thread which hangs in the birth canal does not absorb fluid from birth canal neither transmits bacteria up into the womb. The partner do not feel the thread during lovemaking process neither the male organ is hurt by the thread.
The string has two purposes. It is primarily meant for easy removal of the device with the help of an instrument called ‘artery forceps’. The string also gives an opportunity to the woman clinician to know if the IUD is still in the correct position i.e. inside the womb. As said earlier, the women or her husband should periodically check (once a month is sufficient) its presence by touching the string. It is best palpated in squatting position or else woman can put one foot on a low tool and then insert her index and middle fingers in the birth canal. It should be searched more in backwards than upward direction. Usually, the thread is readily palpable. If not, then one can put her fingers up in the birth canals. When she will be able to feel cervix which feel like tip of nose with a small hole i.e. depression at centre. Some amount of mucus is easily felt at this part and it is in this portion the string should be searched.
If the string seems to shorten or lengthen, the IUD it may mean that have moved up inside then womb or has come down. This mandates an ultrasonography (imaging  the womb) to verify correct location of IUD in relation to longstudinel axis of womb (uterus).
If the string can’t be located at all it may mean that IUD has expelled spontaneously possibly without the knowledge of the acceptor. On very rare occasion device may have perforated the womb and travelled to tummy (abdomen). In summary the purpose of putting a sting in IUD is as follows –
a)     It satisfies the client that the IUD has not fallen off the body.
b)    It helps in easy removal of IUD.
c)       If there is there is lengthening or shortening of thread then it implies that IUD has either come down from womb or has coiled up in the womb.

Brand Names:
A) Copper bearing IUDS:
1)     Multiload cu 250 (ML-Cu-250) and Multiload Cu-375 (ML-Cu-375):  The intrauterine life span of such IUDs is 3 and 5 years respectively. The cost such IUD in Indian market.
i)           Multiload IUDs - Multiload IUDs have curved flexible arms with spurs. These spurs seek anchorage to fundus, thus reducing expulsion rate. Copper wire on the stem is worn around vertical limb of T and two popular designs are with 250 mm2 and 375 mm2 surface area of copper. Multiload 250 has lesser side effects. While Multiload 375 is as effective as Tcu-380A.
ii)       T Cu 380A – Tcu-380A has solid copper sleeves on transverse arm and coil of copper wire around the stem. This is a highly effective copper device with efficacy as high as 99%. By adding silver to this (TCu-380 Ag), efficacy has further improved with a failure rate as low as 0.7%. This is available abroad under the brand name of Paragard or T-safe-Cu 380A. The name paragard was used as its use was initially restricted to porous women only. This device was approved by FDA (Food and Drug Authority of US) in the year 1984. In India it is sold in open market under the brand name of “NUGUARD 380A” & T-Cu-380A is the other name distributed by Govt. of India free of cost through all Govt. hospitals.
Globally two types of Copper IUDs e.g. T-Cu-380A and ML-Cu-375 are the most commonly used copper medicated IUDs which is there are about dozen of other copper bearing IUDs still popular in different parts of the globe. These are Cu-7, T-Cu 200, T-Cu 220C, T-Cu 220B, Cu Nova T, T-Cu 200C. These are not popular in India and neither they are readily available in all the provinces of India.
B) Hormone bearing IUDs:
1)     IUDs impregnated with progesterone hormone:  ‘Progestasert’ is the brand name and these have life span 1 year only – As stated earlier the devices are rarely used now-a-days. This is not available in India.
2)     Device containing levonorgestrel hormone:  This device is available under the brand names of ‘LevoNova’ or more commonly ‘Mirena’ (intrauterine dwelling time 5 years). Instead of IUD scientists often call it as IUS (Intrauterine System). This device is manufactured by Bayer Healthcare Pharmaceticals, Wayne, New Gersey. It is marketed in India by German Remedies and the approximate cost in India is Rs. 6000/-.

There are some newer IUDs which has become available recently:
In the last two decades some newer IUDs has come in the market. They are ‘T-safe-Cu-380A’, ‘Gynae-fix’, ‘NOVA T’, ‘Flexi-T-380’, ‘Fibroplant IUS’. These are used with varying degree of satisfaction.  Sadly, such modern IUDs are not available in our country. Which brand of IUCD to choose?? he brands are T Cu 380A::, ML Cu 250 ML:: Cu 375 ML , These three brands are most popular in our country.and choiced by acceptors & provider. .. There is little to choose about efficacy and side effects as those side effects are related to A) Inappropriate case selection(wrong method selection by acceptor/ Contraceptive provider),Most imp index of side effects like A) , perforation,B) spontaneous expulsion C) pelvic pain unrlealed to periods D) Dysmenorrhoea E) ,BTB F) Preg with IUCD in situ-uterine / Ectopic are related to proper fitting of the device in uterus -Fundus seeking device is most important., here are some newer IUDs which has become available recently:
In the last two decades some newer IUDs has come in the market. They are ‘T-safe-Cu-380A’, ‘Gynae-fix’, ‘NOVA T’, ‘Flexi-T-380’, ‘Fibroplant IUS’. These are used with varying degree of satisfaction. Sadly, such modern IUDs are not available in our country. There is little to choose . I personally advocate Govt supply T Cu 380A which is effective for 12 yrs (dwelling time). ew brands of copper wire woven IUCD are 1)Prega-T Cu 380A2) Care Cu 375 / 250 3) Trust Copper 380A 4) Khushi - T Cu 380A / 375 5) Fredom 5 - Cu 375 .Good old copper IUDS used in the decades of seventies and eighties were Cu 7, Cu T 200 ,Nova T, T Cu 200 C, T safe Cu..Currently for PP insertion people are using Gynae Fix PP & after abortion GynaecPA..The efficacy ,side effects, compl all depends on the driver ( who fits the device in womb) .no fault with thr Car ( women concerned).To conclude a survey among lady doctors of US reveled that as many as 60% are using Copper device after one child birth.

Why newer devices?
    For last several decades modifications of size, shape and chemical content are being aimed at to reduce the expulsion rate of side effects while maintaining the exceptionally high effectiveness and safety profiles of IUDs. Reproductive scientists are working on different frame designs too. In the process frames of different sizes and shapes with various active substances incorporated in the frame for pregnancy prevention has been made available. Some are still in newer clinical trial phase. Hopefully, IUDs will bring many more options for fertility regulation. The uterine cavity has a hollow space. However, in reality, this space, which varies in size and shape peculiar to each woman, can better be described as a potential cavity that widens at the tubal openings. The area adjacent to the tubal openings is often described as being overly sensitive for irritation, and hence, leads to increased uterine contractions when IUDs are fitted. So scientists are trying hard to design such IUDs which will minimize repeated trauma in these parts of uterus i.e. the most sensitive parts.
    As on in 2004, Chinese women had 21 types of IUCs to choose from. Examples of research on in IUC include smaller less bulky devices intended to geometrically adapt to smaller nullparous uteri, frameless copper IUDs fixed to the endometrium with a thread, devices with movable joints in the cross bars to help them expand and contract with uterine contractions and adapt to different uterine sizes and contours (geometric adaptation). Some newer devices have cervical components and cervical anchoring systems. Still smaller devices appropriate for the smaller atrophic perimenopausal uterus are also under clinical trial. For detailed information on newer devices reader is requested to refer appendix.

IUD acceptability: IUD use by Indian women:
There were three National Family Health Survey in India. The study period were 92, 93, 98, 99 and 05, 06. The contraceptive use amongst married women aged 13-49 years and % as per NFHS I, II & III. In these survey it was revealed that %, %  and % of women used IUD.

IUD use in other Countries:
Almost 156 million married women of reproductive age worldwide use IUD. Amongst all married women who use any family planning method as many as 20% rely on IUD.
Copper IUD is very popular In China and 92 million of Chinese women are wearing copper IUDs. Globally sixty percent all IUD users live in China. In China 83% of married women use some form of contraceptive. This is commonly expressed as CPR i.e. Couple Protection Rate. Thirty six percent of them use IUD!!!
IUD is also popular form of contraceptive in Egypt, Mongolia, Vietnam, North Korea & Latin America particularly Mexico. Similarly this contraceptive device is also popular in Eastern Europe, Finland and Norway. Ten to thirty percent of women contraceptors of those countries use IUC.
USA doctors prefer to use IUC for themselves! In USA though the prevalence amongst general population is only 2% but the use amongst female physicians and female gynecologists were 5% and 9% respectively. Female fellows of the American College of Obstetricians and Gynecologists answered that would choose IUC as their first choice contraceptive method when childbearing was completed and as their second choice after oral contraceptives, if desiring to space their children. US women who have the most knowledge to make their contraceptive decisions i.e. obstetrician/gynecologists choose IUC more frequently than their patients.
Mode of Action as Contraceptive:
    The way an IUD works as contraceptive is not fully understood. The most recent studies however indicate that the very presence of an IUD impedes the movement of sperm inside the womb thereby preventing fertilization of eggs. This action applies both to inert i.e. nonmdeicated IUDs (not available nowadays) and modern medicated IUDs. Additionally, copper released from copper containing IUDs disrupts sperm-oocyte interaction. We know that union between sperm and ova which occur in egg transport tube are depended on about dozen of enzymes. Released copper ions impair the efficacy of such enzymes involved in the fertilization process. Thus copper IUDs acts prior to fertilization and thus it is not an abortificient per se. Copper ions which diffuse from the copper bearing IUDs also damage the spermatozoal enzymes system and other enzymes present in the womb necessary for blastocyst (future embryo) inplantation. In contrast to oral pills neither copper bearing IUDs nor the hormone containing IUDs alter ovary and function and suppress release of eggs.
    In summary, the main effect of copper IUDs is prevention of fertilization and even if fertilization occurs there is ‘implantation blocking effect’ which acts as a back-up contraceptive mechanism.

Effectiveness or Reliability of IUD as contraceptive:
Modern IUDs are very effective in preventing pregnancy. The first year failure rate for the copper IUDs is about 1.5 to 0.8 %, which is slightly higher than that of tubal sterilization (0.5% in the first year). The efficacy of this device can be compared favorably with ‘combined’ pills (first year failure rate 0.1%) and progesterone only pill (first year failure rate of 2%). Fortunately, the failure rate for copper IUDs appear to be highest in the first year and declines thereafter. Similarly pregnancy rate in first-year perfect users are 0.8 to 0.6 and 0.1 per 100 women, in LNG-IUS users and Copper T380A users respectively.

Life span of IUD: Intrauterine Dwelling Time: How long an IUD is going to offer contraceptive protection after it is fitted in womb?
International agencies differ on this issue so also the Drug Controller Authorities of different countries. It will be prudent for the HCP to strictly follow guidelines approved by the country in which he/she practices. For instance Govt. of India recommend 10 year intrauterine efficacy of T-Cu 380A device (the most popular IUD) though WHO has declared that the particular IUD is effective for 14 years without any loss of contraceptive efficacy. The life span of other two commonly used copper IUD e.g. Multiload Cu 375 and ML Cu 250 are five year and three years respectively. These two IUDs are freely available in Indian market.

Continuation Rates & Clients Satisfaction:
Women spend most of their reproductive years on average 30 years trying to avoid pregnancy. Thus the impact of continuation rates on contraceptive success cannot be underestimated. IUC demonstrates high contraceptive effectiveness and it has high biologic efficacy. It requires almost no compliance. In fact it takes a volitional act to discontinue protection rather than to use protection. IUD has the highest continuation rate of any reversible method.
The copper IUD continuation rate is 78%, and the LNG IUS continuation rate is 81% at the end of first Year of use. In contrast, oral contraceptive continuation rates at 1 year range from 50% to 68%. Although the efficacy of depo-provera is considered top-tier, the overall continuation rate at 1 year is only 56% and is as low as 22% in some populations.
Although continuation rates with the two IUDs are similar, reasons for discontinuation differ. More women discontinue the copper device because of bleeding and cramping complaints, whereas more women discontinue the LNG-IUS device because of amenorrhea (stoppage of menstruation) and hormone related side effects. Overall, continuation rates are similar.

E) Advantages of IUDs as contraceptive: Why woman will opt for IUD?
1)                 Immediately effective and very little to remember subsequently.
2)                 Can be used during breastfeeding. Does not alter the quantity of breastmilk.
3)                 A single decision leads to effective long term prevention of pregnancy. IUD is a long acting contraceptive, therefore often called as ‘forgettable contraceptives’.
4)                 T-Cu 380A is distributed at no cost by Govt. of India and available even in remote rural areas e.g. PHCS, BPHCS (Block Primary Health Centers).
5)                 Less follow up to clinic. The contraceptive induced side effects after six months are minimal (worry free contraceptives).
6)                 Requires no attention except for monthly checks for the string (to be done by self/husband).
7)                 Does not interrupt sex. Efficacy of this method is very high, so increased sexual enjoyment because there is no need to worry about pregnancy or contraceptive failure.
8)                 Fertility resumes immediately upon removal.
9)                 There are no hormonal side effects with copper bearing IUDs. In fact there are no systemic side effects like oral pills, hormonal injections, implants or transdermal patches.
10)     There is no interaction with any drugs.

11)     There are certain ailments or diseases where oestrogen hormone use is contraindicated. Such women should avoid combined oral contraceptives which contains oestrogen hormone. Fortunately most of them can use copper IUDs which do not contain any hormones whatsoever.

The clinical conditions when oestrogen hormone should be avoided are:
    List of such clinical situations where IUD can be safely used are 1) Heavy smokers and or obesity 2) Diabetes mellitus of all severity. 3) Benign breast diseases 4) Migraine (IUD can be used in all types of migraine). 5) Controlled high blood pressure if BP is upto 160/100 or even beyond 6) Thrombophilia i.e. blood coagulation problem e.g. women with past history of deep vein thrombosis may be fitted with IUD. 7) Past history of stroke 8) Gall bladder diseases 9) Varicose veins 10) Ischemic heart disease 11) Hyperlipidaemia (excessive bad cholesterol in blood) 12) uncomplicated valvular diseases of heart in absence of pulmonary hypertension and atrial fibrillation (to be fitted with the consert of cardiologist) 13) Depressive disorders 14) Women suffering from tuberculosis provided tuberculosis is outside the genital organs (e.g. non pelvic tuberculosis) 15) Diseases of the mouth of womb i.e. cervix. These are often called CIN (cervical intraepithlial neoplasia) & ectropion of cervix.
    Copper bearing IUDs however can be safely used in above quoted conditions provided if she does not have concomitant diseases of womb e.g. tumors, or descent of genital organs or infections. These diseases of womb may make the client unsuitable for IUD use. Thus HCP coming across such women with above quoted ‘systemic or general diseases seeking contraception may be motivated for using copper IUD as first choice contraceptive and women should be counseled and made aware of relative safety of IUD. Such counseling should preferably be done both during antenatal visits and also during postpartum visits.

Covert use of IUD:
    Husband and some family members often do not approve contraceptive used, particularly in rural India. This is a complex social issue involving gender inequality and woman’s control of their own health and fertility no pane.
    This is often nowadays called ‘altitudinal factor’ for any social problem and not limited to contraceptive non use only. Fortunately, this contraceptive device can be used without the knowledge of the husband and family members. In some societies social norms many make it difficult for a woman to discuss sexual matters with her husband or adoption of methods that control her fertility. This not only true for rural Indian women but for slum dwellers too. This particular long-term contraceptive may be used without the permission of husband. Covertly quarterly shots (total four doses of injection per year) can also be taken without disclosing to her husband provided the wife is motivated.
     In summary there are three special situations where copper IUD surpasses all other contraceptives. Firstly, it can be used in a variety of medical diseases where hormonal contraceptives are contraindicated and may be harmful to client. Secondly, once fitted it will offer contraceptive protection for 12-14 years with virtually no follow up. Thirdly IUD is used covertly without the knowledge of husband and family members. It can also be used soon after birth (puerperal insertion of IUD) or it can be fitted after six weeks of childbirth without affecting breast-milk production.

Candidacy for IUDs i.e. selection of acceptors: Who are the ideal women for IUD? The most ideal women for IUDs should have following characteristics:
1)     Have had children but do not wish to have more by another 3-4 years time. It is not a good contraceptive where short term contraception is planned.
2)     Have no history or clinical evidence of pelvic infection e.g. pelvic pain, white discharge or dyspareunia etc.
3)     Have no history of sexually transmitted infections (S.T.I.).
4)     Have only one sexual partner.
5)     No uterine tumor or distortion of womb.
6)     No dysmenorrhoea or menstrual irregularity.
IUD can be used in women who had ectopic pregnancy earlier. The absolute risk of ectopic pregnancy is extremely low due to high effectiveness of IUDs. However when a woman becomes pregnant during IUD use, the relative chance of ectopic pregnancy as compared to uterine pregnancy is considerably increased.

Poor candidates for IUDs: Contraindication of IUD as a contraceptive:
a)     Recurrent or current pelvic infection (PID). This is the most important contraindication for IUD use. But IUD can be used if there is one pregnancy after an attack  of PID and there is no risk of acquiring S.T.I.
b)    behavior of the acceptor or her husband is so that there is a fair chance for acquiring sexually transmitted disease. It any of the spouse has multiple sex partners then ideally sexual copper bearing IUD should not be fitted. Hormone containing IUDs may however will be a better option.
c)       Those who are already suffering from menstrual cramps and/or heavy periods. Hormone containing IUC (Mirena) may be beneficial in such women. Such IUD will serve the dual purpose of contraception and disease transmission.
d)    Similarly those who are suffering from abnormal bleeding or anemia are also not good candidates for IUD.
e)     Part history of ectopic pregnancy: It is better to avoid IUD for those group of women though opinion differs. Now only a few gynecologists believe that IUD should not be fitted in such women.
f)         Uterine Fibroids hormone containing IUDs may however be used. According to WHO if myomas do not distort the uterine cavity then copper IUD may be used if no other suitable contraceptive is available?
g)     A very large/small uterus and other anatomical abnormalities of womb.
h)    Obvious cervical or uterine cancer.

The assessment of suitability of IUD is done in stepwise manner. e.g. -
1)     Replies by the client in response to some question.
2)     Clinical examination by the HCP.
3)     Laboratory lists to desires exclude STI.
Checklist (question) for screening clients who to initiate Use of the copper IUDs:
  Intrauterine devices (IUDs) are generally safe and effective for use by many women, including those who have not given birth, who want to space births, and those who are at risk of HIV infection or living with HIV infection. But some women are unsuitable for IUD due to the presence of certain female diseases, such as current cervical infections (infections of the mouth of the womb), PID or other diseases of womb (uterus). For these reasons, women who desire to use an IUD must be screened for associated gynecological conditions to determine whether if they are appropriate candidates for the IUD. It no such screening is done prior to IUD insertion then post insertion complications will increase considerably which must be avoided by all means.
    The checklist consists of a series of questions planned to identify any medical condition or behavior that would either prevent safe IUD use or require further screening in the form of investigation. As well as provide further guidance and directions based on client responses. A health care provider should analyze her response to all questions before inserting an IUD and thus assess eligibility of IUD use.

Answers to be replied by prospective acceptor:
1)           Have you given birth within the last 4 weeks? IUD should be fitted after 4 weeks of childbirth and not before.
2)           Have you been told that you have pelvic tuberculosis or any type of cancer in your genital organs?
3)           Do you have bleeding between menstrual periods that is unusual for you or bleeding after sex?
4)           Within the last 3 months, have you had more than one sexual partner?
5)           Within the last 3 months, do you think your partner has had another sexual partner?
6)           Within the last 3 months, have you been told you have an STI?
7)           Within the last 3 months, has your partner been told that he has an STI or has he had any symptoms for example, penile discharge?
8)           Are you HIV positive?
9)           Have you developed AIDS?
a)                       If answers to Q No. 3 are yes then it implies that she has probably some female (gynecological) disease then she should be treated for that specific disease and IUD fitted at a later data with the approval of gynecologist.
b)                      If answer to any of the questions 4 to 7 is affirmative then also IUD should be avoided. IUD can be fitted after cure of suspected gonorrhea or Chlamydia infection (STI)
c) If answer to Q 8 is yes and there is no evidence of AIDS disease then she can use IUD.
d)                      If answer to Q. 9 is yes then IUD may be used if she is doing clinically well on ARV drugs (antiretroviral agents). But if she is not on ARV then IUD should not fitted.
Additionally, no pregnant women should be fitted with IUD. Pregnancy can be excluded by home monitoring of urine for pregnancy test after the expected date of period in over. But occasionally such kit may not be available in remote areas of India. Then putting the following questions to the acceptor can reasonably assess whether she is pregnant or not. These questions will also give a possibility of having pregnancy in the running cycle before the expected date. Pregnancy is almost always impossible under the following situations.
1)     She has abstained from sex since last period.
2)     She has given birth in the last four weeks or she had an abortion in last two weeks.
3)     The baby is less than six months age, and she is fully or nearly fully breastfeeding and has not resumed menstruation as yet (Lactation Amenorrhea Method).
4)     Pregnancy is also unlikely in the current cycle if she was using a reliable contraceptive ‘consistently and correctly'.
B)      Pre-insertion clinical examination by the HCP:-
1)           Is there any ulcer on the vulva vagina or cervix?
2)           Is   there purulent cervical discharge?
3)           Does the cervix bleed easily when touched?
4)           Were you unable to determine the size and/or position of the uterus?
5)           Is there any ‘motion tenderness’ i.e. movement of cervix does the client feel pain in her lower abdomen when one move the cervix sideways?

C) Laboratory investigation to exclude STI:
Is it essential to screen all women for STI if she desires for IUC? Gonorrhea and Chlamydia are the too common STIs which cause immense local damage in genital organs. There are many other fatal and nonfatal STIs which do not primarily affect the genital tract but cause damage of other parts of body e.g. syphilis, hepatitis B, HIV etc. etc. So far as screening for fitness of IUD is concerned on should ?????? on gonorrhea and/or Chlamydia only but screening for STIs should be individualized to the patient population. For instance evidence does not support routine screening for gonorrhea and chlamydia in populations at low risk of STIs. Factors that indicate high risk include history of a new sexual partner, age under 25, or recent history of STIs. If  screening in indicated, it can be done at the time of the insertion, and the patient can be called for treatment and encouraged to employ dual form of protection IUC for pregnancy protection and consistent condom use for STI prevention.
    Side effects and/or complications of IUD are minimal if the acceptors are properly selected. Properly fitted IUD in eligible women rarely cause any annoying side effects. Occasionally there can be missing of threads and irregular vaginal bleeding with or without pelvic pain and only on rare occasion there can be accidental pregnancy (uterine or extra uterine). Pelvic infection is also a possibility which has been long debated. This is particularly time if the couple dies not maintain a monogamous relationship. All these complicates are discussed at length.

Timing of insertion: When to get an IUD fitted?
A)   With no evidence of recent pregnancy –
a)                 Within twelve das of commencement of menstrual period : A woman can be fitted with IUD within first twelve days of commencement of menstrual bleeding. The device offers immediate protection and no additional protection is required in that cycle even if she had unprotected sex in that cycle prior to the insertion of IUD.
Probability of an existing pregnancy is extremely low before day twelve of the menstrual cycle, based on the extremely low risk of ovulation before day eight and the 5-to-7day emergency contraceptive coverage effect of copper bearing IUDs.
b)                Any day of menstrual cycle : IUD can also be inserted at any time during menstrual cycle at her convenience if she is reasonably certain that she is not pregnant i.e. either she had no coitus in that cycle or had coitus with due protection e.g. condom or were under cover of oral pills.
c)                   During amenorrhea provided urine test for pregnancy is negative: Amenorrhea i.e. cessation of menstrual period six months a beyond may be due to pregnancy, lactation or due to some gynecological, endocrine or nor commonly psychological facts. IUD can be fitted if amenorrhea is due to endocrine, psychological or local (uterine) cause and no harm will result. But results from international clinical trials do not confirm this belief and IUD insertion is quite safe six weeks after childbirth. The only care that HCP (Health Care Providers) should exercise is that uterine size must be determined carefully by bimanual examination and by passing a uterine sound (a thick flexible wire) into the uterus. Because at this stage womb is often small, therefore, a small sized IUD like ML Cu 250 (short), ML Cu 375 (short) or NOVA T (if available) may be the better choice. Standard size IUDs may however be chosen in lactation period, after resumption of menstrual period.
d)                Emergency IUD insertion as post-coital contraceptive: Use of copper containing devices as emergency contraception is safe and effective and can help prevent unintended pregnancy if used within 120 hours of unprotected intercourse. Emergency contraceptive pills (ECPs) containing only levonorgestrel are also effective and have fewer side effects.
       The advantages of the IUD as a post coital method are its high efficacy and the fact that it can be used up to seven days after coital exposure. For certain parous woman it is the method of choice if the women desires to use the IUD as her angoing method of contraception. At this time the women is highly motivation. It is particularly appropriate for the parous women with a single sexual partner who is at a high risk of pregnancy due to failure of a barrier method. It also is appropriate for a woman who has been sexually inactive for some time and suddenly finds herself in an unprotected and unplanned sexual relationship (source: OUTLOOK).
       The efficacy of copper-relasing IUD as emergency contraception is very high. It can reduce the chance of pregnancy by more than 99% when inserted within 5 days after unprotected intercourse.
       This method may be particularly useful when the client is considering its use for long-term contraception and/or when the hormonal regimens are less effective because more than 72 hours have elapsed. When using on IUD for emergency contraception, the eligibility criteria are the same as those for regular use of these device. Making emergency contraception more widely available can be an important step in preventing unintended pregnancies.
B)    In postpartum period –
                         i.            Insertion of IUD in immediate Postpartum period & after abortion (soon after vaginal delivery i.e. at Labor Room) IUD can be fitted Postpartum insertion within 48 hours of delivery is a recommended procedure with all safety. Though postpartum insertion is not popular in India but in some countries this procedure is being accepted by the women and community.
    How the programme can be made effective in India too? To be effective counseling of the couple should start in antenatal visits since a woman may have difficulty making a carefully considered decision about contraceptive use while she is in labor pain. Further, help of a HCP who is specially trained in postpartum IUD insertion must be available when a woman delivers which is not an easy proposition in India. The major disadvantage of postpartum insertion is the higher expulsion rate and increased probability of perforation of uterus. The IUD is more easily expelled after childbirth because the uterus (womb) is frequently contracting and the cervix (mouth of the womb) remains partly dilated. Surprisingly, expulsion rates following postpartum IUD insertion are lowest when the IUD is inserted within 10 minutes after the expulsion of the placenta. Placement of IUD correctly i.e. high in the fundus is mandatory to minimize expulsion. When a copper T IUD is inserted within 48 hours after delivery by an experienced provider, expulsion rates at six months ranges from 6 to 15 per 100 insertions and the health care provider’s skill and experience are probably very important to minimize of expulsion rate and other complications.
Technique of insertion of IUC soon after childbirth
    The process of introduction of IUD is techmiquelly a bit different at this stage. One can use a specially devised long insert for post partum insertion. Sounding the uterus should be avoided because of the risk of perforating the soft uterus. IUDs are usually inserted in immediate postpartum period by hand rather than with a standard inserter. Immediate postpartum insertion of the IUD can also be done by means of a sponge holding forceps. However if the inserter is used at all then the arms of T-shaped IUD should be released from the inserter once it has passed the cervical canal. Then the open IUD can be lifted up to the fundus. The uterus may be massaged to imitate a contraction so that wall of womb becomes relatively firm thus preventing perforation.
    The disadvantages of immediate postpartum insertion of the IUD is its higher expulsion rate and uterine perforation, Therefore most authorities advocate insertion after 4-6 weeks of delivery. Insertion between the time period 48 hours to six weeks after childbirth carries an increased risk of sepsis and perforation. Many therefore advise against inserting IUDs during this period.
During caesarean Section:
    Occasionally a woman can fitted with an IUD at the time of delivery by abdominal route. In these settings possibly it is the Obstetricians choice rather than acceptors decision, but when there has been prolonged labor or premature rupture of membranes, insertion during caesarean operation should be avoided because of the risk of infection.
Role of antibiotics in immediate postpartum period:
    There is still debate about routine use of antibiotics after fitting an IUD. The present consensus is not to use prophylactic antibiotics routinely in all cases. However, in settings of both high prevalence of STIs and limited STI screening, facility such prophylaxis may be considered or else HCP may counsel the IUD user to watch for symptoms of PID, especially during the first month. If symptoms appear (pain, fever, white discharge) then one can prescribe antibiotics.
i. During lactation period without having restoration of menstrual period: IUD can be fitted if urine for pregnancy test is negative but this should be fitted at least six weeks after childbirth. Earlier, there was some concern that insertion during lactation might involve a higher risk of uterine perforation as the womb is still small and soft.
                  ii.            IUD insertion after abortion –
IUD can be introduced after surgical evacuation of uterus (abortion) if there is no sepsis.
Insertion during postabortal period
i)           When abortion occurs/contemplated before 14 weeks of gestation -
IUDs can be safely inserted during evacuation of the uterus (surgical abortion). Provided the pregnancy is less than 14 weeks. The couple should be made aware that conception can occur as early as 10 days after abortion. Therefore effective contraception is needed soon after abortion. IUDs can safely be inserted after spontaneous or induced abortion except in women with evidence of pelvic infections or septic abortion.
  WHO studies show moderate expulsion rates associated with IUD insertion following first trimester abortions – ranging at two years from 5 to 9 per 100 women after induced abortion and from 10 to 14 after spontaneous abortions.
ii) When spontaneous abortion occurs or Medical Termination is contemplated between the period 14 weeks to 20 weeks pregnancy. It is not customary to fit IUD after second trimester abortion (14-20 weeks of pregnancy). Because there is 5-10 times more chance of expulsion of the IUD is being inserted immediately after second trimester abortion (WHO Task Force Study, 1985). So it is better to wait for 4 weeks or till the next period ensue whichever is earlier.
Safety Concerns: It is a safe contraceptive though misperceptions about the risks associated with IUD use are well documented. Although every contraceptive intervention has its risks, including failure and the much greater medical risks associated with pregnancy and childbirth, the overall safety profile of modern IUC is among the best in the contraceptive armamentarium.

When to consult HCP; Warning symptom s & Signs while with IUD:
    One needs to call a health care provider immediately if any of the following symptoms or abnormalities appear e.g.
1)     String can no longer be felt, possibly the device has fallen out of womb.
2)     Something hard is felt in her vagina or at the lower end of cervix. It means that one is palpating the lower part of vertical arm of the device. It the device remains at its proper place then it can neither be seem by HCP nor can be felt by the acceptor. Therefore if device itself becomes palpable it implies that device has come down and possibly is on the way of expulsion.
3)     Strings seem shorter: It may imply that the device might have undergone some rotation on long axis of womb and has coiled up in the womb. If the string seems longer than before it may imply that device has started to descent while the device still remaining in the womb.
4)     A missed or a late period, a very light period, severe cramping and/or abdominal pain which was not experienced earlier may mean pregnancy outside the womb i.e. ectopic pregnancy.
5)     Client considers that she has been exposed to STD.
6)     Bleeding during intercourse or,
7)     Foul smelling vaginal discharge (acute pelvic infection i.e. infection of upper genital organs).
If any such situation arises then the acceptor should consult HCP within couple of hours.

Management of possible side effects of the IUD:
The list of possible side effects associated with IUD use are:
i)           Uterine Cramps
ii)      Menstrual irregularities
iii)                        Pelvic infection
iv)                        Spontaneous expulsion
v)      Accidental Pregnancy
    Many do not have any adverse effect at all and keeps fine. That is also why the IUD called worry-free contraceptive a forgettable contraceptive. Only few have symptoms and a few are bothered or distresed with side effects. The common discomfort quoted by the acceptors are ‘bleeding irregularities’ and ‘pelvic pain’. Why some women have side effects and other women escape? Firstly, health care providers need to know that not all women are suitable for IUD. Therefore if the acceptors are not properly selected then IUD related side effects will be more. For instance if there is pelvic infection, or uterine abnormality then side effects are bound to occur. If IUD is fitted inadvertently in such women. Side effects thus can be minimized by proper selection of clients and strictly adhering to contraindications of IUD use as framed by W.H.O. and other international agencies. Secondly, these side effects can be further minimized if the IUDs are fitted by an experienced and skilled nurse or doctor who has adequate training on IUD insertion. The cause of cramps in lower part of tummy either during menstruation (dysmenorrhoea) or in between periods are often caused by slight malposition or malrotation of IUD inside the uterine cavity (womb). The pain is usually relieved by usual analgesics and NSAIDS. Persistene pelvic pain however may not only be due to abnormal position of the IUD associated PID, but also occasionally uterine perforation, beginning of expulsion of the IUD, or rarely ectopic pregnancy may also be the cause pelvic pain. One has to remember that womb is a hollow muscular organ and constantly undergoes contractions and relaxation. During a height of continue muscles of uterus pres the device particularly if it the device is not properly fitted. This may recurrently cause cramp in lower part of belly and irregular bleeding. Scientists have now devise newer frames with flexible joints in the transverse bar of ‘T’ device which allows the IUC to repeatedly yield and accommodate the changing shape of womb with each contraction and relaxation sadly, these devices are still not available in the market.

IUD induced menstrual disturbances (Bleeding related problems):
Variety of menstrual disorders which however occasionally quoted by the acceptor are as follows. 1) Spotting between periods i.e. inter menstrual bleeding 2) heavy periods or longer menstrual flow (menorrhagia). These menstrual aberrations usually last for first three months after insertion of IUD and fortunately most of these subside by three to six months time. Only in few cases HCPs (Health Care Providers) are forced to remove the IUD if the magnitude of suffering is considerable persistent or non relieved by drugs.
a)     Incidence and severity of bleeding:   In a normal menstrual cycle i.e. without any IUD, the mean amount of menstrual blood loss (MBL) was previously thought to be approximately 35 ml. With improved techniques of extraction of blood from sanitary napkins, this amount is now estimated to be approximately 60ml. Excessive or prolonged menstrual bleeding (menorhagia) affects between 5% to 30% of women of reproductive age i.e. general population not using contraceptives. It is more common among women under the age of twenty and over the age forty years than.
The amount of blood lost in each menstrual cycle is slightly greater in women using copper-bearing IUDs than in nonusers. With the most commonly used IUD there is only an average increase of 20-55% in MBL which most women accept. By contrast, with the leonorgestrel releasing IUD (Mirena IUS) which is now used in India for last 5 years the amount of blood loss is significantly reduced, declining to approximately 25ml/cycle.
b)    How to gaze severity of bleeding?  A personal interview and total number of napkins needed per 24 hours will often help the HCP to assers the severity of bleeding. If a woman who is on IUD complaint of weakness in addition to excessive bleeding then HCP can think of chronic anemia due to persistent heavy bleeding. In absence of any other evidence of blood loss e.g. piles, worms infestation and haematemesis the possibility of IUD induced anemia should always be considered. It implies that menstrual bleeding is too much to cause anemia. In these cases the HCP should insist on hemoglobin estimation. If the level is below 9gm% then he (HCP) can request for estimation of serum ferritin level in blood provided such laboratory facilities exists in the locality in which the client resides. Serum ferritin is a very sensitive indicator of tissue iron stores. Persistent menorhagia without concomitant iron supplementation is likely to cause significant decrease in serum ferritin levels. Low blood ferritin is an indicator of depletion of iron store in the bone narrow as well. Therefore a conscientious HCP may occasionally request for ferrtin estimation amongst women with menstrual bleeding disorder and levels less than 4mg/lit should always require oral iron supplementation to prevent further anemia.
c)       Why bleeding and pain? As said earlier most bleeding irregularities including painful cramps occur due to inproper fitting of IUD. If there is slight tilt or rotation of IUD inside the womb or angulation between the long axis of womb and long axis of IUD then device will lead to repeated mild trauma in the inner wall of womb and induce pain and menstrual bleeding. We know that muscle of womb contracts and relaxes at definite intervals even in nonpregnant state. If the device inside the womb is ill fitting then it will hinge the inner wall of womb and induce pain and bleeding during height of contractions. A simili can be drawn with small foreign body (fishbone) stuck at throat which causes pain during each act of swallowing unless the fishbone passes down (antoadjustment) or removed.
In addition to ill-fitting the other causes of pain and excessive bleeding are due to – i) P.I.D. ii) at the beginning of expulsion of IUD iii) associated PID or ectopic pregnancy (tubal pregnancy) All these may cause pelvic pain and bleeding. Hence persistent pain or bleeding should be always investigated properly by the experts.
d)    How to prevent bleeding:  Besides selecting the acceptor the proper selection of appropriate sized IUD and proper placement of IUD by a skilled person are key factors to minimize bleeding related side effects. Researchers have now been able to devise new devices which cause minimal menorrhagia (excessive menstrual loss). These new IUDs have also succeed in reducing the likelihood of expulsion and lowering of pregnancy rate further. It is hoped that future designs of IUD will focus on reducing these side effects even further.
e)     How to treat pain and bleeding:  For short-term relief three types of drugs are used with varying success. These are tranexarmic acid, NSAIDS or mefanamic acids with varying success. One can try with tranexamic acid, 500 mg 3 times daily for three days and then 500 mg twice daily for 2 day particulars during heavy or prolonged bleeding phases. This drug is available as Pause 500, TX 500 etc. Alternatively, NSAID group of drugs e.g. ibuprofen (400 mg), indomethacin (25 mg) two times daily may be tried. Mefnamic acid tablets are increasingly used nowadays. These should  be taken twice daily after meals for 5 days and this may ameliorate heavy or prolonged bleeding. These are available as ponstan 500 or meftal 500 etc.
Some doctors do prescribe these nonsteroidal anti-flammatory drugs (NSAIDS) e.g. ibuprofen, mufanamic acid etc. prophylactically i.e. from the onset of first menses after IUD insertion and maintain such schedule for three to five consecutive days. This by decreasing pain and bleeding certainly increase clients her confidence on IUD. NSAIDS therefore prescribed in anticipation will yield a dividend most cases.
Occasionally these drugs will not work and heavy or prolonged bleeding persists. If there is no reason to suspect on underlying local i.e. gynecological cause of bleeding, there are two options. Firstly she can continue using IUD method and in that event she should take iron tablets and/or eat foods containing iron, to help prevent anemia. This policy, however, is only acceptable when pain and bleding is partly reduced by above mentioned drugs and the woman is not that distressed with pain and bleeding. But if she shows signs of severe anemia and severity of bleeding is unacceptable then one should remove the device and advise her to choose another method.
Removal due to pain and bleeding is less common among older women, multipara and in long-term users. The removal rate depends a lot on the preinsertion counseling and support that a woman receives and on her altitude, both familial personal, towards her trouble with IUDs.
How does bleeding affects general health of a woman? The effect of bleeding is almost nil in healthy women but may lead to increased anemia already anaemic woman. Indian National Family Health Survey-3 (study period 2005-’06) has unearthed the fact that 39% of Indian women are mildly anaemic haemoglobin level <10 to 10.9 gm/d and 16% are moderately anaemic. There is of   women by 4% the period 1098-99 to 2004-05. <70-9.9 gm (d) and 2% are severely, anaemic (H level   7 g/d).
Anaemic usually passes off within a month or two. The client should be reassured about it. In fact, no aggressive treatment is warranted.
f)         Removal Rate: The single most common side effect leading to IUD discontinuation is disturbance in menstrual bleeding. The experience of excess bleeding is often accompanied by pain also. These two side effects either alone or in combination are not too uncommon. Inspite of adequate counseling and medical treatment in 2-10% of cases IUD have to be removed for persistent menstrual bleeding and pelvic pain. Providers should always offer clients the choice of switching method if they are not satisfied or if their needs or preferences have changed.
g)     How women and society view about normal menstruation?:  Women’s attitudes about menstruation are shaped not only by experience but also by beliefs about the social and cultural meaning of menstruation and what is acceptable monthly bleeding, taboos, and behavioral restrictions. Although not all belifs are reflected in practice, in many places cultural and religious beliefs prevent menstruating wome from participating in worship, sex, domestic works and many social activities. In some societies menstruating women should not visit places of worship. In some conservative societies menstruating women are not allowed to perform event heir domestic chores such as cooking and washing clothes. Sexual intercourse should be avoided during monthly bleeding. In contrast, only about half of women in the united kingdom, the only developed country in the study, believed sex should be avoided during monthly bleeding. Even among women who thought that it was acceptable, however, many did not have sex then as a matter of personal choice.
h)    How a woman react to menorrhagia?: If is retreated that these bleeding changes are rarely harmful, and they do not signify underlying or impending illness. But a woman reacts to bleeding changes and to what extent one tolerates depend on many factors, such as on the type and severity of bleeding changes and how severe it is, or whether it interferes with her daily activities or personal relationship, and also traditional beliefs or restrictions surrounding bleeding days. These changes however are not signs that something is wrong with her health. It is not the bleeding change itself, but rather how the woman feels about it and interprets it that will determine how she reacts. It should be stressed that these bleeding changes are normal and not signs of serious illness.

i)           Do other contraceptives cause such bleeding?: Bleeding and spotting at unexpected times are also common among women using oral contraceptives (20% of cases particularly during the first three months). The good news is that this drop to about 10% of cycles during the next three months, and to approximately 5% of cycles during the last six months of a 12-month period.
In summary, the following information may help the clients.



a)     Spotting or light bleeding        b)   Heavier or longer menstrual
between menstrual periods.            bleeding than normal
(not amounting to anaemia)            menstrual periods. (The amount
                               blood loss is such that there is a
                               threat for becoming anaemic)

a)                 HCP should counsel that spotting or light bleeding is common during the first 3-6 months of copper-bearing IUD use. It is not harmful and usually decreases over time.
a)                 The following treatment should be offered during the days of menstrual bleeding.
Non-steroidal anti-flammatory drugs (NSAIDS) or Tranexamic acid haemostatic agent). Aspirin should not be used.
b)                If she desires treatment, a short course of non-steroidal anti-flammatory drugs (NSAIDS) may be prescribed during the days of bleeding.
b)                If bleeding continues to be very heavy or inspite of blood coagulating agents and there are clinical signs of anaemia, or if she finds the bleeding unacceptable, early removal of the IUD is the best option.
c)                   If women is bothered with persistent spotting and bleeding then one should exclude other gynecologic problem. If a gynecologic problem is identified, it should be treated by a specialist. There is no need to removel IUD.

d)                If no gynaecologic diseae can be held responsible for bleeding, and she finds the bleeding unacceptable removal of the IUD should be done and one should help her to choose another method.

(Courtsey:   World Health Organisation)

3. Pelvic infection (PID-Pelvic inflammatory disease):
    Female genital organs are arbitrarily divided into two compartments e.g. lower genital tract and upper genital tract comprises of external genitalia (vulva) and birth canal (Vagina). The upper genital tract comprises of womb (uterus and its mouth i.e. cervix), fallopian tubes, with i.e. egg transport tube which carries eggs from egg relasing organ (ovaries) to womb.
PID is the infection of upper genital organs. The abbreviation ‘P.I.D.’ stands for ‘Plevic Inflammetory Disease’. There are many organisms responsible for PID. Some organism responsible for sexually transmitted diseases can also cause PID. Poor hygiene, under-nutrition, pelvic tuberculosis and above all repeated induced abortions can initiate PID. Abortion can procedure even if carried by experts in an clean environment can result PID. So surgical abortion is not cent percent safe and should be avoided as far as possible. The long term ill effects of PID are chonic pelvic pain. low backache. Infertility or pregnancy in fallopian tube, i.e. ectopic pregnancy. The very anatomy of fallopian tube and crypts in cervix are such that any infection in these areas are difficult to cure by drugs surgery permanent.
Coming to the question of whether IUD inserted inside the womb will invite PID or not was a debatable issue. Opinion of scientists still vary people have different views. In the decades of seventies and eighties both reproductive scientists as well as acceptors of IUD firmly believed that the risk of genital infection will remain high during the entire period of IUD wearing. In the 1992 international conference on IUD critically analyzed the review published by WHO which was meta analysis (summary of many studies analyzed together) involving nearly 22, 908 IUD users (using a total of 10 different IUD types) around the world. Result of that reviend supports the relative safety of IUD use so far as PID is concerned. All the researchers unanimously and firmly concluded that copper IUDs do not promote PID.
    Metaanalysis also point that PID rates were highest among young IUD users in certain geographic regions. PID rates were high among IUD users in Africa and lowest in China were bilateral monogamy is the usual rule.
The observers who were in charge of analyzing such data finally concluded that much of the IUD associated PID occurs in women who are at higher risk of STD infection, i.e. primarily women with more than one sexual partner or whose partner has other sexual partner.
To summarise on the issue of IUD induced PID’ it may be infersed that a) overall, the rate of PID among IUD users was very low (1.6 cases per 1,000 woman years of use) b) the rate of PID was highest during the first twenty days after insertion (9.7 cases per 1,000 insertion) and remains low and stable thereafter (0.5 to 1.4 cases per 1,000 woman years of use) c) some physicians employ preventive antibiotics before inserting the IUD, but the meta analysis did not find that this was helpful. d) twenty days after insertion of IUD the risk of PID remain very low, even among users who had an IUD in place for eight years or more. In the event the woman develops evidence of genital infection (P.I.D.) while on IUD it is not necessary to remove IUD. Instead potent antibiotics should be prescribed in consultation with HCP. Removal of the device during the infection does not ameliorate her symptoms or modify the course of PID in any way. IUD, however can be removed if the client so demands or if evidences of infection do not subside inspite of adequated treatment for reasonable period of time.

Spontaneous expulsion of IUD and management of missing thread:
    The management of such complications is detailed below and a knowledgeable acceptor can react readily if such mishap ensues.
    An estimated 2% to 8% of IUDs are expelled from the uterus within the first year of use. After insertion of IUD there is a natural tendency of uterine contractions to push the device (a foreign body) downwards, causing partial or complete expulsion though the T-shaped frame itself and the irregularity present in the T-arm prevent downward displacement of IUD.
    Expulsion is most likely to occur during the first three months after insertion. Several factors influence the chances of expulsion. Young mulliparous women have higher expulsion rates for all devices than parous women. After the first child there is a negligible effect of increasing parity on the expulsion rate. However, IUD expulsion rates seem to decline in a fairly linear fashion with increasing age. Women who had painful menstruation or abnormally large menstrual flow are more prone to expel copper-T-IUDs. The main increase in expulsion rate occurs when IUDs are inserted during the menstrual flow and is probably linked with extra myometrial activity (muscles of womb) at that time due to presence of excessive prostaglandins (a chemical agent).
What is the advice for acceptors?
All acceptor should palpate the thread after cessation of each menstrual period. If client is unable to feel the string herself she should seek help of HCP. Till then she should use some other contraceptives Similarity if the client can feels the plastic part of device it means that device has slipped down and then also she should visit HCP. Thus if the client can feel the lower part of frame in the cervical canal (neck of the womb to be more precise) then possibility of threatened expulsion is suspected, and she should immediately consult HCP. HCP too if cannot feel or visualize the string then the provider should consider three possibilities.
a)     The IUD has fallen out of body without the knowledge of the acceptor. This may happen during menstruation, defecation or urination.
b)    The IUD has changed its position inside the womb (coiling up) and in the process it has drawn string upwards inside the womb.
c)       The least possible cause is its perforation inside tummy (very rare).
What HCP will do in such situation?
    In this situation, after pelvic examination has been performed and the possibility of pregnancy excluded by urine test an ultrasonography should be done which will confirm or refute the position of IUD inside the womb. Ultrasonography can enrich us with three types of report e.g. a) The device is still inside the womb (coiling of IUD). In such situation the device should be removed by a minor operation e.g. hysteroscopy or more D & C depending on the expertise of the surgeon. A fresh device may be inserted if the couple commonly dicers. b) Device but has perforated the uterus and is in tummy. If sonography confirms that the device has gone inside the belly then it should be removed by laparoscopy. c) More commonly the sonography will reveal that there is no IUD either inside the womb or inside tummy. Then it may be inferred that device fallen out of the body. In such case another device may be fitted provided woman agrees else couple can opt for some other contraceptive method of their choice.
    In all such cases where string can’t be palpated a postcoital contraceptive should be considered if she has recent sexual activity and a backup contraceptive should be adopted till another contraceptive selected.

Limitations as a contraceptive:
1)     Side effects in some women in the form of pelvic cramps and irregular bleeding.
2)     Spontaneous expulsion of IUD:  IUD may be expelled spontaneously from the womb without the knowledge of the woman in up to 10% of women. This will be evidenced by inability of the woman to feel the string of IUD in the upper part of birth canal. The expulsion rate of IUD during first year of use is high and it is rare to have IUD expelled after first year of use.
3)     Invites infection to genital tract:       There was a longstanding debate whether presence of IUD inside the womb invites infection to cause P.I.D. (pelvic inflammatory diseases). Now different international studies have proved that in monogamous relationship IUD does not promote P.I.D. Still many skeptic scientists do not recommend IUD insertion in nulliparous women in care there is IUD induced infection which may lead to infertility in later life and according to them IUD is not a good choice for nulliparous women (category 2 risk). But many unmarried or nullparous married women have been fitted with IUD and results are encouraging. We will have to wait to see whether IUD can still be used in polygamous women and nulliparous women but certainly the old belief that IUD incucing PID is fast fading.
4)     Discomfort during fitting:  Insertion of IUD requires a minor medical procedure which may be somewhat uncomfortable particularly who are apprehensive.
5)     No preventive action on STI:  Contraceptives are primarily viewed as method of pregnancy prevention rather than STI prevention. Most women especially those who are married or in stable relationships choose methods to prevent pregnancy rather than to prevent STI. As IUD does not offer STI protection hence women should use her own judgement regarding necessity of condom use in addition to IUD in their married life. She can use barrier method in and for many women suggesting condom use is difficult since condoms are often associated with commercial sex rather than marital sex.
6)     Stoppage of method necessitates medical help:  Unlike barrier methods or oral pills client cannot stop using IUD of her own. The woman should never try to pull the string herself. She has to go to a clinic for removal of IUC.
7)     Compared to combined oral pills there is slightly increased risk of ectopic pregnancy i.e. pregnancy occurring is fallopian tubes, but this risk is less than women not using any contraceptive whatsoever.
8)     Rarely perforation of uterus may follow and device can go inside to the tummy (very rare indeed).
9)     Misplacent of IUD: An IUD can descent while still remaining inside the womb and thus occasional failure i.e. accidental pregnancy can follow. In fact contraceptive failure may be due to expulsion, perforation, descent or coiling up of the device inside the womb.

Risk stratification of women as per WHO guidelines:
    Women with some associated gynecological or medical diseases face some risk if IUD is fitted. The anticipated risks or dangers are graded as 1,2,3 & 4. Earlier people used to categorize the risk of contraceptive use as obsolete contraindication and relative contraindications. Nowadays category risk 1 implies no risk and category 2 risk means slight risk (relative contraindication). Category 4 means absolute contraindication and category 3 implies it is better to avoid the choiced contraceptive in that particular diseases.

WHO risk categorization of IUD use is as follows:
A)   Category 1 risk:  The existing medical or gynecological disease does not cause any harm to client neither it intensify IUC related side effects.
B)    Category 2 risk:
a)                 Age menarche to women.
b)                Endometriosis
c)                   Menorrhagia
d)                History of previous pelvic infectious diseases without subsequent pregnancy and assuring that there is no current risk factor for STD.
e)                 Vaginitis including trichomonal vaginitis and bacterial vaginosis
f)                     Thalassaemia & iron deficiency anemia
g)                 Complicated valvular diseases of heart
h)                Soon after second trimester abortion.

Uterine pregnancy:
A.   Causes of pregnancy:
a)                 This unfortunate event usually follows when the device has fallen off the body without the knowledge of the acceptor.
b)                Pregnancy may also occur if the device is coiled up inside the womb i.e. upward displacent of the device but the device still remaining inside the womb. HCP should always remember that to have desired contraceptive effect the IUD should be so located that it almost touches the top part of womb. This area is medically called fundus of uterus. If the device is coiled up inside the womb then copper ions will be released low down in the womb and contraceptive efficacy with fall.
c)       If device has descended downward i.e. in the lowermost part of womb thereby vertical limb of the device lying in the cervical canal.
B.   How to minimize accidental pregnancy:
As mentioned earlier spontaneous expulsion of IUD or malposition of the IUD can often be minimised if IUD is inserted by a HCP who has adequate training and skill in IUD insertion. Correct high placement of IUD is a prerequisite for proper achieving near 100% contraceptive action. But the author has witnessed about six dozen of such cases where the device which was inserted by a skilled doctor has descended down still remaining in the womb. This is possibly unavoidable and happens due to contractions of uterus. Normal uttering contraception’s sometimes succeed in pushing the device down particularly if the uterus is relatively large in size. A six monthly ultrasonography may detect the correct position of IUC in womb and can alert the HCP & client that the device has started falling from its original location. The other ill-effect of decent of IUD is that if the deice comes down then copper ions released will be well below fundus of uterus. This will be unable to exert desired contraceptive effect. The process of descent of IUD from womb to final expulsion can be associated with cramping increased vaginal discharge, or uterine bleeding. However, in some cases, the only premonitory symptom is lengthening of the IUD string thus the golden rule is to palpate and search not only for strings but also to search or hard any plastic mans in the neck of the womb i.e. opening of the womb (external os).
C.   Incidence of accidental pregnancy:
Fortunately, the annual incidence of accidental pregnancy decreases steadily after the first year of IUD use. The cumulative pregnancy rate after seven years of use of the copper T380A IUD (most common brand used in India) is only 1.6%.

D.   Complication of pregnancy while IUD still remaining inside womb:
If she is pregnant with IUD still inside then there will be an increases risk of spontaneous abortion. If the IUD is not removed then the incidence of spontaneous abortion which is approximately 55%, or roughly three times greater than would occur in pregnancies without an IUD. More than half of the spontaneous abortions in IUD users occur in the second trimester. However, if the IUD is removed right after conception than the risk of abortion is close to average abortion rate (about 20%). For some reason or other the gestational period between 14-24 weeks is dangerous (if the IUD is not removed) because severe infection (sepsis) may occur. The genital sepsis can be fatal and hence once pregnancy is diagnosed, IUD should always be removed.
E.   Client wishes to continue pregnancy - What to do?
If a woman using the IUD becomes pregnant and wishes to continue the pregnancy then IUD should be removed at the earliest to avoid increased risk of spontaneous abortion. These will also obviate the increased risk of septic abortion in the second trimester and increased risk of premature delivery. There is no evidence that the IUD in a pregnant woman increases the risk for birth defects in the foetos.

F.   The client does not wish to continue pregnancy:
She should be advised to undergo surgical termination of pregnancy preceded by removal IUD. Medical abortion i.e. abortion by drugs is not recommended while IUD is still inside the womb. However, abortion by drugs can be carried out after removal of the device. The following procedure should be adopted if a woman using IUC is having delay in starting period. Firstly she should palpate for strings. Secondly, urine for pregnancy test is to be contemplated. If the urine test is negative she can repeat the test after ten days. If this test is also negative she can take tablet Orgamed (10), one tablet for ten days which will help menstrual bleeding and allay her anxieties. This natural delay in period is most commonly due to breastfeeding. If urine test is positive then one should exclude possibility of ectopic pregnancy i.e. pregnancy occuing outside womb. This can be done by serial blood testing for βhCG hormone and ultrasonography. In addition gynecologist’s advice is a must.
    The concerned HCP should alert the acceptor that if the device is not removed as soon as pregnancy is diagnosed then she is at risk of second trimester miscarriage, pre-term delivery and above all severe infection of womb if the IUD is left in place IUD removal is mandatory and the removal of the IUD reduces these risks, although the procedure itself entails a small risk of miscarriage. After removal of IUD she can continue the pregnancy if she so wishes but there will be always some risk of miscarriage, preterm delivery. If she opts to continue pregnancy she should be advised to seek medical care promptly if she has heavy bleeding, cramping, pain, abnormal vaginal discharge or fever. If she does not want to continue the pregnancy, surgical termination of pregnancy may be contemplated along with removal of the device.

Ectopic Pregnancy (Pregnancy occurring outside the womb i.e. in the egg-transport tube).
    Any pregnancy in an IUD user, inside or outside womb is uncommon and thus IUD users are 50% less likely to have an ectopic pregnancy when compared with women using no contraception. It is well known that infection of fallopian tube (P.I.D.) can favor ectopic pregnancy at a later date. Earlier, medical fraternity used to believe that IUD promotes pelvic sepsis including infection of fallopian tubes. HCP many believe that IUD may promote ectopic pregnancy at a greater rate than usual population. But that is not true. It has been proved now that IUD does not provoke pelvic infection if cases are properly selected (clients without risk of STD). Sadly, the bad reputation of IUDs regarding increased incidences of PID and increased rate of ectopic pregnancy (EP) still prevails not only in the minds of common people, but also amongst doctors.
    The rate of ectopic pregnancy in the general population vary depending on sociocultural and sexual behavior of the men and women of the locality. The estimated ectopic pregnancy rate among sexually active women using no method of contraception has been estimated to be between 3.25 and 8.0 per 1000 woman years. Contrary to popular belief the incidence of ectopic pregnancy among IUD users is between 0.125 and 4.0 per 1,000 women years of IUD use.
    If we consider the ratio of ectopic pregnancies, to total accidental pregnancies while still wearing copper IUDs it is seen that rate of EP is 39 per 1000 total pregnancies. This is almost similar to the ratio of 43 per 1000 pregnancies while not on contraceptives. From this stand point it may be inferred that if a woman becomes pregnant with IUD in place, her risk of ectopic pregnancy is increased compared with the overall population of pregnant women. In fact, protection against all tubes of pregnancies provided by both Tcu-380A is so great that WHO has put these devices as category 1 (i.e. safe to use) even in women with previous ectopic pregnancies.
    Though the incidence of ectopic is very low still it will be prudent to warn the women using IUDs about the features of ectopic pregnancy. They should be informed about common symptoms of EP e.g. abdominal pain, ‘dark and scanty’ or ‘inter menstrual bleeding’ along with the usual signs of pregnancy. The women concerned should visit HCP urgently if these symptoms appear. Another note of caution. If an IUD user conceives, health care provider should always look for ectopic pregnancy by sonography and serial blood tests for beta-hCG hormone.
    In summary it may be said that IUD users are statistically less protected against ectopic pregnancy than users of other contraceptive methods. One should remember that IUD does not prevent ovulation and possibly does not impede fertilization. IUD prevents nidation by primarily altering the inner environment of womb. Thus IUDs protect intrauterine pregnancy more effectively than extra uterine pregnancies.

Newer Copper IUDs:
    Researchers continue to develop and test new IUDs that may reduce expulsion rates and other side effects. Among the devices being that has become successful is CU-SAFE 300. It is smaller, lightweight, and flexible T-shaped copper IUD which can be inserted without a plunger and is designed to move towards the uterine fundus (the top of the uterus) when the uterus contracts. Additionally another new device is getting fast popularity i.e. frameless IUD consisting of six copper sleeves on a surgical nylon thread. It is also Flexi Gard 330, or Cu Fix PP 330. The thread is knotted at one end, which is anchored in the muscle of the fundus. In clnical trials the device has proved to be highly effective and comfortable to use. A Copper bearing IUD with a T-Shaped frame, called the Sof-T is becoming popular at smiliserlad. In thus new device. The tip of each end of the arm consists of a soft ball, designed to prevent perforation and to block the openings to the fallopian tubes in order to prevent sperm from entering.
    The very purpose of these new devices is to reduce pain and irregular bleeding associated with in the existing copper beeaing IUDs including the most popular type i.e. T-Cu-380A. Earlier the plastic frame where of different shapes e.g. coil, ‘s’ shaped, circular, triangular or elliptical. Now the only shape recommended is ‘T’ shaped because the cavity of womb is like ‘T’ which fits well with geometric of uterus and adaptation inside the womb is satisfactory if the plastic is of some other type then the frame will hinge the inner wall of womb and cause uterine camps and possibly bleeding.
Additionally the very plastic used is now made up of more flexible material. We are aware of the fact that womb contracts and relaxes spontaneously at varying intervals without the knowledge of a woman. If a ‘rigid’ plastic frame is used then it will not yield or bend to accommodate the shape of the contracted womb. So a rigid plastic frame is bovend to cause cramps and bleeding irregularities. However new copper IUDs discussed below are not approved for use in all countries. Till date the developers and manufactures report fewer expulsions, higher continuation rates, lower failure rates and easy insertion-removal as main advantages of all these new copper IUDs.
Chapter XII ABC BOOK (Contraceptives for sick women)
Role of POP in women with high blood pressure:
    Women with high blood pressure are prone to have ‘heart attack’ or ‘cerebral stroke’ i.e. bleeding from arteries inside brain matter or clotting of blood in venis inside the brain substance. It is said that hormonal contraceptives by changing coagulation system in the body and by altering fat metabolism adversely promote these fetal accidents. Thus one should try to avoid hormonal contraceptives in hypertensive women. But it is equally true that the hormonal contraceptive and IUD (Intrauterine Device) are the two most reliable temporary methods of contraception. The existing other temporary methods are not so much effective. Therefore, if one options for effective temporary method the option will be either IUD or hormonal methods. But many Indian women do suffer from variety of gynecological diseases where use of IUD is contraindicated. In them one has no other option but toprescribe hormonal contraceptives even if her blood pressure is slightly raised. Thus one has to make a balance between efficacy and risk of contraceptive use in women with high blood pressure.
    POP, though a hormonal contraceptive but the hormone is used in very low dose. So POP is reasonably safe to prescribe in women with mild to moderate hypertension even if she is on antihypertensive (i.e. drugs to check high blood pressure). To initiate POP the upper level of blood pressure (systolic) should be ideally less than 159 mm of mercury and the lower limit of blood pressure (i.e. diastolic) should be below 99 mm o mercury. These readings may be with or without blood pressure reducing drugs. But POP is not usually prescribed in women if blood pressure is above 160 systolic and or above 100 mm of mercury diastolic (WHO category 2 women for POP usage). That is only in special circumstances particularly when more appropriate methods are not available acceptable to the couple then only POP may be used in such women. The HCP need to assess the severity of her circulatory system and whether the woman will come regularly for follow up. Conceivably, these women mandate frequent three monthly follow up of POP is at all used.
    It may be recalled that traditional COCs are very risky (category 3) in women with such high blood pressure. Copper bearing IUDs are the safest the temporary contraceptive method for hypertensives and diabetics too. The other options are POP Mirena IUS (Hormonal IUD). Though women with slight elevation of blood pressure may use hormonal IUS but if hypertensive is severe (blood pressure > 160/100) then she should not use LNG-IUS.
RISK SATISFACTION OF HYPERSENSIVE WOMEN

Mild hypertension
BP < 140-159/90-99
Severe hypertensive
(> 160/100)

Barrier
1
1

LAM
1
1

COC
3
4

POP
1
2

Quarterly Shots
2
3

Implants (Implanon)
1
2

Combined monthly Injection
3
4

Copper containing IUD
1
1

Hormone releasing IUS
1
2

History high BP in pregnancy but current level is normal – COC is category 2 risk but POP and Quarterly Shot may be used.

Safety POP in Diabetes: (high blood sugar):
    In recent times prevalence of diabetes and high blood pressure has gone up in India. What about use of POP in diabetics? Is POP safe? The following is the guideline.
1)     Those who had temporary rise of blood sugar during pregnancy (gestational diabetes mellitus) they can safely use POP. Alternatively, they can also use COC with no added risk (zero risk or category I women for COC usage). In fact all methods are safe for women who had such temporary rise of blood sugar.
2)     Those with established diabetes but sugar is within control, they can also use POP or COC provided there is already no change in the blood vessels as evidenced by eye (retinal) examination. Even those who are using insulin can use COC or POP provided diabetes is well controlled and there is no associated vascular disease. However, these two hormonal contraceptives i.e. POP and COC are contraindicated if diabetes is not well controlled.
3)     Those diabetics who had already some retinal changes (vascular changes in the eye ball as evidenced by simple clinical examination by ophthalmoscope, Kidney changes or nerve changes they too can use POP (category 2 risk). COC will be more risky in such women (category 3 risk). In fact all methods except copper bearing IUDs are category 2 risk for women with established diabetes mellitus. It is needless to mention that barrier contraceptive and natural family planning methods fertility Awareness method) are safe options but efficacy of these are limited. Use of spermicides in uncontrolled diabetics may invite severe pelvic infection and thus not recommended.

POP in HIV and contraceptive choices for HIV Women:
    Women account for nearly half of the estimated 40million cases of HIV infection worldwide. In 2006 on estimated 17.7 million women ages 15 and older, or about 13 in every 1,000 such women, were infected-approximately one million more than in 2004.
    Like all other women, women with HIV have the right to make their own decisions about their reproduction and sexual health.
    Women with HIV face many decisions about living with HIV. Decisions about sex and childbearing can be among the most important. She may also need to ask her partner if he knows his HIV status and, if not, encourage him to seek HIV testing.
    Preventing unwanted pregnancy is a key element in the four-element strategy for preventing mother-to-child transmission of HIV. As indentified by the UN in the Glion Call to Action on Family Planning and HIV/AIDS in Women and Children, the four elements respond to health care providers’ four opportunities to reduce mother-to-child transmission. The Glion Call to Action states that all four elements are essential for meeting the UN goal of halving the proportion of infants infected with HIV by 2010.
    All hormonal methods appear to be safe for women with HIV. Theoretically, certain antiretroviral (ARV) medications could reduce the effectiveness of low-dose hormonal methods, but

CHAPTER – IV(Final)
Intrauterine Devices: Intrauterine contraceptives:
(Contraceptive Coil)
INDEX
   
Basics of IUDs – P, Type of IUD – P, Information on string of IUD – P, Brand names & Life span – P, Mode of Action – P, How soon become effective – P, Contraceptive efficacy – P, Users satisfaction & Continuation Rate – P, Advantages as contraceptive – P, Side effect and their management – P, Disadvantages as contraceptive – P, Candidacy for IUDs – P, Who criteria & Checklist – P, IUD & Timing of insertion – P, Insertion Procedure – P, Follow up – P, When to remove (Indications for removal) – P, Procedure of removal – P, Switching to some other method – P, Return of fertility – P, Complications, Health Risks & warring – P, Skill of HCP – P, Pill or IUD which one to choose – P, LNG IUS or copper beaing IUD – P, Conclusion – P, Further Reading – P, Webs – P.

The basics of IUDs:
An IUD (also called IUC) is a small ‘T-shaped’ flexible plastic device that is inserted inside the womb (uterus) through birth canal to avert pregnancy (Fig-1). It is the world’s most widely used reversible birth control method for women. The letters ‘IUD’ stands for “Intrauterine Device” and IUC is for intrauterine contraceptives. Both abbreviations are for the same device. The ‘contraceptive coil’ or ‘loops’ are just other names for the same contraceptive. Earlier it was used to be called as IUCD i.e. intrauterine contraceptive device. Globally the present abbreviation is IUD and only in some countries it is called IUC.
IUD is an easy, convenient, highly effective form of contraception that does not interfere with sexual spontaneity. Once introduced the IUD is immediately effective. It can also be used as emergency contraceptive i.e.  as after sex conceptive if the IUD is fitted within seven days of unprotected sex. The sooner the device is fitted after unprotected sex more will be the contraceptive efficacy.
Not all IUDs are alike. There are several types, and they come in different sizes and varying shapes. Like other drugs and devices there is long history of its evolution and hundreds of IUD have been tried in last two centuries. Readers will be surprised to know that the idea of putting some device inside the womb to prevent conception initiated with contraception camels. Camels frequently undergo long journey in the desert. To avoid pregnancy during this long voyage some pebbles (stone like material) used to be inserted in the womb of camel. Thus the camels did not fall sick in the voyage.
Basically there are two types of IUDs. One is copper impregnated IUDs which when fitted inside the womb release copper ions and other one is progesterone hormone containing IUDs which releases in sick the womb. It is the released copper or progesterone which effect contraception though plastic frame itself has some contraceptive effect. Copper bearing IUDs have proven the test of time and most popular form of IUD. In fact, there is a museum which exhibits over 300 IUD designed over two centuries collected from different countries.
Copper containing IUDs are the most inexpensive long-term reversible method of contraception. It can be removed at any time and fertility resumes within couple of months. The IUD requires no daily attention and this is the distinct advantage over contraceptive pills, or condom. The only responsibility of the acceptor is to confirm the placement of IUD after each menstrual period by feeling the thread of IUD which hangs in the upper part of birth canal. The thread is tied to the lowermost part of the device.
Like other contraceptives it has its own limitations and disadvantages. For instance, IUDs must be inserted and removed by a health care professional. It should never be removed by the client even if the thread is easily palpable. Occasionally the device causes menstrual irregularities and cramps in the lower part of belly (uterine cramps). Rarely there can be spontaneous expulsion of the device through birth canal particularly during excessive straining at defecation.

Principal Types of IUDs:
    Classification of Medicated IUDs: All modern IUD contain some active sustances either in the form of metal (e.g. copper) contain synthetic progesterone hormones. So modern IUDs are called medicated IUDs. Unmedicated i.e. only plastic devices are less effective. Though these were once popular in the decade sixties and seventies are no longer used nowadays.



Classification of Medicated IUDs:
Medicated IUDs are of two types a) Copper bearing IUDs and b) Hormone releasing IUDs. First group and most widely used is copper bearing IUDs has a band of copper (either in the form of wire or sleeve) worn around the plastic device. This type of copper bearing device can be kept inside the womb for 3-14 years depending upon the copper content. The most popular copper containing IUD is T-cu-380A which when fitted is effective for fourteen years. In U.K. & U.S.A. it is sold under the brand name of ‘PARAGARD’. The second group is hormone containing IUDs which contains a special hormonal reservoirs from which small amount of female hormone called ‘progesterone’ is released daily inside the womb and effect contraception.
This second group of IUDs again is of two types depending upon the type of progesterone used. If ‘pure progesterone’ is used then it has to be replaced annually. Such device is available in the market under the trade name Progestasert but for varying reasons it is no longer used and it was never been available in Indian market.
The other type of hormone containing IUD is impregnated with ‘levonorgestrel’ type of progesterone. This relatively newer type of hormonal IUD is gaining popularity at a very fast rate because it has the ability to ameliorate variety of gynecological diseases in addition to contraceptive effect. Fortunately it has become available in India since 2002 (under the brand name Mirena IUS Fig.-2). Scientists often call it ‘LNG-IUS’ or LNG-20. The word LNG-     stands for ‘levonongestrel intrauterine system’. In this book the word ‘LNG-IUS’ will be used to mean this type of hormone releasing IUD. The contraceptive efficacy of this IUS lasts for five years.
Many other IUDs which were used in the twentieth century are no longer used. These are safe coils, Lippes loop, Dalcon Shield, Cu-7. The modern copper IUDs however are safe, effective and inexpensive method of achieving reversible contraception in properly selected women.
Most copper medicated IUDs have an abbreviation depending on the design of the frame and exposed surface area of copper wire. For instance the most commonly used copper containing device is abbreviated as T-Cu-380A which means the shape of the device is ‘T’, and the exposed copper wire winded around the device is 380 sq.mm. In fact this copper wire is winded both in vertical limb as well as on the collar i.e. transverse bar of the plastic device.



Remarks on the string of IUD:
As mentioned earlier the only commitment of the client after the IUD is fitted is to cheek the presence in the upper part of vagina at monthly intervals. Thus it is worthy to know few relevant points pertaining to the string attached to IUD.
Both copper medicated and hormone containing IUDs have one or two ‘filaments’ or ‘strings’ – that is threaded through a hole in the bottom of the vertical arm of the device which is shaped as T (sig. Fig.-3). The strings are tied in the device with a knot and strings hang through the lower opening of the cervix into the upper birth canal. The string is monofilament i.e. a single strand of strong plastic. Contrary to popular belief, this thread which hangs in the birth canal does not absorb fluid from birth canal neither transmits bacteria up into the womb. The partner do not feel the thread during lovemaking process neither the male organ is hurt by the thread.
The string has two purposes. It is primarily meant for easy removal of the device with the help of an instrument called ‘artery forceps’. The string also gives an opportunity to the woman clinician to know if the IUD is still in the correct position i.e. inside the womb. As said earlier, the women or her husband should periodically check (once a month is sufficient) its presence by touching the string. It is best palpated in squatting position or else woman can put one foot on a low tool and then insert her index and middle fingers in the birth canal. It should be searched more in backwards than upward direction. Usually, the thread is readily palpable. If not, then one can put her fingers up in the birth canals. When she will be able to feel cervix which feel like tip of nose with a small hole i.e. depression at centre. Some amount of mucus is easily felt at this part and it is in this portion the string should be searched.
If the string seems to shorten or lengthen, the IUD it may mean that have moved up inside then womb or has come down. This mandates an ultrasonography (imaging  the womb) to verify correct location of IUD in relation to longstudinel axis of womb (uterus).
If the string can’t be located at all it may mean that IUD has expelled spontaneously possibly without the knowledge of the acceptor. On very rare occasion device may have perforated the womb and travelled to tummy (abdomen). In summary the purpose of putting a sting in IUD is as follows –
d)    It satisfies the client that the IUD has not fallen off the body.
e)     It helps in easy removal of IUD.
f)         If there is there is lengthening or shortening of thread then it implies that IUD has either come down from womb or has coiled up in the womb.

Brand Names:
A) Copper bearing IUDS:
2)     Multiload cu 250 (ML-Cu-250) and Multiload Cu-375 (ML-Cu-375):  The intrauterine life span of such IUDs is 3 and 5 years respectively. The cost such IUD in Indian market.
iii)Multiload IUDs - Multiload IUDs have curved flexible arms with spurs. These spurs seek anchorage to fundus, thus reducing expulsion rate. Copper wire on the stem is worn around vertical limb of T and two popular designs are with 250 mm2 and 375 mm2 surface area of copper. Multiload 250 has lesser side effects. While Multiload 375 is as effective as Tcu-380A.
iv) T Cu 380A – Tcu-380A has solid copper sleeves on transverse arm and coil of copper wire around the stem. This is a highly effective copper device with efficacy as high as 99%. By adding silver to this (TCu-380 Ag), efficacy has further improved with a failure rate as low as 0.7%. This is available abroad under the brand name of Paragard or T-safe-Cu 380A. The name paragard was used as its use was initially restricted to porous women only. This device was approved by FDA (Food and Drug Authority of US) in the year 1984. In India it is sold in open market under the brand name of “NUGUARD 380A” & T-Cu-380A is the other name distributed by Govt. of India free of cost through all Govt. hospitals.
Globally two types of Copper IUDs e.g. T-Cu-380A and ML-Cu-375 are the most commonly used copper medicated IUDs which is there are about dozen of other copper bearing IUDs still popular in different parts of the globe. These are Cu-7, T-Cu 200, T-Cu 220C, T-Cu 220B, Cu Nova T, T-Cu 200C. These are not popular in India and neither they are readily available in all the provinces of India.
B) Hormone bearing IUDs:
3)     IUDs impregnated with progesterone hormone:  ‘Progestasert’ is the brand name and these have life span 1 year only – As stated earlier the devices are rarely used now-a-days. This is not available in India.
4)     Device containing levonorgestrel hormone:  This device is available under the brand names of ‘LevoNova’ or more commonly ‘Mirena’ (intrauterine dwelling time 5 years). Instead of IUD scientists often call it as IUS (Intrauterine System). This device is manufactured by Bayer Healthcare Pharmaceticals, Wayne, New Gersey. It is marketed in India by German Remedies and the approximate cost in India is Rs. 6000/-.

There are some newer IUDs which has become available recently:
In the last two decades some newer IUDs has come in the market. They are ‘T-safe-Cu-380A’, ‘Gynae-fix’, ‘NOVA T’, ‘Flexi-T-380’, ‘Fibroplant IUS’. These are used with varying degree of satisfaction.  Sadly, such modern IUDs are not available in our country.

Why newer devices?
    For last several decades modifications of size, shape and chemical content are being aimed at to reduce the expulsion rate of side effects while maintaining the exceptionally high effectiveness and safety profiles of IUDs. Reproductive scientists are working on different frame designs too. In the process frames of different sizes and shapes with various active substances incorporated in the frame for pregnancy prevention has been made available. Some are still in newer clinical trial phase. Hopefully, IUDs will bring many more options for fertility regulation. The uterine cavity has a hollow space. However, in reality, this space, which varies in size and shape peculiar to each woman, can better be described as a potential cavity that widens at the tubal openings. The area adjacent to the tubal openings is often described as being overly sensitive for irritation, and hence, leads to increased uterine contractions when IUDs are fitted. So scientists are trying hard to design such IUDs which will minimize repeated trauma in these parts of uterus i.e. the most sensitive parts.
    As on in 2004, Chinese women had 21 types of IUCs to choose from. Examples of research on in IUC include smaller less bulky devices intended to geometrically adapt to smaller nullparous uteri, frameless copper IUDs fixed to the endometrium with a thread, devices with movable joints in the cross bars to help them expand and contract with uterine contractions and adapt to different uterine sizes and contours (geometric adaptation). Some newer devices have cervical components and cervical anchoring systems. Still smaller devices appropriate for the smaller atrophic perimenopausal uterus are also under clinical trial. For detailed information on newer devices reader is requested to refer appendix.

IUD acceptability: IUD use by Indian women:
There were three National Family Health Survey in India. The study period were 92, 93, 98, 99 and 05, 06. The contraceptive use amongst married women aged 13-49 years and % as per NFHS I, II & III. In these survey it was revealed that %, %  and % of women used IUD.

IUD use in other Countries:
Almost 156 million married women of reproductive age worldwide use IUD. Amongst all married women who use any family planning method as many as 20% rely on IUD.
Copper IUD is very popular In China and 92 million of Chinese women are wearing copper IUDs. Globally sixty percent all IUD users live in China. In China 83% of married women use some form of contraceptive. This is commonly expressed as CPR i.e. Couple Protection Rate. Thirty six percent of them use IUD!!!
IUD is also popular form of contraceptive in Egypt, Mongolia, Vietnam, North Korea & Latin America particularly Mexico. Similarly this contraceptive device is also popular in Eastern Europe, Finland and Norway. Ten to thirty percent of women contraceptors of those countries use IUC.
USA doctors prefer to use IUC for themselves! In USA though the prevalence amongst general population is only 2% but the use amongst female physicians and female gynecologists were 5% and 9% respectively. Female fellows of the American College of Obstetricians and Gynecologists answered that would choose IUC as their first choice contraceptive method when childbearing was completed and as their second choice after oral contraceptives, if desiring to space their children. US women who have the most knowledge to make their contraceptive decisions i.e. obstetrician/gynecologists choose IUC more frequently than their patients.
Mode of Action as Contraceptive:
    The way an IUD works as contraceptive is not fully understood. The most recent studies however indicate that the very presence of an IUD impedes the movement of sperm inside the womb thereby preventing fertilization of eggs. This action applies both to inert i.e. nonmdeicated IUDs (not available nowadays) and modern medicated IUDs. Additionally, copper released from copper containing IUDs disrupts sperm-oocyte interaction. We know that union between sperm and ova which occur in egg transport tube are depended on about dozen of enzymes. Released copper ions impair the efficacy of such enzymes involved in the fertilization process. Thus copper IUDs acts prior to fertilization and thus it is not an abortificient per se. Copper ions which diffuse from the copper bearing IUDs also damage the spermatozoal enzymes system and other enzymes present in the womb necessary for blastocyst (future embryo) inplantation. In contrast to oral pills neither copper bearing IUDs nor the hormone containing IUDs alter ovary and function and suppress release of eggs.
    In summary, the main effect of copper IUDs is prevention of fertilization and even if fertilization occurs there is ‘implantation blocking effect’ which acts as a back-up contraceptive mechanism.

Effectiveness or Reliability of IUD as contraceptive:
Modern IUDs are very effective in preventing pregnancy. The first year failure rate for the copper IUDs is about 1.5 to 0.8 %, which is slightly higher than that of tubal sterilization (0.5% in the first year). The efficacy of this device can be compared favorably with ‘combined’ pills (first year failure rate 0.1%) and progesterone only pill (first year failure rate of 2%). Fortunately, the failure rate for copper IUDs appear to be highest in the first year and declines thereafter. Similarly pregnancy rate in first-year perfect users are 0.8 to 0.6 and 0.1 per 100 women, in LNG-IUS users and Copper T380A users respectively.

Life span of IUD: Intrauterine Dwelling Time: How long an IUD is going to offer contraceptive protection after it is fitted in womb?
International agencies differ on this issue so also the Drug Controller Authorities of different countries. It will be prudent for the HCP to strictly follow guidelines approved by the country in which he/she practices. For instance Govt. of India recommend 10 year intrauterine efficacy of T-Cu 380A device (the most popular IUD) though WHO has declared that the particular IUD is effective for 14 years without any loss of contraceptive efficacy. The life span of other two commonly used copper IUD e.g. Multiload Cu 375 and ML Cu 250 are five year and three years respectively. These two IUDs are freely available in Indian market.

Continuation Rates & Clients Satisfaction:
Women spend most of their reproductive years on average 30 years trying to avoid pregnancy. Thus the impact of continuation rates on contraceptive success cannot be underestimated. IUC demonstrates high contraceptive effectiveness and it has high biologic efficacy. It requires almost no compliance. In fact it takes a volitional act to discontinue protection rather than to use protection. IUD has the highest continuation rate of any reversible method.
The copper IUD continuation rate is 78%, and the LNG IUS continuation rate is 81% at the end of first Year of use. In contrast, oral contraceptive continuation rates at 1 year range from 50% to 68%. Although the efficacy of depo-provera is considered top-tier, the overall continuation rate at 1 year is only 56% and is as low as 22% in some populations.
Although continuation rates with the two IUDs are similar, reasons for discontinuation differ. More women discontinue the copper device because of bleeding and cramping complaints, whereas more women discontinue the LNG-IUS device because of amenorrhea (stoppage of menstruation) and hormone related side effects. Overall, continuation rates are similar.

E) Advantages of IUDs as contraceptive: Why woman will opt for IUD?
12)     Immediately effective and very little to remember subsequently.
13)     Can be used during breastfeeding. Does not alter the quantity of breastmilk.
14)     A single decision leads to effective long term prevention of pregnancy. IUD is a long acting contraceptive, therefore often called as ‘forgettable contraceptives’.
15)     T-Cu 380A is distributed at no cost by Govt. of India and available even in remote rural areas e.g. PHCS, BPHCS (Block Primary Health Centers).
16)     Less follow up to clinic. The contraceptive induced side effects after six months are minimal (worry free contraceptives).
17)     Requires no attention except for monthly checks for the string (to be done by self/husband).
18)     Does not interrupt sex. Efficacy of this method is very high, so increased sexual enjoyment because there is no need to worry about pregnancy or contraceptive failure.
19)     Fertility resumes immediately upon removal.
20)     There are no hormonal side effects with copper bearing IUDs. In fact there are no systemic side effects like oral pills, hormonal injections, implants or transdermal patches.
21)     There is no interaction with any drugs.

22)     There are certain ailments or diseases where oestrogen hormone use is contraindicated. Such women should avoid combined oral contraceptives which contains oestrogen hormone. Fortunately most of them can use copper IUDs which do not contain any hormones whatsoever.

The clinical conditions when oestrogen hormone should be avoided are:
    List of such clinical situations where IUD can be safely used are 1) Heavy smokers and or obesity 2) Diabetes mellitus of all severity. 3) Benign breast diseases 4) Migraine (IUD can be used in all types of migraine). 5) Controlled high blood pressure if BP is upto 160/100 or even beyond 6) Thrombophilia i.e. blood coagulation problem e.g. women with past history of deep vein thrombosis may be fitted with IUD. 7) Past history of stroke 8) Gall bladder diseases 9) Varicose veins 10) Ischemic heart disease 11) Hyperlipidaemia (excessive bad cholesterol in blood) 12) uncomplicated valvular diseases of heart in absence of pulmonary hypertension and atrial fibrillation (to be fitted with the consert of cardiologist) 13) Depressive disorders 14) Women suffering from tuberculosis provided tuberculosis is outside the genital organs (e.g. non pelvic tuberculosis) 15) Diseases of the mouth of womb i.e. cervix. These are often called CIN (cervical intraepithlial neoplasia) & ectropion of cervix.
    Copper bearing IUDs however can be safely used in above quoted conditions provided if she does not have concomitant diseases of womb e.g. tumors, or descent of genital organs or infections. These diseases of womb may make the client unsuitable for IUD use. Thus HCP coming across such women with above quoted ‘systemic or general diseases seeking contraception may be motivated for using copper IUD as first choice contraceptive and women should be counseled and made aware of relative safety of IUD. Such counseling should preferably be done both during antenatal visits and also during postpartum visits.

Covert use of IUD:
    Husband and some family members often do not approve contraceptive used, particularly in rural India. This is a complex social issue involving gender inequality and woman’s control of their own health and fertility no pane.
    This is often nowadays called ‘altitudinal factor’ for any social problem and not limited to contraceptive non use only. Fortunately, this contraceptive device can be used without the knowledge of the husband and family members. In some societies social norms many make it difficult for a woman to discuss sexual matters with her husband or adoption of methods that control her fertility. This not only true for rural Indian women but for slum dwellers too. This particular long-term contraceptive may be used without the permission of husband. Covertly quarterly shots (total four doses of injection per year) can also be taken without disclosing to her husband provided the wife is motivated.
     In summary there are three special situations where copper IUD surpasses all other contraceptives. Firstly, it can be used in a variety of medical diseases where hormonal contraceptives are contraindicated and may be harmful to client. Secondly, once fitted it will offer contraceptive protection for 12-14 years with virtually no follow up. Thirdly IUD is used covertly without the knowledge of husband and family members. It can also be used soon after birth (puerperal insertion of IUD) or it can be fitted after six weeks of childbirth without affecting breast-milk production.

Candidacy for IUDs i.e. selection of acceptors: Who are the ideal women for IUD? The most ideal women for IUDs should have following characteristics:
7)     Have had children but do not wish to have more by another 3-4 years time. It is not a good contraceptive where short term contraception is planned.
8)     Have no history or clinical evidence of pelvic infection e.g. pelvic pain, white discharge or dyspareunia etc.
9)     Have no history of sexually transmitted infections (S.T.I.).
10)                 Have only one sexual partner.
11)                 No uterine tumor or distortion of womb.
12)                 No dysmenorrhoea or menstrual irregularity.
IUD can be used in women who had ectopic pregnancy earlier. The absolute risk of ectopic pregnancy is extremely low due to high effectiveness of IUDs. However when a woman becomes pregnant during IUD use, the relative chance of ectopic pregnancy as compared to uterine pregnancy is considerably increased.

Poor candidates for IUDs: Contraindication of IUD as a contraceptive:
j)           Recurrent or current pelvic infection (PID). This is the most important contraindication for IUD use. But IUD can be used if there is one pregnancy after an attack  of PID and there is no risk of acquiring S.T.I.
k)      behavior of the acceptor or her husband is so that there is a fair chance for acquiring sexually transmitted disease. It any of the spouse has multiple sex partners then ideally sexual copper bearing IUD should not be fitted. Hormone containing IUDs may however will be a better option.
l)           Those who are already suffering from menstrual cramps and/or heavy periods. Hormone containing IUC (Mirena) may be beneficial in such women. Such IUD will serve the dual purpose of contraception and disease transmission.
m)                      Similarly those who are suffering from abnormal bleeding or anemia are also not good candidates for IUD.
n)    Part history of ectopic pregnancy: It is better to avoid IUD for those group of women though opinion differs. Now only a few gynecologists believe that IUD should not be fitted in such women.
o)    Uterine Fibroids hormone containing IUDs may however be used. According to WHO if myomas do not distort the uterine cavity then copper IUD may be used if no other suitable contraceptive is available?
p)    A very large/small uterus and other anatomical abnormalities of womb.
q)    Obvious cervical or uterine cancer.

The assessment of suitability of IUD is done in stepwise manner. e.g. -
4)     Replies by the client in response to some question.
5)     Clinical examination by the HCP.
6)     Laboratory lists to desires exclude STI.
Checklist (question) for screening clients who to initiate Use of the copper IUDs:
  Intrauterine devices (IUDs) are generally safe and effective for use by many women, including those who have not given birth, who want to space births, and those who are at risk of HIV infection or living with HIV infection. But some women are unsuitable for IUD due to the presence of certain female diseases, such as current cervical infections (infections of the mouth of the womb), PID or other diseases of womb (uterus). For these reasons, women who desire to use an IUD must be screened for associated gynecological conditions to determine whether if they are appropriate candidates for the IUD. It no such screening is done prior to IUD insertion then post insertion complications will increase considerably which must be avoided by all means.
    The checklist consists of a series of questions planned to identify any medical condition or behavior that would either prevent safe IUD use or require further screening in the form of investigation. As well as provide further guidance and directions based on client responses. A health care provider should analyze her response to all questions before inserting an IUD and thus assess eligibility of IUD use.

Answers to be replied by prospective acceptor:
10)                       Have you given birth within the last 4 weeks? IUD should be fitted after 4 weeks of childbirth and not before.
11)                       Have you been told that you have pelvic tuberculosis or any type of cancer in your genital organs?
12)                       Do you have bleeding between menstrual periods that is unusual for you or bleeding after sex?
13)                       Within the last 3 months, have you had more than one sexual partner?
14)                       Within the last 3 months, do you think your partner has had another sexual partner?
15)                       Within the last 3 months, have you been told you have an STI?
16)                       Within the last 3 months, has your partner been told that he has an STI or has he had any symptoms for example, penile discharge?
17)                       Are you HIV positive?
18)                       Have you developed AIDS?
e)                       If answers to Q No. 3 are yes then it implies that she has probably some female (gynecological) disease then she should be treated for that specific disease and IUD fitted at a later data with the approval of gynecologist.
f)   If answer to any of the questions 4 to 7 is affirmative then also IUD should be avoided. IUD can be fitted after cure of suspected gonorrhea or Chlamydia infection (STI)
g)                       If answer to Q 8 is yes and there is no evidence of AIDS disease then she can use IUD.
h)                      If answer to Q. 9 is yes then IUD may be used if she is doing clinically well on ARV drugs (antiretroviral agents). But if she is not on ARV then IUD should not fitted.
Additionally, no pregnant women should be fitted with IUD. Pregnancy can be excluded by home monitoring of urine for pregnancy test after the expected date of period in over. But occasionally such kit may not be available in remote areas of India. Then putting the following questions to the acceptor can reasonably assess whether she is pregnant or not. These questions will also give a possibility of having pregnancy in the running cycle before the expected date. Pregnancy is almost always impossible under the following situations.
5)     She has abstained from sex since last period.
6)     She has given birth in the last four weeks or she had an abortion in last two weeks.
7)     The baby is less than six months age, and she is fully or nearly fully breastfeeding and has not resumed menstruation as yet (Lactation Amenorrhea Method).
8)     Pregnancy is also unlikely in the current cycle if she was using a reliable contraceptive ‘consistently and correctly'.
B)      Pre-insertion clinical examination by the HCP:-
6)           Is there any ulcer on the vulva vagina or cervix?
7)           Is   there purulent cervical discharge?
8)           Does the cervix bleed easily when touched?
9)           Were you unable to determine the size and/or position of the uterus?
10)                       Is there any ‘motion tenderness’ i.e. movement of cervix does the client feel pain in her lower abdomen when one move the cervix sideways?

C) Laboratory investigation to exclude STI:
Is it essential to screen all women for STI if she desires for IUC? Gonorrhea and Chlamydia are the too common STIs which cause immense local damage in genital organs. There are many other fatal and nonfatal STIs which do not primarily affect the genital tract but cause damage of other parts of body e.g. syphilis, hepatitis B, HIV etc. etc. So far as screening for fitness of IUD is concerned on should ?????? on gonorrhea and/or Chlamydia only but screening for STIs should be individualized to the patient population. For instance evidence does not support routine screening for gonorrhea and chlamydia in populations at low risk of STIs. Factors that indicate high risk include history of a new sexual partner, age under 25, or recent history of STIs. If  screening in indicated, it can be done at the time of the insertion, and the patient can be called for treatment and encouraged to employ dual form of protection IUC for pregnancy protection and consistent condom use for STI prevention.
    Side effects and/or complications of IUD are minimal if the acceptors are properly selected. Properly fitted IUD in eligible women rarely cause any annoying side effects. Occasionally there can be missing of threads and irregular vaginal bleeding with or without pelvic pain and only on rare occasion there can be accidental pregnancy (uterine or extra uterine). Pelvic infection is also a possibility which has been long debated. This is particularly time if the couple dies not maintain a monogamous relationship. All these complicates are discussed at length.

Timing of insertion: When to get an IUD fitted?
C)    With no evidence of recent pregnancy –
e)                 Within twelve das of commencement of menstrual period : A woman can be fitted with IUD within first twelve days of commencement of menstrual bleeding. The device offers immediate protection and no additional protection is required in that cycle even if she had unprotected sex in that cycle prior to the insertion of IUD.
Probability of an existing pregnancy is extremely low before day twelve of the menstrual cycle, based on the extremely low risk of ovulation before day eight and the 5-to-7day emergency contraceptive coverage effect of copper bearing IUDs.
f)                     Any day of menstrual cycle : IUD can also be inserted at any time during menstrual cycle at her convenience if she is reasonably certain that she is not pregnant i.e. either she had no coitus in that cycle or had coitus with due protection e.g. condom or were under cover of oral pills.
g)                 During amenorrhea provided urine test for pregnancy is negative: Amenorrhea i.e. cessation of menstrual period six months a beyond may be due to pregnancy, lactation or due to some gynecological, endocrine or nor commonly psychological facts. IUD can be fitted if amenorrhea is due to endocrine, psychological or local (uterine) cause and no harm will result. But results from international clinical trials do not confirm this belief and IUD insertion is quite safe six weeks after childbirth. The only care that HCP (Health Care Providers) should exercise is that uterine size must be determined carefully by bimanual examination and by passing a uterine sound (a thick flexible wire) into the uterus. Because at this stage womb is often small, therefore, a small sized IUD like ML Cu 250 (short), ML Cu 375 (short) or NOVA T (if available) may be the better choice. Standard size IUDs may however be chosen in lactation period, after resumption of menstrual period.
h)                Emergency IUD insertion as post-coital contraceptive: Use of copper containing devices as emergency contraception is safe and effective and can help prevent unintended pregnancy if used within 120 hours of unprotected intercourse. Emergency contraceptive pills (ECPs) containing only levonorgestrel are also effective and have fewer side effects.
       The advantages of the IUD as a post coital method are its high efficacy and the fact that it can be used up to seven days after coital exposure. For certain parous woman it is the method of choice if the women desires to use the IUD as her angoing method of contraception. At this time the women is highly motivation. It is particularly appropriate for the parous women with a single sexual partner who is at a high risk of pregnancy due to failure of a barrier method. It also is appropriate for a woman who has been sexually inactive for some time and suddenly finds herself in an unprotected and unplanned sexual relationship (source: OUTLOOK).
       The efficacy of copper-relasing IUD as emergency contraception is very high. It can reduce the chance of pregnancy by more than 99% when inserted within 5 days after unprotected intercourse.
       This method may be particularly useful when the client is considering its use for long-term contraception and/or when the hormonal regimens are less effective because more than 72 hours have elapsed. When using on IUD for emergency contraception, the eligibility criteria are the same as those for regular use of these device. Making emergency contraception more widely available can be an important step in preventing unintended pregnancies.
D)  In postpartum period –
              iii.            Insertion of IUD in immediate Postpartum period & after abortion (soon after vaginal delivery i.e. at Labor Room) IUD can be fitted Postpartum insertion within 48 hours of delivery is a recommended procedure with all safety. Though postpartum insertion is not popular in India but in some countries this procedure is being accepted by the women and community.
    How the programme can be made effective in India too? To be effective counseling of the couple should start in antenatal visits since a woman may have difficulty making a carefully considered decision about contraceptive use while she is in labor pain. Further, help of a HCP who is specially trained in postpartum IUD insertion must be available when a woman delivers which is not an easy proposition in India. The major disadvantage of postpartum insertion is the higher expulsion rate and increased probability of perforation of uterus. The IUD is more easily expelled after childbirth because the uterus (womb) is frequently contracting and the cervix (mouth of the womb) remains partly dilated. Surprisingly, expulsion rates following postpartum IUD insertion are lowest when the IUD is inserted within 10 minutes after the expulsion of the placenta. Placement of IUD correctly i.e. high in the fundus is mandatory to minimize expulsion. When a copper T IUD is inserted within 48 hours after delivery by an experienced provider, expulsion rates at six months ranges from 6 to 15 per 100 insertions and the health care provider’s skill and experience are probably very important to minimize of expulsion rate and other complications.
Technique of insertion of IUC soon after childbirth
    The process of introduction of IUD is techmiquelly a bit different at this stage. One can use a specially devised long insert for post partum insertion. Sounding the uterus should be avoided because of the risk of perforating the soft uterus. IUDs are usually inserted in immediate postpartum period by hand rather than with a standard inserter. Immediate postpartum insertion of the IUD can also be done by means of a sponge holding forceps. However if the inserter is used at all then the arms of T-shaped IUD should be released from the inserter once it has passed the cervical canal. Then the open IUD can be lifted up to the fundus. The uterus may be massaged to imitate a contraction so that wall of womb becomes relatively firm thus preventing perforation.
    The disadvantages of immediate postpartum insertion of the IUD is its higher expulsion rate and uterine perforation, Therefore most authorities advocate insertion after 4-6 weeks of delivery. Insertion between the time period 48 hours to six weeks after childbirth carries an increased risk of sepsis and perforation. Many therefore advise against inserting IUDs during this period.
During caesarean Section:
    Occasionally a woman can fitted with an IUD at the time of delivery by abdominal route. In these settings possibly it is the Obstetricians choice rather than acceptors decision, but when there has been prolonged labor or premature rupture of membranes, insertion during caesarean operation should be avoided because of the risk of infection.
Role of antibiotics in immediate postpartum period:
    There is still debate about routine use of antibiotics after fitting an IUD. The present consensus is not to use prophylactic antibiotics routinely in all cases. However, in settings of both high prevalence of STIs and limited STI screening, facility such prophylaxis may be considered or else HCP may counsel the IUD user to watch for symptoms of PID, especially during the first month. If symptoms appear (pain, fever, white discharge) then one can prescribe antibiotics.
ii.                   During lactation period without having restoration of menstrual period: IUD can be fitted if urine for pregnancy test is negative but this should be fitted at least six weeks after childbirth. Earlier, there was some concern that insertion during lactation might involve a higher risk of uterine perforation as the womb is still small and soft.
            iv.            IUD insertion after abortion –
IUD can be introduced after surgical evacuation of uterus (abortion) if there is no sepsis.
Insertion during postabortal period
r)        When abortion occurs/contemplated before 14 weeks of gestation -
IUDs can be safely inserted during evacuation of the uterus (surgical abortion). Provided the pregnancy is less than 14 weeks. The couple should be made aware that conception can occur as early as 10 days after abortion. Therefore effective contraception is needed soon after abortion. IUDs can safely be inserted after spontaneous or induced abortion except in women with evidence of pelvic infections or septic abortion.
  WHO studies show moderate expulsion rates associated with IUD insertion following first trimester abortions – ranging at two years from 5 to 9 per 100 women after induced abortion and from 10 to 14 after spontaneous abortions.
ii) When spontaneous abortion occurs or Medical Termination is contemplated between the period 14 weeks to 20 weeks pregnancy. It is not customary to fit IUD after second trimester abortion (14-20 weeks of pregnancy). Because there is 5-10 times more chance of expulsion of the IUD is being inserted immediately after second trimester abortion (WHO Task Force Study, 1985). So it is better to wait for 4 weeks or till the next period ensue whichever is earlier.
Safety Concerns: It is a safe contraceptive though misperceptions about the risks associated with IUD use are well documented. Although every contraceptive intervention has its risks, including failure and the much greater medical risks associated with pregnancy and childbirth, the overall safety profile of modern IUC is among the best in the contraceptive armamentarium.

When to consult HCP; Warning symptom s & Signs while with IUD:
    One needs to call a health care provider immediately if any of the following symptoms or abnormalities appear e.g.
8)     String can no longer be felt, possibly the device has fallen out of womb.
9)     Something hard is felt in her vagina or at the lower end of cervix. It means that one is palpating the lower part of vertical arm of the device. It the device remains at its proper place then it can neither be seem by HCP nor can be felt by the acceptor. Therefore if device itself becomes palpable it implies that device has come down and possibly is on the way of expulsion.
10)                 Strings seem shorter: It may imply that the device might have undergone some rotation on long axis of womb and has coiled up in the womb. If the string seems longer than before it may imply that device has started to descent while the device still remaining in the womb.
11)                 A missed or a late period, a very light period, severe cramping and/or abdominal pain which was not experienced earlier may mean pregnancy outside the womb i.e. ectopic pregnancy.
12)                 Client considers that she has been exposed to STD.
13)                 Bleeding during intercourse or,
14)                 Foul smelling vaginal discharge (acute pelvic infection i.e. infection of upper genital organs).
If any such situation arises then the acceptor should consult HCP within couple of hours.

Management of possible side effects of the IUD:
The list of possible side effects associated with IUD use are:
vi)                        Uterine Cramps
vii)                   Menstrual irregularities
viii)             Pelvic infection
ix) Spontaneous expulsion
x)      Accidental Pregnancy
    Many do not have any adverse effect at all and keeps fine. That is also why the IUD called worry-free contraceptive a forgettable contraceptive. Only few have symptoms and a few are bothered or distresed with side effects. The common discomfort quoted by the acceptors are ‘bleeding irregularities’ and ‘pelvic pain’. Why some women have side effects and other women escape? Firstly, health care providers need to know that not all women are suitable for IUD. Therefore if the acceptors are not properly selected then IUD related side effects will be more. For instance if there is pelvic infection, or uterine abnormality then side effects are bound to occur. If IUD is fitted inadvertently in such women. Side effects thus can be minimized by proper selection of clients and strictly adhering to contraindications of IUD use as framed by W.H.O. and other international agencies. Secondly, these side effects can be further minimized if the IUDs are fitted by an experienced and skilled nurse or doctor who has adequate training on IUD insertion. The cause of cramps in lower part of tummy either during menstruation (dysmenorrhoea) or in between periods are often caused by slight malposition or malrotation of IUD inside the uterine cavity (womb). The pain is usually relieved by usual analgesics and NSAIDS. Persistene pelvic pain however may not only be due to abnormal position of the IUD associated PID, but also occasionally uterine perforation, beginning of expulsion of the IUD, or rarely ectopic pregnancy may also be the cause pelvic pain. One has to remember that womb is a hollow muscular organ and constantly undergoes contractions and relaxation. During a height of continue muscles of uterus pres the device particularly if it the device is not properly fitted. This may recurrently cause cramp in lower part of belly and irregular bleeding. Scientists have now devise newer frames with flexible joints in the transverse bar of ‘T’ device which allows the IUC to repeatedly yield and accommodate the changing shape of womb with each contraction and relaxation sadly, these devices are still not available in the market.

IUD induced menstrual disturbances (Bleeding related problems):
Variety of menstrual disorders which however occasionally quoted by the acceptor are as follows. 1) Spotting between periods i.e. inter menstrual bleeding 2) heavy periods or longer menstrual flow (menorrhagia). These menstrual aberrations usually last for first three months after insertion of IUD and fortunately most of these subside by three to six months time. Only in few cases HCPs (Health Care Providers) are forced to remove the IUD if the magnitude of suffering is considerable persistent or non relieved by drugs.
j)           Incidence and severity of bleeding:   In a normal menstrual cycle i.e. without any IUD, the mean amount of menstrual blood loss (MBL) was previously thought to be approximately 35 ml. With improved techniques of extraction of blood from sanitary napkins, this amount is now estimated to be approximately 60ml. Excessive or prolonged menstrual bleeding (menorhagia) affects between 5% to 30% of women of reproductive age i.e. general population not using contraceptives. It is more common among women under the age of twenty and over the age forty years than.
The amount of blood lost in each menstrual cycle is slightly greater in women using copper-bearing IUDs than in nonusers. With the most commonly used IUD there is only an average increase of 20-55% in MBL which most women accept. By contrast, with the leonorgestrel releasing IUD (Mirena IUS) which is now used in India for last 5 years the amount of blood loss is significantly reduced, declining to approximately 25ml/cycle.
k)      How to gaze severity of bleeding?  A personal interview and total number of napkins needed per 24 hours will often help the HCP to assers the severity of bleeding. If a woman who is on IUD complaint of weakness in addition to excessive bleeding then HCP can think of chronic anemia due to persistent heavy bleeding. In absence of any other evidence of blood loss e.g. piles, worms infestation and haematemesis the possibility of IUD induced anemia should always be considered. It implies that menstrual bleeding is too much to cause anemia. In these cases the HCP should insist on hemoglobin estimation. If the level is below 9gm% then he (HCP) can request for estimation of serum ferritin level in blood provided such laboratory facilities exists in the locality in which the client resides. Serum ferritin is a very sensitive indicator of tissue iron stores. Persistent menorhagia without concomitant iron supplementation is likely to cause significant decrease in serum ferritin levels. Low blood ferritin is an indicator of depletion of iron store in the bone narrow as well. Therefore a conscientious HCP may occasionally request for ferrtin estimation amongst women with menstrual bleeding disorder and levels less than 4mg/lit should always require oral iron supplementation to prevent further anemia.
l)           Why bleeding and pain? As said earlier most bleeding irregularities including painful cramps occur due to inproper fitting of IUD. If there is slight tilt or rotation of IUD inside the womb or angulation between the long axis of womb and long axis of IUD then device will lead to repeated mild trauma in the inner wall of womb and induce pain and menstrual bleeding. We know that muscle of womb contracts and relaxes at definite intervals even in nonpregnant state. If the device inside the womb is ill fitting then it will hinge the inner wall of womb and induce pain and bleeding during height of contractions. A simili can be drawn with small foreign body (fishbone) stuck at throat which causes pain during each act of swallowing unless the fishbone passes down (antoadjustment) or removed.
In addition to ill-fitting the other causes of pain and excessive bleeding are due to – i) P.I.D. ii) at the beginning of expulsion of IUD iii) associated PID or ectopic pregnancy (tubal pregnancy) All these may cause pelvic pain and bleeding. Hence persistent pain or bleeding should be always investigated properly by the experts.
m)                      How to prevent bleeding:  Besides selecting the acceptor the proper selection of appropriate sized IUD and proper placement of IUD by a skilled person are key factors to minimize bleeding related side effects. Researchers have now been able to devise new devices which cause minimal menorrhagia (excessive menstrual loss). These new IUDs have also succeed in reducing the likelihood of expulsion and lowering of pregnancy rate further. It is hoped that future designs of IUD will focus on reducing these side effects even further.
n)    How to treat pain and bleeding:  For short-term relief three types of drugs are used with varying success. These are tranexarmic acid, NSAIDS or mefanamic acids with varying success. One can try with tranexamic acid, 500 mg 3 times daily for three days and then 500 mg twice daily for 2 day particulars during heavy or prolonged bleeding phases. This drug is available as Pause 500, TX 500 etc. Alternatively, NSAID group of drugs e.g. ibuprofen (400 mg), indomethacin (25 mg) two times daily may be tried. Mefnamic acid tablets are increasingly used nowadays. These should  be taken twice daily after meals for 5 days and this may ameliorate heavy or prolonged bleeding. These are available as ponstan 500 or meftal 500 etc.
Some doctors do prescribe these nonsteroidal anti-flammatory drugs (NSAIDS) e.g. ibuprofen, mufanamic acid etc. prophylactically i.e. from the onset of first menses after IUD insertion and maintain such schedule for three to five consecutive days. This by decreasing pain and bleeding certainly increase clients her confidence on IUD. NSAIDS therefore prescribed in anticipation will yield a dividend most cases.
Occasionally these drugs will not work and heavy or prolonged bleeding persists. If there is no reason to suspect on underlying local i.e. gynecological cause of bleeding, there are two options. Firstly she can continue using IUD method and in that event she should take iron tablets and/or eat foods containing iron, to help prevent anemia. This policy, however, is only acceptable when pain and bleding is partly reduced by above mentioned drugs and the woman is not that distressed with pain and bleeding. But if she shows signs of severe anemia and severity of bleeding is unacceptable then one should remove the device and advise her to choose another method.
Removal due to pain and bleeding is less common among older women, multipara and in long-term users. The removal rate depends a lot on the preinsertion counseling and support that a woman receives and on her altitude, both familial personal, towards her trouble with IUDs.
How does bleeding affects general health of a woman? The effect of bleeding is almost nil in healthy women but may lead to increased anemia already anaemic woman. Indian National Family Health Survey-3 (study period 2005-’06) has unearthed the fact that 39% of Indian women are mildly anaemic haemoglobin level <10 to 10.9 gm/d and 16% are moderately anaemic. There is of   women by 4% the period 1098-99 to 2004-05. <70-9.9 gm (d) and 2% are severely, anaemic (H level   7 g/d).
Anaemic usually passes off within a month or two. The client should be reassured about it. In fact, no aggressive treatment is warranted.
o)    Removal Rate: The single most common side effect leading to IUD discontinuation is disturbance in menstrual bleeding. The experience of excess bleeding is often accompanied by pain also. These two side effects either alone or in combination are not too uncommon. Inspite of adequate counseling and medical treatment in 2-10% of cases IUD have to be removed for persistent menstrual bleeding and pelvic pain. Providers should always offer clients the choice of switching method if they are not satisfied or if their needs or preferences have changed.
p)    How women and society view about normal menstruation?:  Women’s attitudes about menstruation are shaped not only by experience but also by beliefs about the social and cultural meaning of menstruation and what is acceptable monthly bleeding, taboos, and behavioral restrictions. Although not all belifs are reflected in practice, in many places cultural and religious beliefs prevent menstruating wome from participating in worship, sex, domestic works and many social activities. In some societies menstruating women should not visit places of worship. In some conservative societies menstruating women are not allowed to perform event heir domestic chores such as cooking and washing clothes. Sexual intercourse should be avoided during monthly bleeding. In contrast, only about half of women in the united kingdom, the only developed country in the study, believed sex should be avoided during monthly bleeding. Even among women who thought that it was acceptable, however, many did not have sex then as a matter of personal choice.
q)    How a woman react to menorrhagia?: If is retreated that these bleeding changes are rarely harmful, and they do not signify underlying or impending illness. But a woman reacts to bleeding changes and to what extent one tolerates depend on many factors, such as on the type and severity of bleeding changes and how severe it is, or whether it interferes with her daily activities or personal relationship, and also traditional beliefs or restrictions surrounding bleeding days. These changes however are not signs that something is wrong with her health. It is not the bleeding change itself, but rather how the woman feels about it and interprets it that will determine how she reacts. It should be stressed that these bleeding changes are normal and not signs of serious illness.

r)        Do other contraceptives cause such bleeding?: Bleeding and spotting at unexpected times are also common among women using oral contraceptives (20% of cases particularly during the first three months). The good news is that this drop to about 10% of cycles during the next three months, and to approximately 5% of cycles during the last six months of a 12-month period.
In summary, the following information may help the clients.



b)    Spotting or light bleeding        b)   Heavier or longer menstrual
between menstrual periods.            bleeding than normal
(not amounting to anaemia)            menstrual periods. (The amount
                               blood loss is such that there is a
                               threat for becoming anaemic)

e)                 HCP should counsel that spotting or light bleeding is common during the first 3-6 months of copper-bearing IUD use. It is not harmful and usually decreases over time.
c)                   The following treatment should be offered during the days of menstrual bleeding.
Non-steroidal anti-flammatory drugs (NSAIDS) or Tranexamic acid haemostatic agent). Aspirin should not be used.
f)                     If she desires treatment, a short course of non-steroidal anti-flammatory drugs (NSAIDS) may be prescribed during the days of bleeding.
d)                If bleeding continues to be very heavy or inspite of blood coagulating agents and there are clinical signs of anaemia, or if she finds the bleeding unacceptable, early removal of the IUD is the best option.
g)                 If women is bothered with persistent spotting and bleeding then one should exclude other gynecologic problem. If a gynecologic problem is identified, it should be treated by a specialist. There is no need to removel IUD.

h)                If no gynaecologic diseae can be held responsible for bleeding, and she finds the bleeding unacceptable removal of the IUD should be done and one should help her to choose another method.

(Courtsey:   World Health Organisation)

3. Pelvic infection (PID-Pelvic inflammatory disease):
    Female genital organs are arbitrarily divided into two compartments e.g. lower genital tract and upper genital tract comprises of external genitalia (vulva) and birth canal (Vagina). The upper genital tract comprises of womb (uterus and its mouth i.e. cervix), fallopian tubes, with i.e. egg transport tube which carries eggs from egg relasing organ (ovaries) to womb.
PID is the infection of upper genital organs. The abbreviation ‘P.I.D.’ stands for ‘Plevic Inflammetory Disease’. There are many organisms responsible for PID. Some organism responsible for sexually transmitted diseases can also cause PID. Poor hygiene, under-nutrition, pelvic tuberculosis and above all repeated induced abortions can initiate PID. Abortion can procedure even if carried by experts in an clean environment can result PID. So surgical abortion is not cent percent safe and should be avoided as far as possible. The long term ill effects of PID are chonic pelvic pain. low backache. Infertility or pregnancy in fallopian tube, i.e. ectopic pregnancy. The very anatomy of fallopian tube and crypts in cervix are such that any infection in these areas are difficult to cure by drugs surgery permanent.
Coming to the question of whether IUD inserted inside the womb will invite PID or not was a debatable issue. Opinion of scientists still vary people have different views. In the decades of seventies and eighties both reproductive scientists as well as acceptors of IUD firmly believed that the risk of genital infection will remain high during the entire period of IUD wearing. In the 1992 international conference on IUD critically analyzed the review published by WHO which was meta analysis (summary of many studies analyzed together) involving nearly 22, 908 IUD users (using a total of 10 different IUD types) around the world. Result of that reviend supports the relative safety of IUD use so far as PID is concerned. All the researchers unanimously and firmly concluded that copper IUDs do not promote PID.
    Metaanalysis also point that PID rates were highest among young IUD users in certain geographic regions. PID rates were high among IUD users in Africa and lowest in China were bilateral monogamy is the usual rule.
The observers who were in charge of analyzing such data finally concluded that much of the IUD associated PID occurs in women who are at higher risk of STD infection, i.e. primarily women with more than one sexual partner or whose partner has other sexual partner.
To summarise on the issue of IUD induced PID’ it may be infersed that a) overall, the rate of PID among IUD users was very low (1.6 cases per 1,000 woman years of use) b) the rate of PID was highest during the first twenty days after insertion (9.7 cases per 1,000 insertion) and remains low and stable thereafter (0.5 to 1.4 cases per 1,000 woman years of use) c) some physicians employ preventive antibiotics before inserting the IUD, but the meta analysis did not find that this was helpful. d) twenty days after insertion of IUD the risk of PID remain very low, even among users who had an IUD in place for eight years or more. In the event the woman develops evidence of genital infection (P.I.D.) while on IUD it is not necessary to remove IUD. Instead potent antibiotics should be prescribed in consultation with HCP. Removal of the device during the infection does not ameliorate her symptoms or modify the course of PID in any way. IUD, however can be removed if the client so demands or if evidences of infection do not subside inspite of adequated treatment for reasonable period of time.

Spontaneous expulsion of IUD and management of missing thread:
    The management of such complications is detailed below and a knowledgeable acceptor can react readily if such mishap ensues.
    An estimated 2% to 8% of IUDs are expelled from the uterus within the first year of use. After insertion of IUD there is a natural tendency of uterine contractions to push the device (a foreign body) downwards, causing partial or complete expulsion though the T-shaped frame itself and the irregularity present in the T-arm prevent downward displacement of IUD.
    Expulsion is most likely to occur during the first three months after insertion. Several factors influence the chances of expulsion. Young mulliparous women have higher expulsion rates for all devices than parous women. After the first child there is a negligible effect of increasing parity on the expulsion rate. However, IUD expulsion rates seem to decline in a fairly linear fashion with increasing age. Women who had painful menstruation or abnormally large menstrual flow are more prone to expel copper-T-IUDs. The main increase in expulsion rate occurs when IUDs are inserted during the menstrual flow and is probably linked with extra myometrial activity (muscles of womb) at that time due to presence of excessive prostaglandins (a chemical agent).
What is the advice for acceptors?
All acceptor should palpate the thread after cessation of each menstrual period. If client is unable to feel the string herself she should seek help of HCP. Till then she should use some other contraceptives Similarity if the client can feels the plastic part of device it means that device has slipped down and then also she should visit HCP. Thus if the client can feel the lower part of frame in the cervical canal (neck of the womb to be more precise) then possibility of threatened expulsion is suspected, and she should immediately consult HCP. HCP too if cannot feel or visualize the string then the provider should consider three possibilities.
d)    The IUD has fallen out of body without the knowledge of the acceptor. This may happen during menstruation, defecation or urination.
e)     The IUD has changed its position inside the womb (coiling up) and in the process it has drawn string upwards inside the womb.
f)         The least possible cause is its perforation inside tummy (very rare).
What HCP will do in such situation?
    In this situation, after pelvic examination has been performed and the possibility of pregnancy excluded by urine test an ultrasonography should be done which will confirm or refute the position of IUD inside the womb. Ultrasonography can enrich us with three types of report e.g. a) The device is still inside the womb (coiling of IUD). In such situation the device should be removed by a minor operation e.g. hysteroscopy or more D & C depending on the expertise of the surgeon. A fresh device may be inserted if the couple commonly dicers. b) Device but has perforated the uterus and is in tummy. If sonography confirms that the device has gone inside the belly then it should be removed by laparoscopy. c) More commonly the sonography will reveal that there is no IUD either inside the womb or inside tummy. Then it may be inferred that device fallen out of the body. In such case another device may be fitted provided woman agrees else couple can opt for some other contraceptive method of their choice.
    In all such cases where string can’t be palpated a postcoital contraceptive should be considered if she has recent sexual activity and a backup contraceptive should be adopted till another contraceptive selected.

Limitations as a contraceptive:
10)                 Side effects in some women in the form of pelvic cramps and irregular bleeding.
11)                 Spontaneous expulsion of IUD:   IUD may be expelled spontaneously from the womb without the knowledge of the woman in up to 10% of women. This will be evidenced by inability of the woman to feel the string of IUD in the upper part of birth canal. The expulsion rate of IUD during first year of use is high and it is rare to have IUD expelled after first year of use.
12)                 Invites infection to genital tract:     There was a longstanding debate whether presence of IUD inside the womb invites infection to cause P.I.D. (pelvic inflammatory diseases). Now different international studies have proved that in monogamous relationship IUD does not promote P.I.D. Still many skeptic scientists do not recommend IUD insertion in nulliparous women in care there is IUD induced infection which may lead to infertility in later life and according to them IUD is not a good choice for nulliparous women (category 2 risk). But many unmarried or nullparous married women have been fitted with IUD and results are encouraging. We will have to wait to see whether IUD can still be used in polygamous women and nulliparous women but certainly the old belief that IUD incucing PID is fast fading.
13)                 Discomfort during fitting:  Insertion of IUD requires a minor medical procedure which may be somewhat uncomfortable particularly who are apprehensive.
14)                 No preventive action on STI:  Contraceptives are primarily viewed as method of pregnancy prevention rather than STI prevention. Most women especially those who are married or in stable relationships choose methods to prevent pregnancy rather than to prevent STI. As IUD does not offer STI protection hence women should use her own judgement regarding necessity of condom use in addition to IUD in their married life. She can use barrier method in and for many women suggesting condom use is difficult since condoms are often associated with commercial sex rather than marital sex.
15)                 Stoppage of method necessitates medical help:  Unlike barrier methods or oral pills client cannot stop using IUD of her own. The woman should never try to pull the string herself. She has to go to a clinic for removal of IUC.
16)                 Compared to combined oral pills there is slightly increased risk of ectopic pregnancy i.e. pregnancy occurring is fallopian tubes, but this risk is less than women not using any contraceptive whatsoever.
17)                 Rarely perforation of uterus may follow and device can go inside to the tummy (very rare indeed).
18)                 Misplacent of IUD: An IUD can descent while still remaining inside the womb and thus occasional failure i.e. accidental pregnancy can follow. In fact contraceptive failure may be due to expulsion, perforation, descent or coiling up of the device inside the womb.

Risk stratification of women as per WHO guidelines:
    Women with some associated gynecological or medical diseases face some risk if IUD is fitted. The anticipated risks or dangers are graded as 1,2,3 & 4. Earlier people used to categorize the risk of contraceptive use as obsolete contraindication and relative contraindications. Nowadays category risk 1 implies no risk and category 2 risk means slight risk (relative contraindication). Category 4 means absolute contraindication and category 3 implies it is better to avoid the choiced contraceptive in that particular diseases.

WHO risk categorization of IUD use is as follows:
C)    Category 1 risk:  The existing medical or gynecological disease does not cause any harm to client neither it intensify IUC related side effects.
D)  Category 2 risk:
i)                       Age menarche to women.
j)                       Endometriosis
k)                  Menorrhagia
l)                       History of previous pelvic infectious diseases without subsequent pregnancy and assuring that there is no current risk factor for STD.
m)          Vaginitis including trichomonal vaginitis and bacterial vaginosis
n)                Thalassaemia & iron deficiency anemia
o)                Complicated valvular diseases of heart
p)                Soon after second trimester abortion.

Uterine pregnancy:
A.   Causes of pregnancy:
d)                This unfortunate event usually follows when the device has fallen off the body without the knowledge of the acceptor.
e)                 Pregnancy may also occur if the device is coiled up inside the womb i.e. upward displacent of the device but the device still remaining inside the womb. HCP should always remember that to have desired contraceptive effect the IUD should be so located that it almost touches the top part of womb. This area is medically called fundus of uterus. If the device is coiled up inside the womb then copper ions will be released low down in the womb and contraceptive efficacy with fall.
f)         If device has descended downward i.e. in the lowermost part of womb thereby vertical limb of the device lying in the cervical canal.
B.   How to minimize accidental pregnancy:
As mentioned earlier spontaneous expulsion of IUD or malposition of the IUD can often be minimised if IUD is inserted by a HCP who has adequate training and skill in IUD insertion. Correct high placement of IUD is a prerequisite for proper achieving near 100% contraceptive action. But the author has witnessed about six dozen of such cases where the device which was inserted by a skilled doctor has descended down still remaining in the womb. This is possibly unavoidable and happens due to contractions of uterus. Normal uttering contraception’s sometimes succeed in pushing the device down particularly if the uterus is relatively large in size. A six monthly ultrasonography may detect the correct position of IUC in womb and can alert the HCP & client that the device has started falling from its original location. The other ill-effect of decent of IUD is that if the deice comes down then copper ions released will be well below fundus of uterus. This will be unable to exert desired contraceptive effect. The process of descent of IUD from womb to final expulsion can be associated with cramping increased vaginal discharge, or uterine bleeding. However, in some cases, the only premonitory symptom is lengthening of the IUD string thus the golden rule is to palpate and search not only for strings but also to search or hard any plastic mans in the neck of the womb i.e. opening of the womb (external os).
C.   Incidence of accidental pregnancy:
Fortunately, the annual incidence of accidental pregnancy decreases steadily after the first year of IUD use. The cumulative pregnancy rate after seven years of use of the copper T380A IUD (most common brand used in India) is only 1.6%.

D.   Complication of pregnancy while IUD still remaining inside womb:
If she is pregnant with IUD still inside then there will be an increases risk of spontaneous abortion. If the IUD is not removed then the incidence of spontaneous abortion which is approximately 55%, or roughly three times greater than would occur in pregnancies without an IUD. More than half of the spontaneous abortions in IUD users occur in the second trimester. However, if the IUD is removed right after conception than the risk of abortion is close to average abortion rate (about 20%). For some reason or other the gestational period between 14-24 weeks is dangerous (if the IUD is not removed) because severe infection (sepsis) may occur. The genital sepsis can be fatal and hence once pregnancy is diagnosed, IUD should always be removed.
E.   Client wishes to continue pregnancy - What to do?
If a woman using the IUD becomes pregnant and wishes to continue the pregnancy then IUD should be removed at the earliest to avoid increased risk of spontaneous abortion. These will also obviate the increased risk of septic abortion in the second trimester and increased risk of premature delivery. There is no evidence that the IUD in a pregnant woman increases the risk for birth defects in the foetos.

F.   The client does not wish to continue pregnancy:
She should be advised to undergo surgical termination of pregnancy preceded by removal IUD. Medical abortion i.e. abortion by drugs is not recommended while IUD is still inside the womb. However, abortion by drugs can be carried out after removal of the device. The following procedure should be adopted if a woman using IUC is having delay in starting period. Firstly she should palpate for strings. Secondly, urine for pregnancy test is to be contemplated. If the urine test is negative she can repeat the test after ten days. If this test is also negative she can take tablet Orgamed (10), one tablet for ten days which will help menstrual bleeding and allay her anxieties. This natural delay in period is most commonly due to breastfeeding. If urine test is positive then one should exclude possibility of ectopic pregnancy i.e. pregnancy occuing outside womb. This can be done by serial blood testing for βhCG hormone and ultrasonography. In addition gynecologist’s advice is a must.
    The concerned HCP should alert the acceptor that if the device is not removed as soon as pregnancy is diagnosed then she is at risk of second trimester miscarriage, pre-term delivery and above all severe infection of womb if the IUD is left in place IUD removal is mandatory and the removal of the IUD reduces these risks, although the procedure itself entails a small risk of miscarriage. After removal of IUD she can continue the pregnancy if she so wishes but there will be always some risk of miscarriage, preterm delivery. If she opts to continue pregnancy she should be advised to seek medical care promptly if she has heavy bleeding, cramping, pain, abnormal vaginal discharge or fever. If she does not want to continue the pregnancy, surgical termination of pregnancy may be contemplated along with removal of the device.

Ectopic Pregnancy (Pregnancy occurring outside the womb i.e. in the egg-transport tube).
    Any pregnancy in an IUD user, inside or outside womb is uncommon and thus IUD users are 50% less likely to have an ectopic pregnancy when compared with women using no contraception. It is well known that infection of fallopian tube (P.I.D.) can favor ectopic pregnancy at a later date. Earlier, medical fraternity used to believe that IUD promotes pelvic sepsis including infection of fallopian tubes. HCP many believe that IUD may promote ectopic pregnancy at a greater rate than usual population. But that is not true. It has been proved now that IUD does not provoke pelvic infection if cases are properly selected (clients without risk of STD). Sadly, the bad reputation of IUDs regarding increased incidences of PID and increased rate of ectopic pregnancy (EP) still prevails not only in the minds of common people, but also amongst doctors.
    The rate of ectopic pregnancy in the general population vary depending on sociocultural and sexual behavior of the men and women of the locality. The estimated ectopic pregnancy rate among sexually active women using no method of contraception has been estimated to be between 3.25 and 8.0 per 1000 woman years. Contrary to popular belief the incidence of ectopic pregnancy among IUD users is between 0.125 and 4.0 per 1,000 women years of IUD use.
    If we consider the ratio of ectopic pregnancies, to total accidental pregnancies while still wearing copper IUDs it is seen that rate of EP is 39 per 1000 total pregnancies. This is almost similar to the ratio of 43 per 1000 pregnancies while not on contraceptives. From this stand point it may be inferred that if a woman becomes pregnant with IUD in place, her risk of ectopic pregnancy is increased compared with the overall population of pregnant women. In fact, protection against all tubes of pregnancies provided by both Tcu-380A is so great that WHO has put these devices as category 1 (i.e. safe to use) even in women with previous ectopic pregnancies.
    Though the incidence of ectopic is very low still it will be prudent to warn the women using IUDs about the features of ectopic pregnancy. They should be informed about common symptoms of EP e.g. abdominal pain, ‘dark and scanty’ or ‘inter menstrual bleeding’ along with the usual signs of pregnancy. The women concerned should visit HCP urgently if these symptoms appear. Another note of caution. If an IUD user conceives, health care provider should always look for ectopic pregnancy by sonography and serial blood tests for beta-hCG hormone.
    In summary it may be said that IUD users are statistically less protected against ectopic pregnancy than users of other contraceptive methods. One should remember that IUD does not prevent ovulation and possibly does not impede fertilization. IUD prevents nidation by primarily altering the inner environment of womb. Thus IUDs protect intrauterine pregnancy more effectively than extra uterine pregnancies.

Newer Copper IUDs:
    Researchers continue to develop and test new IUDs that may reduce expulsion rates and other side effects. Among the devices being that has become successful is CU-SAFE 300. It is smaller, lightweight, and flexible T-shaped copper IUD which can be inserted without a plunger and is designed to move towards the uterine fundus (the top of the uterus) when the uterus contracts. Additionally another new device is getting fast popularity i.e. frameless IUD consisting of six copper sleeves on a surgical nylon thread. It is also Flexi Gard 330, or Cu Fix PP 330. The thread is knotted at one end, which is anchored in the muscle of the fundus. In clnical trials the device has proved to be highly effective and comfortable to use. A Copper bearing IUD with a T-Shaped frame, called the Sof-T is becoming popular at smiliserlad. In thus new device. The tip of each end of the arm consists of a soft ball, designed to prevent perforation and to block the openings to the fallopian tubes in order to prevent sperm from entering.
    The very purpose of these new devices is to reduce pain and irregular bleeding associated with in the existing copper beeaing IUDs including the most popular type i.e. T-Cu-380A. Earlier the plastic frame where of different shapes e.g. coil, ‘s’ shaped, circular, triangular or elliptical. Now the only shape recommended is ‘T’ shaped because the cavity of womb is like ‘T’ which fits well with geometric of uterus and adaptation inside the womb is satisfactory if the plastic is of some other type then the frame will hinge the inner wall of womb and cause uterine camps and possibly bleeding.
Additionally the very plastic used is now made up of more flexible material. We are aware of the fact that womb contracts and relaxes spontaneously at varying intervals without the knowledge of a woman. If a ‘rigid’ plastic frame is used then it will not yield or bend to accommodate the shape of the contracted womb. So a rigid plastic frame is bovend to cause cramps and bleeding irregularities. However new copper IUDs discussed below are not approved for use in all countries. Till date the developers and manufactures report fewer expulsions, higher continuation rates, lower failure rates and easy insertion-removal as main advantages of all these new copper IUDs.
Chapter XII ABC BOOK (Contraceptives for sick women)
Role of POP in women with high blood pressure:
    Women with high blood pressure are prone to have ‘heart attack’ or ‘cerebral stroke’ i.e. bleeding from arteries inside brain matter or clotting of blood in venis inside the brain substance. It is said that hormonal contraceptives by changing coagulation system in the body and by altering fat metabolism adversely promote these fetal accidents. Thus one should try to avoid hormonal contraceptives in hypertensive women. But it is equally true that the hormonal contraceptive and IUD (Intrauterine Device) are the two most reliable temporary methods of contraception. The existing other temporary methods are not so much effective. Therefore, if one options for effective temporary method the option will be either IUD or hormonal methods. But many Indian women do suffer from variety of gynecological diseases where use of IUD is contraindicated. In them one has no other option but toprescribe hormonal contraceptives even if her blood pressure is slightly raised. Thus one has to make a balance between efficacy and risk of contraceptive use in women with high blood pressure.
    POP, though a hormonal contraceptive but the hormone is used in very low dose. So POP is reasonably safe to prescribe in women with mild to moderate hypertension even if she is on antihypertensive (i.e. drugs to check high blood pressure). To initiate POP the upper level of blood pressure (systolic) should be ideally less than 159 mm of mercury and the lower limit of blood pressure (i.e. diastolic) should be below 99 mm o mercury. These readings may be with or without blood pressure reducing drugs. But POP is not usually prescribed in women if blood pressure is above 160 systolic and or above 100 mm of mercury diastolic (WHO category 2 women for POP usage). That is only in special circumstances particularly when more appropriate methods are not available acceptable to the couple then only POP may be used in such women. The HCP need to assess the severity of her circulatory system and whether the woman will come regularly for follow up. Conceivably, these women mandate frequent three monthly follow up of POP is at all used.
    It may be recalled that traditional COCs are very risky (category 3) in women with such high blood pressure. Copper bearing IUDs are the safest the temporary contraceptive method for hypertensives and diabetics too. The other options are POP Mirena IUS (Hormonal IUD). Though women with slight elevation of blood pressure may use hormonal IUS but if hypertensive is severe (blood pressure > 160/100) then she should not use LNG-IUS.
RISK SATISFACTION OF HYPERSENSIVE WOMEN

Mild hypertension
BP < 140-159/90-99
Severe hypertensive
(> 160/100)

Barrier
1
1

LAM
1
1

COC
3
4

POP
1
2

Quarterly Shots
2
3

Implants (Implanon)
1
2

Combined monthly Injection
3
4

Copper containing IUD
1
1

Hormone releasing IUS
1
2

History high BP in pregnancy but current level is normal – COC is category 2 risk but POP and Quarterly Shot may be used.

Safety POP in Diabetes: (high blood sugar):
    In recent times prevalence of diabetes and high blood pressure has gone up in India. What about use of POP in diabetics? Is POP safe? The following is the guideline.
4)     Those who had temporary rise of blood sugar during pregnancy (gestational diabetes mellitus) they can safely use POP. Alternatively, they can also use COC with no added risk (zero risk or category I women for COC usage). In fact all methods are safe for women who had such temporary rise of blood sugar.
5)     Those with established diabetes but sugar is within control, they can also use POP or COC provided there is already no change in the blood vessels as evidenced by eye (retinal) examination. Even those who are using insulin can use COC or POP provided diabetes is well controlled and there is no associated vascular disease. However, these two hormonal contraceptives i.e. POP and COC are contraindicated if diabetes is not well controlled.
6)     Those diabetics who had already some retinal changes (vascular changes in the eye ball as evidenced by simple clinical examination by ophthalmoscope, Kidney changes or nerve changes they too can use POP (category 2 risk). COC will be more risky in such women (category 3 risk). In fact all methods except copper bearing IUDs are category 2 risk for women with established diabetes mellitus. It is needless to mention that barrier contraceptive and natural family planning methods fertility Awareness method) are safe options but efficacy of these are limited. Use of spermicides in uncontrolled diabetics may invite severe pelvic infection and thus not recommended.

POP in HIV and contraceptive choices for HIV Women:
    Women account for nearly half of the estimated 40million cases of HIV infection worldwide. In 2006 on estimated 17.7 million women ages 15 and older, or about 13 in every 1,000 such women, were infected-approximately one million more than in 2004.
    Like all other women, women with HIV have the right to make their own decisions about their reproduction and sexual health.
    Women with HIV face many decisions about living with HIV. Decisions about sex and childbearing can be among the most important. She may also need to ask her partner if he knows his HIV status and, if not, encourage him to seek HIV testing.
    Preventing unwanted pregnancy is a key element in the four-element strategy for preventing mother-to-child transmission of HIV. As indentified by the UN in the Glion Call to Action on Family Planning and HIV/AIDS in Women and Children, the four elements respond to health care providers’ four opportunities to reduce mother-to-child transmission. The Glion Call to Action states that all four elements are essential for meeting the UN goal of halving the proportion of infants infected with HIV by 2010.
    All hormonal methods appear to be safe for women with HIV. Theoretically, certain antiretroviral (ARV) medications could reduce the effectiveness of low-dose hormonal methods, but
CHAPTER – V(Final)
Intrauterine System---Hormone bearing IUDs

Overview:
    Intrauterine contraceptive devices or IUDs are materials which when introduced inside the womb (uterus) exert contraceptive effect usually 3-12 years depending upon the material with which the device prepared. Intrauterine contraceptive device of ‘first generation’ were made only of plastic material. These were called insert IUDs or plastic IUDs. Unlike present day copper releasing IUDs there first generation IUD did not contain only active metal or hormonal agent which could exert added contraceptive efficacy. There insert IUDs exerted their contraceptive efficacy mainly by mechanical limitation inside womb. None these less these IUDs were popular in the decodes of sixties and early seventies but due to their poor contraceptive efficacy and increased side effects (bleeding and pelvic pain) these insert IUD ere replaces by copper containing IUDs which soon because popular. There are called second generation IUDs. In fact copper containing IUDs which was introduced the late seventies are still the most popular IUD.
    There are some women who are unsuitable for copper containing IUDs. These women usually have some gynaecological complaints or disease e.g. menorrhogia, small myoma (tumors of womb) or endrometrioss etc). Such women will be benefited by fitting with an IUD which contain progesterone hormone. These progesterone are called first generation IUDs. The progesterone hormone used in the device is Levonorgestrel the abbreviation of which LNG and the contraceptive device is called ‘LNG-IUS’.
    In view of the fact that such hormone containing IUDs release progesterone inside the womb these devices will take care of existing gynecological disease in addition exerting contraceptive action. Thus women suffering from above quoted gynaecological diseases will achieve dual benefit of ‘disease control’ as well as ‘contraception’ by the use of ‘LNG IUS’. But readers should not be impression that  these IUS are meant for contraception of diseased women only. LNG IUS device can certainly be used in healthy women too particularly where copper containing devices are not chosen by the acceptor.

Composition:
    Like copper bearing IUDs the frame of IUS device is also made of a light, T-Shaped plastic frame with the stem for the T a bit thicker than IUDs. It is stem which contains a tiny storage system of contraceptive hormone levonorgestrel. The device is 32 mm in length and 4.8 mm in diameter. Like copper being devices it is also impregnated with barium sulphate which makes it radio-opaque. So that device became visible by ordinary X-Ray.
    In fact the hormone reservoir designed as a sleeve of 52mg of levonorgestrel mixed with polydimethyl siloxane elastomer (see fig). This sleeve in turn surrounds the vertical stem and is covered on its outer asfeet by a membrane, which regulates the intrauterine release of progesterone hormone from reservoir. There is release of 20 mcg per 24 hours with passage of time. The release rate slowly decreases to about 15 mcg per day with the fifth year of use and to about 12 mcg per day at the end 7 years.
   
Brand Name:
    The levonorgestrel-releasing intrauterine system (LNG-IUS) ‘Mirena’ or ‘Levo Nova’. This device was approved in the country of origin, Finland, in 1990 FDA of US issued its approval in the year 2000. It is manufactured by Leiras OY (Turku, Finland), and it is currently on the market for contraceptive use in 88 countries including India. In some country have, it is viewed chiefly for treatment of menorrhagia and as progestin component in postmenopausal hormone replacement therapy.
Mode of Action:
1)     Progesterone hormone released from the device impains upward migration of sperm by increasing cervical mucus viscosity.
2)     Progesterone also cause damage to sperms by causing changes in enzyme present in the womb which facilitates sperm transport from womb to egg-carrying tubes (fallopian tubes).
3)     Additionally LNG-IUS acts locally on the endometrium (inner lining of womb) and cause profound changes the future bed of embryo so that fertilized ova cannot get embedded. Thus in case occasionally union between sperm and ova occur in the usual site i.e. egg carrying tube (fallopian tube). When fertilized ova arrived at womb for nidation or (implantation) it foces adverse environment in womb and unable to get embedded.
In summary LNG-IUS either immboliges sperms or inhibits sperm changes necessary for fertilization. It is not an abortificient even if one considers life beings as soon as fertilization occurs.
Unlike oral pills IUS does not alter ovarian function. Because the amount of progesterone absorbed from womb is minimal too modify normal functioning of ovaries. In fact blood level of progesterone is well below 50% of minipill.

Intrauterine Dwelling Time Duration of Efficacy:
    The device is currently approved for a period of five years and removal should follow thereafter. If a woman desire to continue contraceptive use, the device can be replaced after stipulated five years and a new one fitted immediately after removal of the used device. But recently evidence is fast accumulating that LNG-IUS retains its contraceptive efficacy for seven years. Many trials have affirmed such claim.
     There is evidence that the copper T 380A the most popular brand of IUD has an effective life span of at least 12 years, during which time the pregnancy rate remains very low.
Contraceptive Efficacy:
    LNG-IUS (Mirena a Leva Nova) is a highly effective long-acting, reversible contraceptive associated with a cumulative gross pregnancy rate of 0.0 to 0.5 for 4 or 5 years or with a pearl index (See Page   ) of 0.0 to 0.2 for 7 years. In fact it is so effective contraceptive that it is aptly called ‘reversible sterilization’.

STD Prevention:
    Unlike male or female condom it does not offer great protection against STI. Nevertheless LNG-IUS makes cervical mucus thick and viscid. Thus it offers some resistance to upward progress of organisms responsible for sexually transmitted infection (STI). As it does not completely elements the possibility of acquiring STI. Therefore women who are at risk of STI should be advised to use barrier contraceptive in addition (dual protection).

Advantage as Contraceptives:
1)     Highly effective: Failure rate of only 0-2 per 100 women years.
2)     Minimal hormone related systemic side effects:   The hormone used in LNG-IUS is also used in most contraceptive pills including minipills, and subdermal impalants (implanon). In IUS however, a much lower does is released is body than when one takes contraceptive pills. Further in case of IUS the hormone is deposited directly in the lining of the womb, rather than in the blood stream. Hence progesterone related side effects are less common with IUS.
3)     Makes quality of life better in selected women:  LNG-IUS has a definite edge over copper IUDs as it does away with a number of problems associated with conventional IUDs. For instance LNG-IUS causes light and less painful periods instead of excessive and painful periods as with copper containing devices. It also reduces the amount and duration of monthly period.
4)     Does not alter the ovarian function and other natural hormones of body:   The normal ovarian functions are not disturbed neither the ovulation process is suppressed. This is because during use of the LNG-IUS release of progesterone (Levonorgestrel) is limited to 20mcg 24 hours amount yield to a of progesterone well plasma levels below 0.2mg/ml. The level i.e. minimally required suppress ovulation.
In short LNG-IUS is a reversible method and unrelated to sexual: The best features of this system is its high contraceptive efficacy, reduction in MBL (menstrual blood loss), protection against ascending pelvic infection,a nd minimal interference with ovarian function.

Limitations of contraceptives:
1)     High Cost:
It is good contraceptive for women of developing world because the main non contraceptive benefit of LNG-IUS is decrease in menstrual blood loss. This makes it as the best choice in women with anemia. It is well known that both nutritional anemia and iron deficiency anemia are prevalent in women of developing countries. But unfortunately, women of resource poor countries cannot afford to high cost (Rupees six thousands in Indian currency to purchase LNG-IUS contraceptive.
2)     Irregular bleeding:
The other disadvantage is irregular intermenstrual bleeding or amenorrhoea, neither of which are acceptable in some cultures. Nevertheless continued use of the device greatly diminishes menstrual irregularity. But to achieve this she has to use it at least for six to eight months. Thus the first 4-6 months is crucial and great patience is to be exercised. Continuation for first six months depends chiefly on attitude of the client as well as on good counseling before and after the IUS is fitted.
3)     Must be fitted by a trained doctor:
Unlike copper IUDs this specially designed IUS cannot be inserted by nurses or paramedical personnel. This is simply because the stem of vertical limb of the device is much thicker than most copper containing IUDs. So in most cases insertion will require some dilatation of cervix preferably under short anesthesia. Thus fitting of IUS is technically a bit difficult and only skilled persons can fit the device properly.
4)     Spontaneous expulsion:
This is rarely possible. In such an unfortunate the women gets disappointed. She incurs some financial loss too.
5)     Mal position of IUS:
Through rare but this can occur either during the insertion process or subsequently. It is noteworthy that all IUDs and IUS are susceptible to undergo axial rotation while still remaining inside the womb. This happens due to normal contraception and relaxation of the musculature of womb.
6)     Not all women are suitable for IUS: Role of Pre insertion hysteroscopic evaluation:
There are some women who has some disease of womb e.g. inside partition, small tumors or polyps abuting the inner cavity of womb. They are unsuitable for any intrauterine device. If LNG-IUS is fitted without assessing cavity of womb then there remains faint possibility of having persistently annoying side effects which may last for months together such an event will impede the rising popularity of this IUS. To put in other way not all women are fit for IUS and a pre-insertion evaluation by putting a small endoscope inside the womb to access the inner walls or cavity of womb is desirable though not essential.   In fact hystroscopic agreement is seldom practised and this practice is possibly limited to skeptic doctors only.
7)     Unlike copper bearing IUDs, LNG-IUS cannot be used as postcoital emergency contraception.
8)     Pregnancy can follow if the device is expelled spontaneously without the knowledge of the acceptor. This is again a rare event. In summary, though the LNG-IUS may not replace copper intrauterine devices due to its above quoted limitations and high costs, it could certainly be used as a selective contraceptive method for women who would benefit from it.

Non Contraceptive Benefits:
1)     Makes periods lighter from. Most copper IUDs make a woman’s periods heavier, By contrast the LNG-IUS makes periods lighter than usual. As a matter of fact there may be reduction of blood loss up to 94% after 3 months of use and after 12 months reduction may be up to 96%. Many clients won’t believe this! Because of this, it is frequently used as a treatment for heavy periods, even in women who don’t need contraception.
2)     Helpful in many gynecological disease: LNG-IUS ameliorates many gynecological diseases notably memorhagia, (excessive flow either in amount or duration), dysmenorrhoea (painful periods), endometriosis (collection of menstrual blood in the tummy) and myom (a common begin tumor of womb).
3)     Improves premenstrual syndrome often called PMS.
4)     Reduction of pelvic infection:  The device appears to be protective against pelvic inflammatory disease (PID) because of thickening effect on cervical mucus thus preventing ascending infection. The incidence of pelvic infants disease (PID) with LNG-IUS was found to be 0.8 per 100 woman years as compared to 2.2 with copper IUD.

Ideal Candidate:
    IUS is most appropriate contraceptive method for women with menorrhagia (excessive menstrual bleeding) or who prone to have to iron deficiency anemia. It is also suitable for women who are candidates of thalassaemia or sickle cell disease. It is also suitable for women suffering for dysmenorrhoea and or endometriosis. It is an ideal contraceptive who are candidates with bleeding disorders or an anticoagulation therapy. Breastfeeding women after 4-6 weeks postpartum can use it similarly it can be used in women who are mentally retanded as a long term contraceptive. It is safe for epileptics too. In short it is ideal for women who are mother of one or two children and seek long term contraception but there should not be any anatomical abnormality of womb i.e. cavity distortion.

Side effects and managing the problems:
I.           Menstrual Bleeding Disorders:  After insertion of the LNG-IUS there is often a period of frequent irregular bleeding or spotting during the first 2-3 months. This bleeding although small in quantity may be very frequent or continuous in some women. These episodes can cause considerable discomfort and inconvenience particularly to working women. Interestingly though during first two to four months the number of bleeding/spotting days are increased but the total volume of blood loss is reduced compared with the woman’s normal menstruation. However if the woman is dissatisfied with bleeding pattern then it can be managed by prescribing mefamic acid tablets (e.g. meftal tablet 500mg) 1 tab twice daily for 5 days.
She should be counseled that with increasing duration of use she will develop amenorrhea. The rate of amenorrhea towards the end of the 5 year period of use is around 25 percent. This is of considerable advantage to women who are already anemic. Reassuringly the menstruation returns in these amenorrhoeic women within 30 days of removal of IUS.
II.     Progesterone related side effects:
Progesterone induced side effects/bloatedness e.g. Breast tenderness, headache, acne and occasionally depression may occur. These symptoms occur only in few women and pass off as the release rate of progesterone from IUS decreases. 3) Spontaneous expulsion of the device. In such an event the women will be unable to feel the thread in the upper part of vagina. 4) Partial expulsion of the device is also rare. This should be suspected if the women complain that she is feeling something hard in the mouth of womb (cervix) or in the upper part of vagina. This may be associated with pain and cramping. On examination HCP can visualize the lower part of the vertical limb of the device in the cervix. Normally no part of the device should be visible. Only the strings should be thus visible. Thus lengthing of the strings or visualization of part of the device are indications that the device has come down and is going to expel in no time. In such situation the device should be removed and a new one fitted.
Wearing Signs:
1)     Persistent irregular bleeding with pelvic pain:   This may mean ‘disturbed uterine pregnancy’ while IUS still remaining inside or it may be due to ectopic pregnancy (0.02 per 100 woman years.).
2)     Pelvic pain alone:       This may be due to pregnancy occurring in fallopian tube (egg transport tube) torsion of small cyst of ovary or acute P.I.D. (pelvic inflammatory disease). Thought 10-12% of IUS users exhibit sonographic evidence of cyst formation but torsion of such small cyst is very rare (1:2000).
3)     Fever and pelvic Pain:    This may be due to pelvic inflammatory disease or acquiring fresh STI.

Contraindication:
    Absolute contra-indications are a) known or suspected pregnancy, b) current on recurrent pelvic inflammatory disease, c) lower genital tract infections particularly mucopurullent cervicities. d) postpartum or postabortal endometritis i.e. infection of the womb. e) cervical dysplaria f) known or suspected carcinoma breast g) uterine or cervical malignancy h) leukaemia, i) valcular diseases of heart j) severe arterial disease.
    Additionally women with known disease of uterus where cavity distortion has been substantiated by previous investigations (sonography or hystrography or hystrocopy) then such women should be considered as unsuitable for both IUD and IUS.
    Relative contra-indications are history of previous ectopic pregnancy, thromboembolic disease, history of ovarian cyst. Unlike copper bearing devices LNG-IUS cannot be used as emergency contraceptive.

Health Risks:
1)     Pregnancy occurring all side the womb:       The absolute ectopic pregnancy rate is extremely low with LNG-IUS. The ectopic pregnancy rate of 0.02 per 10 woman years can be compared very favourably with copper T users (0.25 per woman years) and sexually active women not using any contraception (1.2-1.6 per woman years). Nevertheless as LNG-IUS is so effective in preventing intrauterine pregnancy, if a pregnancy does occur with the IUS still remaining in womb then there is a high suspicion of being ectopic. The client should be forewarned about this very rare possibility whenever period is missed and home monitoring of UPT (Urine for pregnancy test) is positive.
2)     Performation of womb:  Occassionally performation of womb can occur particularly when IUS is fitted in early postpartum period when uterus is soft. Like copper IUD performation can be confirmed by sonography and will necessiatate laporoscopic removal of the device under general nesthesia.
3)     Risk caused by systemic absorption of progesterone. The blood level while wearing LNG IUS is 50% less than when women use minipill. Thus of all the hormonal contraceptives adds minimum hormonal level in LNG-IUS blow this minimizes the risk to her health. It is very unlikely that such minimal increase of progesterone hormone in blood will exhibit any adeverse effect on lipid profile or cause arterial changes.

Timing of insertion of IUS:
1)     In regularly menstruating women IUS can be fitted within first six days of commencement of menstrual period. No back up is needed. If IUS is fitted seven days after commencement of period then barrier contraceptive should be advocated for next seven days thus that allowing sufficient time to exert its full contraceptive effect. However insertion may be planned at any other day of cycle if there is no sexual intercourse in that cycle.
2)     Six weeks after normal childbirth and four weeks after induced or spontaneous abortion if there is no clinical evidence of sepsis. Some people however have suggested fitting LNG-IUS as early as seven days after an abortion procedure as soon abortion induced pain and bleeding pass off.
3)     Insertion during lactational ammenohea has been after performed, with great satisfaction of acceptor. It can be done as early as 6 weeks but often carried out 8 weeks after normal childbirth. The use of sounding however is contraindicated during such puerperal insertions because musculature of womb is still soft and may cause perforation of womb. The acceptor may be unnecessarily worried about health of child but the daily amount of LNG excreted in 600ml of breast milk is approximately 0.1% of the intrauterine daily dose. Thus there is interference in the development of the newborn.

Follow Up:
    First follow up visit may be planned one week after insertion and later on monthly basis for first three months. Other after unless there is any complaint no routine follow up is recommended but she should continue to feel the thread after each menstrual period and be satisfied that the device has not silent fallen off the womb.
    The idea of first follow up arranging so soon is to discuss with the woman about bleeding symptoms and if there be any pelvic pain. Additionally she should be encouraged to bear the inconvenient of bleeding for couple of days. These simple encouraging words or even telephonic advice will boost up the moral of client to continue the device in spite of minor sick effects or discomfort.
    At follon up visits she should be enquired about any pelvic pain which may imply either descent of the device or malrotation of the device while still remaining in womb to achieve near 95% continuous rate the caregiver should offer ample opportunity to discuss her concerns about IUS. The staff should be caring, helpful and never dismissive. HCP should never cloud her doubts but should try to clarify the unspoken concerns related to IUS. The duty of HCP is to check her blood pressure and record weight HCP should then perform and interval exception and be satisfied with the visible part of the length of thread though such interval exertion is seldom required in intelligent women. However the continuation rate LNG-IUS is 85% after the end of one year and that of copper IUSs is 78%. At last she should be reminded that LNG-US do not prevent STI and if she considers that there is a possibility of STI. She should insist on barrier contraceptive in addition.

Counseling tips:
    LNG-IUS is usually very well tolerated in women who have received careful counseling about the possibilities of irregular bleeding for first two or three month and subquently amenorrhoea. But poorly counseled women may become concerned and even request removal of the device. Thus before fitting IUS it is desirable that counselor should have an unbiased and unhurried discussion with the acceptor explain pros and cons of IUS. Above all trust and confidence in the care givers is as important as candid discussion on this costly contraceptive. Not only the extensive counseling but successful use of LNG-IUS requires good training of doctors who fit the IUS. In fact acceptance and continuation rate of any contraceptive method are dependent on technical and counseling skills of the providers. Further, management of side effects and due attention to complaints also are important factors for high continuation rate poor selection of users or poor counseling result in unnecessarily high request for removal of device.

Copper being devices Vs. LNG-IUS:
    Which device to choose? The opinion of scientists varies in this regard. The side effects, failure rates, discontinuation rates, spontaneous expulsion rates have been compared by different health institutions. For average women cheaper T Cu 380 is better as it has proven efficacy of long 12 years. But after though counseling if potential acceptor is worried about persistent amenorrhoeic induced by Copper being IUD the LNG-IUS may be a better option. No doubt women with gynecological diseases like dysmenorrheal and endometriosis will opt for LNG-IUS. For interested readers short comparison between the two commonly used devices is mentioned below –

Cu T
LNG-IUS
Cu T
LNG-IUS
Cu T
LNG-IUS
Cost
1-1.4 preg per 100 w years
Do




Failure rate
8.4 per 100 users
11.7




Expulsion the rate
3.6 per 100 users
3.6 per 100 users




PID incidence






Discontinuation rate








Myths & Barriers to LNG-IUS use:
1)     There device promote pelvic infection (P.I.D.) thus may invite infertility. In fact IUS do not promote P.I.D.
2)     The risk ectopic pregnancy is unacceptably high. The reality is that incidence of ectopic pregnancy is considerably less end in LNG users than general population not using contraception.
3)     The device may go to inside tummy. The rate of womb perforation is very rare.
4)     The return of fertility be unduly delayed. This is not true.
5)     It cannot be used in nulliparous women. In fact nulliporous women can use it though introduction i.e. fitting of IUS may be comparatives more difficult.
6)     Women affected with HIV cannot use IUS. IUS can be used in women affected with HIV though it is considered as category 3 risk. But IUS’ is very effective. So it can be used to achieve near 100% prevention of pregnancy. Barrier contraception should be used concomitantly to prevent HIV transmission.
The groing evidence suggest that barrier contraceptive as commonly used do not prevent pregnancy all the time. That is the reason why women suffering from STI should avail dual protection i.e. barrier (to prevent STI) along with some effective contraceptives (to prevent conception).

Take home message:
    The LNG-IUS was marketed in US in the year 1995. It is a highly effective contraceptive method which can be safely used for 5-year period. The release of levonorgestrel (LNG) hormone (progesterone) inside the womb represents a new approach in contraceptive technology as it (hormone) exerts local action thus avoids systemic side effects related to hormone.
    The levonorgestrel releasing intrauterine system (LNG-IUS) continuously release progesterone hormone for at least 5-7 years tus offers an effective ‘estrogen free long-acting, reversible contraceptive. It offers effective protection against ectopic pregnancy and due to its low systemic steroidal dose, any side effects are mild and few. It can be fitted four to six weeks after childbirth. It does not affect production if breast milk neither does it affect growth of infant.
    There are some vices as well. The device is costly and not distributed by Govt. of india nor subsidized by an NGO in resource poor countries.
    Many women do suffer from irregular vaginal bleeding for first few months which may be annoying to them. But after four to six months most will have regular periods and by one year majurity will achieve amenorrhoea i.e. nonoccurrence of monthly periods. Inspite of all thee nuisances LNG-IUS does not predispose to any health risk. Nevertheless LNG-IUS remains the only option for w9omen who intend to have long term reversible contraception (no daily commitment). The other such options are implanon and quarters shots. Subdermal implant ‘Implanon’ which is effective for three years are not readily available in most countries including India. Hopefully this will be available in India by 2010.


********************************************
LNG IUS (Mirena/Leno Nova):
    These IUDs are almost same as copper bearing IUDs except that the vertical limb of the T-shaped plastic frame is so designed that it accomodets a small cylinder of progesterone hormone inside. This progesterone filled cylinder continue to release small amount of progesterone daily inside the womb for five year continuously. The levonorgestrel releasing intrauterine system (LNG-IUS) has now become one of the most effective contraceptive methods available. Additionally this hormonal contraceptive primarily exert its contraceptive action by topical action on womb and there is minimal rise of progesterone hormone in blood. Therefore, LNG-IUS has virtually no systemic hormonal side effect. LNG-IUS thus is a hormonal contraceptive method with the lowest hormonal does to be tolerated by a woman. The common brand names are ‘Mirena’ IUS and Levo Nova the Mirena IUS is like many other types of Intrauterine contraceptive Devices (sometimes located IUCD’s or coils) in that it is lay to be fited by a doctor and remains in the womb for a fixed amount of time, after which it must be changed. It is different, however, in that it is much more effective than usual IUD’s and avoids many of the side effects of copper containing IUDs.
LNG-IUS exerts contraceptive effect at least for five years. Nevertheless it continues to release small amount of progesterone in the fifth and sixth year at a smaller dose i.e. at the rate of 14mcg/day. Even this small dose is sufficient to effects contraception. After seven years, however, the contraceptive efficacy falls markedly. Therefore many scientists now recommended that LNG IUS is effective for seven years. In fact people have tried for seven years and they are satisfied with its contraceptive efficacy in last two years also.
***********************************************************


Extract from the Book published on contraceptives:--Dr Srimanta Pal ( (File Name: C:\Users\Dr.Srimanta Pal\Desktop\All 13 Folders on Books_07_09_2010\1) ABC OF CONTRACEPTIVES\Chapter III - Intrauterine Devices Part – II.docx)
CHAPTER – III (Part – II)
Intrauterine System---Hormone bearing IUDs

Overview:
    Intrauterine contraceptive devices or IUDs are materials which when introduced inside the womb (uterus) exert contraceptive effect usually 3-12 years depending upon the material with which the device prepared. Intrauterine contraceptive device of ‘first generation’ were made only of plastic material. These were called insert IUDs or plastic IUDs. Unlike present day copper releasing IUDs there first generation IUD did not contain only active metal or hormonal agent which could exert added contraceptive efficacy. There insert IUDs exerted their contraceptive efficacy mainly by mechanical limitation inside womb. None these less these IUDs were popular in the decodes of sixties and early seventies but due to their poor contraceptive efficacy and increased side effects (bleeding and pelvic pain) these insert IUD ere replaces by copper containing IUDs which soon because popular. There are called second generation IUDs. In fact copper containing IUDs which was introduced the late seventies are still the most popular IUD.
    There are some women who are unsuitable for copper containing IUDs. These women usually have some gynaecological complaints or disease e.g. menorrhogia, small myoma (tumors of womb) or endrometrioss etc). Such women will be benefited by fitting with an IUD which contain progesterone hormone. These progesterone are called first generation IUDs. The progesterone hormone used in the device is Levonorgestrel the abbreviation of which LNG and the contraceptive device is called ‘LNG-IUS’.
    In view of the fact that such hormone containing IUDs release progesterone inside the womb these devices will take care of existing gynecological disease in addition exerting contraceptive action. Thus women suffering from above quoted gynaecological diseases will achieve dual benefit of ‘disease control’ as well as ‘contraception’ by the use of ‘LNG IUS’. But readers should not be impression that  these IUS are meant for contraception of diseased women only. LNG IUS device can certainly be used in healthy women too particularly where copper containing devices are not chosen by the acceptor.

Composition:
    Like copper bearing IUDs the frame of IUS device is also made of a light, T-Shaped plastic frame with the stem for the T a bit thicker than IUDs. It is stem which contains a tiny storage system of contraceptive hormone levonorgestrel. The device is 32 mm in length and 4.8 mm in diameter. Like copper being devices it is also impregnated with barium sulphate which makes it radio-opaque. So that device became visible by ordinary X-Ray.
    In fact the hormone reservoir designed as a sleeve of 52mg of levonorgestrel mixed with polydimethyl siloxane elastomer (see fig). This sleeve in turn surrounds the vertical stem and is covered on its outer asfeet by a membrane, which regulates the intrauterine release of progesterone hormone from reservoir. There is release of 20 mcg per 24 hours with passage of time. The release rate slowly decreases to about 15 mcg per day with the fifth year of use and to about 12 mcg per day at the end 7 years.
   
Brand Name:
    The levonorgestrel-releasing intrauterine system (LNG-IUS) ‘Mirena’ or ‘Levo Nova’. This device was approved in the country of origin, Finland, in 1990 FDA of US issued its approval in the year 2000. It is manufactured by Leiras OY (Turku, Finland), and it is currently on the market for contraceptive use in 88 countries including India. In some country have, it is viewed chiefly for treatment of menorrhagia and as progestin component in postmenopausal hormone replacement therapy.
Mode of Action:
4)    Progesterone hormone released from the device impains upward migration of sperm by increasing cervical mucus viscosity.
5)    Progesterone also cause damage to sperms by causing changes in enzyme present in the womb which facilitates sperm transport from womb to egg-carrying tubes (fallopian tubes).
6)    Additionally LNG-IUS acts locally on the endometrium (inner lining of womb) and cause profound changes the future bed of embryo so that fertilized ova cannot get embedded. Thus in case occasionally union between sperm and ova occur in the usual site i.e. egg carrying tube (fallopian tube). When fertilized ova arrived at womb for nidation or (implantation) it foces adverse environment in womb and unable to get embedded.
In summary LNG-IUS either immboliges sperms or inhibits sperm changes necessary for fertilization. It is not an abortificient even if one considers life beings as soon as fertilization occurs.
Unlike oral pills IUS does not alter ovarian function. Because the amount of progesterone absorbed from womb is minimal too modify normal functioning of ovaries. In fact blood level of progesterone is well below 50% of minipill.

Intrauterine Dwelling Time Duration of Efficacy:
    The device is currently approved for a period of five years and removal should follow thereafter. If a woman desire to continue contraceptive use, the device can be replaced after stipulated five years and a new one fitted immediately after removal of the used device. But recently evidence is fast accumulating that LNG-IUS retains its contraceptive efficacy for seven years. Many trials have affirmed such claim.
     There is evidence that the copper T 380A the most popular brand of IUD has an effective life span of at least 12 years, during which time the pregnancy rate remains very low.
Contraceptive Efficacy:
    LNG-IUS (Mirena a Leva Nova) is a highly effective long-acting, reversible contraceptive associated with a cumulative gross pregnancy rate of 0.0 to 0.5 for 4 or 5 years or with a pearl index (See Page   ) of 0.0 to 0.2 for 7 years. In fact it is so effective contraceptive that it is aptly called ‘reversible sterilization’.

STD Prevention:
    Unlike male or female condom it does not offer great protection against STI. Nevertheless LNG-IUS makes cervical mucus thick and viscid. Thus it offers some resistance to upward progress of organisms responsible for sexually transmitted infection (STI). As it does not completely elements the possibility of acquiring STI. Therefore women who are at risk of STI should be advised to use barrier contraceptive in addition (dual protection).

Advantage as Contraceptives:
5)    Highly effective: Failure rate of only 0-2 per 100 women years.
6)    Minimal hormone related systemic side effects:   The hormone used in LNG-IUS is also used in most contraceptive pills including minipills, and subdermal impalants (implanon). In IUS however, a much lower does is released is body than when one takes contraceptive pills. Further in case of IUS the hormone is deposited directly in the lining of the womb, rather than in the blood stream. Hence progesterone related side effects are less common with IUS.
7)    Makes quality of life better in selected women:  LNG-IUS has a definite edge over copper IUDs as it does away with a number of problems associated with conventional IUDs. For instance LNG-IUS causes light and less painful periods instead of excessive and painful periods as with copper containing devices. It also reduces the amount and duration of monthly period.
8)    Does not alter the ovarian function and other natural hormones of body:  The normal ovarian functions are not disturbed neither the ovulation process is suppressed. This is because during use of the LNG-IUS release of progesterone (Levonorgestrel) is limited to 20mcg 24 hours amount yield to a of progesterone well plasma levels below 0.2mg/ml. The level i.e. minimally required suppress ovulation.
In short LNG-IUS is a reversible method and unrelated to sexual: The best features of this system is its high contraceptive efficacy, reduction in MBL (menstrual blood loss), protection against ascending pelvic infection,a nd minimal interference with ovarian function.

Limitations of contraceptives:
9)    High Cost:
It is good contraceptive for women of developing world because the main non contraceptive benefit of LNG-IUS is decrease in menstrual blood loss. This makes it as the best choice in women with anemia. It is well known that both nutritional anemia and iron deficiency anemia are prevalent in women of developing countries. But unfortunately, women of resource poor countries cannot afford to high cost (Rupees six thousands in Indian currency to purchase LNG-IUS contraceptive.
10)                Irregular bleeding:
The other disadvantage is irregular intermenstrual bleeding or amenorrhoea, neither of which are acceptable in some cultures. Nevertheless continued use of the device greatly diminishes menstrual irregularity. But to achieve this she has to use it at least for six to eight months. Thus the first 4-6 months is crucial and great patience is to be exercised. Continuation for first six months depends chiefly on attitude of the client as well as on good counseling before and after the IUS is fitted.
11)                Must be fitted by a trained doctor:
Unlike copper IUDs this specially designed IUS cannot be inserted by nurses or paramedical personnel. This is simply because the stem of vertical limb of the device is much thicker than most copper containing IUDs. So in most cases insertion will require some dilatation of cervix preferably under short anesthesia. Thus fitting of IUS is technically a bit difficult and only skilled persons can fit the device properly.
12)                Spontaneous expulsion:
This is rarely possible. In such an unfortunate the women gets disappointed. She incurs some financial loss too.
13)                Mal position of IUS:
Through rare but this can occur either during the insertion process or subsequently. It is noteworthy that all IUDs and IUS are susceptible to undergo axial rotation while still remaining inside the womb. This happens due to normal contraception and relaxation of the musculature of womb.
14)                Not all women are suitable for IUS: Role of Pre insertion hysteroscopic evaluation:
There are some women who has some disease of womb e.g. inside partition, small tumors or polyps abuting the inner cavity of womb. They are unsuitable for any intrauterine device. If LNG-IUS is fitted without assessing cavity of womb then there remains faint possibility of having persistently annoying side effects which may last for months together such an event will impede the rising popularity of this IUS. To put in other way not all women are fit for IUS and a pre-insertion evaluation by putting a small endoscope inside the womb to access the inner walls or cavity of womb is desirable though not essential.  In fact hystroscopic agreement is seldom practised and this practice is possibly limited to skeptic doctors only.
15)                Unlike copper bearing IUDs, LNG-IUS cannot be used as postcoital emergency contraception.
16)                Pregnancy can follow if the device is expelled spontaneously without the knowledge of the acceptor. This is again a rare event. In summary, though the LNG-IUS may not replace copper intrauterine devices due to its above quoted limitations and high costs, it could certainly be used as a selective contraceptive method for women who would benefit from it.

Non Contraceptive Benefits:
5)    Makes periods lighter from. Most copper IUDs make a woman’s periods heavier, By contrast the LNG-IUS makes periods lighter than usual. As a matter of fact there may be reduction of blood loss up to 94% after 3 months of use and after 12 months reduction may be up to 96%. Many clients won’t believe this! Because of this, it is frequently used as a treatment for heavy periods, even in women who don’t need contraception.
6)    Helpful in many gynecological disease: LNG-IUS ameliorates many gynecological diseases notably memorhagia, (excessive flow either in amount or duration), dysmenorrhoea (painful periods), endometriosis (collection of menstrual blood in the tummy) and myom (a common begin tumor of womb).
7)    Improves premenstrual syndrome often called PMS.
8)    Reduction of pelvic infection:  The device appears to be protective against pelvic inflammatory disease (PID) because of thickening effect on cervical mucus thus preventing ascending infection. The incidence of pelvic infants disease (PID) with LNG-IUS was found to be 0.8 per 100 woman years as compared to 2.2 with copper IUD.

Ideal Candidate:
    IUS is most appropriate contraceptive method for women with menorrhagia (excessive menstrual bleeding) or who prone to have to iron deficiency anemia. It is also suitable for women who are candidates of thalassaemia or sickle cell disease. It is also suitable for women suffering for dysmenorrhoea and or endometriosis. It is an ideal contraceptive who are candidates with bleeding disorders or an anticoagulation therapy. Breastfeeding women after 4-6 weeks postpartum can use it similarly it can be used in women who are mentally retanded as a long term contraceptive. It is safe for epileptics too. In short it is ideal for women who are mother of one or two children and seek long term contraception but there should not be any anatomical abnormality of womb i.e. cavity distortion.

Side effects and managing the problems:
III.  Menstrual Bleeding Disorders:  After insertion of the LNG-IUS there is often a period of frequent irregular bleeding or spotting during the first 2-3 months. This bleeding although small in quantity may be very frequent or continuous in some women. These episodes can cause considerable discomfort and inconvenience particularly to working women. Interestingly though during first two to four months the number of bleeding/spotting days are increased but the total volume of blood loss is reduced compared with the woman’s normal menstruation. However if the woman is dissatisfied with bleeding pattern then it can be managed by prescribing mefamic acid tablets (e.g. meftal tablet 500mg) 1 tab twice daily for 5 days.
She should be counseled that with increasing duration of use she will develop amenorrhea. The rate of amenorrhea towards the end of the 5 year period of use is around 25 percent. This is of considerable advantage to women who are already anemic. Reassuringly the menstruation returns in these amenorrhoeic women within 30 days of removal of IUS.
IV.   Progesterone related side effects:
Progesterone induced side effects/bloatedness e.g. Breast tenderness, headache, acne and occasionally depression may occur. These symptoms occur only in few women and pass off as the release rate of progesterone from IUS decreases. 3) Spontaneous expulsion of the device. In such an event the women will be unable to feel the thread in the upper part of vagina. 4) Partial expulsion of the device is also rare. This should be suspected if the women complain that she is feeling something hard in the mouth of womb (cervix) or in the upper part of vagina. This may be associated with pain and cramping. On examination HCP can visualize the lower part of the vertical limb of the device in the cervix. Normally no part of the device should be visible. Only the strings should be thus visible. Thus lengthing of the strings or visualization of part of the device are indications that the device has come down and is going to expel in no time. In such situation the device should be removed and a new one fitted.
Wearing Signs:
4)     Persistent irregular bleeding with pelvic pain:  This may mean ‘disturbed uterine pregnancy’ while IUS still remaining inside or it may be due to ectopic pregnancy (0.02 per 100 woman years.).
5)     Pelvic pain alone:      This may be due to pregnancy occurring in fallopian tube (egg transport tube) torsion of small cyst of ovary or acute P.I.D. (pelvic inflammatory disease). Thought 10-12% of IUS users exhibit sonographic evidence of cyst formation but torsion of such small cyst is very rare (1:2000).
6)     Fever and pelvic Pain: This may be due to pelvic inflammatory disease or acquiring fresh STI.

Contraindication:
    Absolute contra-indications are a) known or suspected pregnancy, b) current on recurrent pelvic inflammatory disease, c) lower genital tract infections particularly mucopurullent cervicities. d) postpartum or postabortal endometritis i.e. infection of the womb. e) cervical dysplaria f) known or suspected carcinoma breast g) uterine or cervical malignancy h) leukaemia, i) valcular diseases of heart j) severe arterial disease.
    Additionally women with known disease of uterus where cavity distortion has been substantiated by previous investigations (sonography or hystrography or hystrocopy) then such women should be considered as unsuitable for both IUD and IUS.
    Relative contra-indications are history of previous ectopic pregnancy, thromboembolic disease, history of ovarian cyst. Unlike copper bearing devices LNG-IUS cannot be used as emergency contraceptive.

Health Risks:
4)    Pregnancy occurring all side the womb:        The absolute ectopic pregnancy rate is extremely low with LNG-IUS. The ectopic pregnancy rate of 0.02 per 10 woman years can be compared very favourably with copper T users (0.25 per woman years) and sexually active women not using any contraception (1.2-1.6 per woman years). Nevertheless as LNG-IUS is so effective in preventing intrauterine pregnancy, if a pregnancy does occur with the IUS still remaining in womb then there is a high suspicion of being ectopic. The client should be forewarned about this very rare possibility whenever period is missed and home monitoring of UPT (Urine for pregnancy test) is positive.
5)    Performation of womb:  Occassionally performation of womb can occur particularly when IUS is fitted in early postpartum period when uterus is soft. Like copper IUD performation can be confirmed by sonography and will necessiatate laporoscopic removal of the device under general nesthesia.
6)    Risk caused by systemic absorption of progesterone. The blood level while wearing LNG IUS is 50% less than when women use minipill. Thus of all the hormonal contraceptives adds minimum hormonal level in LNG-IUS blow this minimizes the risk to her health. It is very unlikely that such minimal increase of progesterone hormone in blood will exhibit any adeverse effect on lipid profile or cause arterial changes.

Timing of insertion of IUS:
4)    In regularly menstruating women IUS can be fitted within first six days of commencement of menstrual period. No back up is needed. If IUS is fitted seven days after commencement of period then barrier contraceptive should be advocated for next seven days thus that allowing sufficient time to exert its full contraceptive effect. However insertion may be planned at any other day of cycle if there is no sexual intercourse in that cycle.
5)    Six weeks after normal childbirth and four weeks after induced or spontaneous abortion if there is no clinical evidence of sepsis. Some people however have suggested fitting LNG-IUS as early as seven days after an abortion procedure as soon abortion induced pain and bleeding pass off.
6)    Insertion during lactational ammenohea has been after performed, with great satisfaction of acceptor. It can be done as early as 6 weeks but often carried out 8 weeks after normal childbirth. The use of sounding however is contraindicated during such puerperal insertions because musculature of womb is still soft and may cause perforation of womb. The acceptor may be unnecessarily worried about health of child but the daily amount of LNG excreted in 600ml of breast milk is approximately 0.1% of the intrauterine daily dose. Thus there is interference in the development of the newborn.

Follow Up:
    First follow up visit may be planned one week after insertion and later on monthly basis for first three months. Other after unless there is any complaint no routine follow up is recommended but she should continue to feel the thread after each menstrual period and be satisfied that the device has not silent fallen off the womb.
    The idea of first follow up arranging so soon is to discuss with the woman about bleeding symptoms and if there be any pelvic pain. Additionally she should be encouraged to bear the inconvenient of bleeding for couple of days. These simple encouraging words or even telephonic advice will boost up the moral of client to continue the device in spite of minor sick effects or discomfort.
    At follon up visits she should be enquired about any pelvic pain which may imply either descent of the device or malrotation of the device while still remaining in womb to achieve near 95% continuous rate the caregiver should offer ample opportunity to discuss her concerns about IUS. The staff should be caring, helpful and never dismissive. HCP should never cloud her doubts but should try to clarify the unspoken concerns related to IUS. The duty of HCP is to check her blood pressure and record weight HCP should then perform and interval exception and be satisfied with the visible part of the length of thread though such interval exertion is seldom required in intelligent women. However the continuation rate LNG-IUS is 85% after the end of one year and that of copper IUSs is 78%. At last she should be reminded that LNG-US do not prevent STI and if she considers that there is a possibility of STI. She should insist on barrier contraceptive in addition.

Counseling tips:
    LNG-IUS is usually very well tolerated in women who have received careful counseling about the possibilities of irregular bleeding for first two or three month and subquently amenorrhoea. But poorly counseled women may become concerned and even request removal of the device. Thus before fitting IUS it is desirable that counselor should have an unbiased and unhurried discussion with the acceptor explain pros and cons of IUS. Above all trust and confidence in the care givers is as important as candid discussion on this costly contraceptive. Not only the extensive counseling but successful use of LNG-IUS requires good training of doctors who fit the IUS. In fact acceptance and continuation rate of any contraceptive method are dependent on technical and counseling skills of the providers. Further, management of side effects and due attention to complaints also are important factors for high continuation rate poor selection of users or poor counseling result in unnecessarily high request for removal of device.

Copper being devices Vs. LNG-IUS:
    Which device to choose? The opinion of scientists varies in this regard. The side effects, failure rates, discontinuation rates, spontaneous expulsion rates have been compared by different health institutions. For average women cheaper T Cu 380 is better as it has proven efficacy of long 12 years. But after though counseling if potential acceptor is worried about persistent amenorrhoeic induced by Copper being IUD the LNG-IUS may be a better option. No doubt women with gynecological diseases like dysmenorrheal and endometriosis will opt for LNG-IUS. For interested readers short comparison between the two commonly used devices is mentioned below –

Cu T
LNG-IUS
Cu T
LNG-IUS
Cu T
LNG-IUS
Cost
1-1.4 preg per 100 w years
Do




Failure rate
8.4 per 100 users
11.7




Expulsion the rate
3.6 per 100 users
3.6 per 100 users




PID incidence






Discontinuation rate








Myths & Barriers to LNG-IUS use:
7)    There device promote pelvic infection (P.I.D.) thus may invite infertility. In fact IUS do not promote P.I.D.
8)    The risk ectopic pregnancy is unacceptably high. The reality is that incidence of ectopic pregnancy is considerably less end in LNG users than general population not using contraception.
9)    The device may go to inside tummy. The rate of womb perforation is very rare.
10)                The return of fertility be unduly delayed. This is not true.
11)                It cannot be used in nulliparous women. In fact nulliporous women can use it though introduction i.e. fitting of IUS may be comparatives more difficult.
12)                Women affected with HIV cannot use IUS. IUS can be used in women affected with HIV though it is considered as category 3 risk. But IUS’ is very effective. So it can be used to achieve near 100% prevention of pregnancy. Barrier contraception should be used concomitantly to prevent HIV transmission.
The groing evidence suggest that barrier contraceptive as commonly used do not prevent pregnancy all the time. That is the reason why women suffering from STI should avail dual protection i.e. barrier (to prevent STI) along with some effective contraceptives (to prevent conception).

Take home message:
    The LNG-IUS was marketed in US in the year 1995. It is a highly effective contraceptive method which can be safely used for 5-year period. The release of levonorgestrel (LNG) hormone (progesterone) inside the womb represents a new approach in contraceptive technology as it (hormone) exerts local action thus avoids systemic side effects related to hormone.
    The levonorgestrel releasing intrauterine system (LNG-IUS) continuously release progesterone hormone for at least 5-7 years tus offers an effective ‘estrogen free long-acting, reversible contraceptive. It offers effective protection against ectopic pregnancy and due to its low systemic steroidal dose, any side effects are mild and few. It can be fitted four to six weeks after childbirth. It does not affect production if breast milk neither does it affect growth of infant.
    There are some vices as well. The device is costly and not distributed by Govt. of india nor subsidized by an NGO in resource poor countries.
    Many women do suffer from irregular vaginal bleeding for first few months which may be annoying to them. But after four to six months most will have regular periods and by one year majurity will achieve amenorrhoea i.e. nonoccurrence of monthly periods. Inspite of all thee nuisances LNG-IUS does not predispose to any health risk. Nevertheless LNG-IUS remains the only option for w9omen who intend to have long term reversible contraception (no daily commitment). The other such options are implanon and quarters shots. Subdermal implant ‘Implanon’ which is effective for three years are not readily available in most countries including India. Hopefully this will be available in India by 2010.


********************************************
LNG IUS (Mirena/Leno Nova):
    These IUDs are almost same as copper bearing IUDs except that the vertical limb of the T-shaped plastic frame is so designed that it accomodets a small cylinder of progesterone hormone inside. This progesterone filled cylinder continue to release small amount of progesterone daily inside the womb for five year continuously. The levonorgestrel releasing intrauterine system (LNG-IUS) has now become one of the most effective contraceptive methods available. Additionally this hormonal contraceptive primarily exert its contraceptive action by topical action on womb and there is minimal rise of progesterone hormone in blood. Therefore, LNG-IUS has virtually no systemic hormonal side effect. LNG-IUS thus is a hormonal contraceptive method with the lowest hormonal does to be tolerated by a woman. The common brand names are ‘Mirena’ IUS and Levo Nova the Mirena IUS is like many other types of Intrauterine contraceptive Devices (sometimes located IUCD’s or coils) in that it is lay to be fited by a doctor and remains in the womb for a fixed amount of time, after which it must be changed. It is different, however, in that it is much more effective than usual IUD’s and avoids many of the side effects of copper containing IUDs.
LNG-IUS exerts contraceptive effect at least for five years. Nevertheless it continues to release small amount of progesterone in the fifth and sixth year at a smaller dose i.e. at the rate of 14mcg/day. Even this small dose is sufficient to effects contraception. After seven years, however, the contraceptive efficacy falls markedly. Therefore many scientists now recommended that LNG IUS is effective for seven years. In fact people have tried for seven years and they are satisfied with its contraceptive efficacy in last two years also.
***********************************************************